1	The	DT	O	the	det	4	SENT_1	[p1l672t81r718b102],
2	NEW	NNP	O	NEW	nn	4	SENT_1	[p1l736t83r821b102],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_1	[p1l840t83r1029b102],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_1	[p1l1048t83r1228b109],
5	of	IN	O	of	_	0	SENT_1	[p1l1247t81r1275b108],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_1	[p1l1287t83r1487b102],

1	E	NN	O	e	nn	2	SENT_2	[p1l894t257r922b289],
2	D	NN	O	d	_	0	SENT_2	[p1l937t257r973b289],
3	I	PRP	O	I	dep	2	SENT_2	[p1l987t257r1004b289],
4	T	NN	O	t	nn	6	SENT_2	[p1l1017t257r1049b289],
5	O	NN	O	o	nn	6	SENT_2	[p1l1062t257r1098b290],
6	R	NN	O	r	dep	3	SENT_2	[p1l1112t257r1148b290],
7	I	PRP	O	I	dep	3	SENT_2	[p1l1161t257r1178b289],
8	A	DT	O	a	det	9	SENT_2	[p1l1192t257r1226b289],
9	L	NN	O	l	dep	2	SENT_2	[p1l1241t257r1268b289],

1	$	$	MONEY	$	_	0	SENT_3	[p1l1038t404r1063b427],
2	9	CD	MONEY	9	num	1	SENT_3	[p1l1038t404r1063b427],
3	W	NN	O	w	dep	1	SENT_3	[p1l1092t404r1116b426],
4	51523	CD	NUMBER	51523	number	3	SENT_3	[p1l1012t462r1080b481],
5	13252	CD	NUMBER	13252	number	3	SENT_3	[p1l1094t459r1144b480],
6	*	CD	NUMBER	*	number	3	SENT_3	[p1l1015t488r1035b507],
7	9	CD	NUMBER	9	num	8	SENT_3	[p1l1015t488r1035b507],
8	I92	NN	O	i92	dep	3	SENT_3	[p1l1055t476r1091b506],
9	§	CD	NUMBER	§	number	10	SENT_3	[p1l1120t481r1141b509],
10	’	CD	NUMBER	’	num	11	SENT_3	[p1l1035t507r1047b523],
11	amo	NN	O	amo	dep	3	SENT_3	[p1l1068t503r1129b537],
12	‘	CD	NUMBER	‘	num	13	SENT_3	[p1l1068t503r1129b537],
13	°	NN	O	°	dep	1	SENT_3	[p1l1068t503r1129b537],

1	Molecular	JJ	O	molecular	amod	2	SENT_4	[p1l553t625r815b673],
2	Signatures	NNS	O	signature	_	0	SENT_4	[p1l831t626r1112b688],
3	of	IN	O	of	_	0	SENT_4	[p1l1131t624r1192b673],
4	Lung	NN	O	lung	nn	6	SENT_4	[p1l1202t629r1332b688],
5	Cancer	NN	O	cancer	nn	6	SENT_4	[p1l1348t628r1533b673],
6	—	NN	O	—	prep_of	2	SENT_4	[p1l1547t654r1612b660],

1	Toward	IN	O	toward	mark	2	SENT_5	[p1l687t698r883b747],
2	Personalized	VBN	O	personalize	_	0	SENT_5	[p1l908t698r1238b747],
3	Therapy	NN	O	therapy	dobj	2	SENT_5	[p1l1257t698r1472b762],

1	Roy	NNP	PERSON	Roy	nn	2	SENT_6	[p1l591t783r650b821],
2	S.	NNP	PERSON	S.	_	0	SENT_6	[p1l664t782r692b811],
3	Herbst	NNP	PERSON	Herbst	nn	7	SENT_6	[p1l710t780r832b817],
4	,	,	O	,	_	0	SENT_6	[p1l710t780r832b817],
5	M.D.	NNP	O	M.D.	appos	7	SENT_6	[p1l851t783r942b817],
6	,	,	O	,	_	0	SENT_6	[p1l851t783r942b817],
7	Ph.D.	NNP	O	Ph.D.	dep	2	SENT_6	[p1l960t780r1060b817],
8	,	,	O	,	_	0	SENT_6	[p1l960t780r1060b817],
9	and	CC	O	and	_	0	SENT_6	[p1l1076t780r1136b811],
10	Scott	NNP	PERSON	Scott	nn	11	SENT_6	[p1l1153t782r1238b811],
11	M.	NNP	PERSON	M.	dep	2	SENT_6	[p1l1255t783r1295b811],
12	Lippman	NNP	PERSON	Lippman	nn	14	SENT_6	[p1l1314t783r1471b820],
13	,	,	O	,	_	0	SENT_6	[p1l1314t783r1471b820],
14	M.D.	NNP	O	M.D.	dep	2	SENT_6	[p1l1490t783r1570b811],

1	Lung	NN	O	lung	nn	2	SENT_7	[p1l10t1017r230b1110],
2	cancer	NN	O	cancer	nsubj	6	SENT_7	[p1l263t1035r544b1088],
3	is	VBZ	O	be	cop	6	SENT_7	[p1l575t1010r640b1088],
4	the	DT	O	the	det	6	SENT_7	[p1l678t1009r811b1088],
5	deadliest	JJS	O	deadliest	amod	6	SENT_7	[p1l847t1009r1234b1088],
6	cancer	NN	O	cancer	_	0	SENT_7	[p1l1264t1035r1545b1088],
7	in	IN	O	in	_	0	SENT_7	[p1l1576t1010r1660b1087],
8	the	DT	O	the	det	9	SENT_7	[p1l1695t1009r1827b1088],
9	world	NN	O	world	prep_in	6	SENT_7	[p1l1859t1009r2128b1088],
10	.	.	O	.	_	0	SENT_7	[p1l1859t1009r2128b1088],

1	Relapses	NNS	O	relapse	nsubj	11	SENT_8	[p1l10t1137r384b1238],
2	are	VBP	O	be	cop	3	SENT_8	[p1l419t1163r548b1216],
3	frequent	JJ	O	frequent	_	0	SENT_8	[p1l582t1137r946b1238],
4	after	IN	O	after	_	0	SENT_8	[p1l974t1137r1177b1216],
5	primary	JJ	O	primary	amod	8	SENT_8	[p1l1206t1138r1556b1238],
6	and	CC	O	and	_	0	SENT_8	[p1l1586t1137r1743b1216],
7	adjuvant	JJ	O	adjuvant	conj_and	5	SENT_8	[p1l1776t1137r2139b1238],
8	therapy	NN	O	therapy	prep_after	3	SENT_8	[p1l12t1265r326b1366],
9	and	CC	O	and	_	0	SENT_8	[p1l350t1265r505b1344],
10	often	RB	O	often	advmod	3	SENT_8	[p1l535t1265r751b1344],
11	evolve	VB	O	evolve	conj_and	3	SENT_8	[p1l782t1265r1029b1344],
12	into	IN	O	into	_	0	SENT_8	[p1l1058t1266r1222b1344],
13	lethal	JJ	O	lethal	amod	15	SENT_8	[p1l1253t1265r1488b1344],
14	metastatic	JJ	O	metastatic	amod	15	SENT_8	[p1l1518t1266r1951b1344],
15	disease	NN	O	disease	prep_into	11	SENT_8	[p1l1981t1265r2132b1344, p1l12t1420r210b1472],
16	.	.	O	.	_	0	SENT_8	[p1l1981t1265r2132b1344, p1l12t1420r210b1472],

1	Currently	RB	DATE	currently	advmod	7	SENT_9	[p1l243t1393r649b1494],
2	,	,	O	,	_	0	SENT_9	[p1l243t1393r649b1494],
3	lung	NN	O	lung	nn	4	SENT_9	[p1l681t1393r1177b1494],
4	—	NN	O	—	nsubj	7	SENT_9	[p1l681t1393r1177b1494],
5	cancer	NN	O	cancer	nn	6	SENT_9	[p1l681t1393r1177b1494],
6	staging	NN	O	staging	dep	4	SENT_9	[p1l1202t1394r1513b1494],
7	rests	VBZ	O	rest	_	0	SENT_9	[p1l1537t1410r1729b1472],
8	on	IN	O	on	_	0	SENT_9	[p1l1760t1419r1864b1472],
9	histopathological	JJ	O	histopathological	amod	12	SENT_9	[p1l1891t1393r2132b1472, p1l10t1521r557b1622],
10	and	CC	O	and	_	0	SENT_9	[p1l595t1521r755b1600],
11	clinical	JJ	O	clinical	amod	12	SENT_9	[p1l795t1521r1116b1600],
12	criteria	NNS	O	criterion	prep_on	7	SENT_9	[p1l1156t1522r1469b1600],
13	that	WDT	O	that	nsubj	14	SENT_9	[p1l1507t1521r1683b1600],
14	have	VBP	O	have	rcmod	12	SENT_9	[p1l1717t1521r1910b1600],
15	only	RB	O	only	advmod	17	SENT_9	[p1l1951t1521r2138b1622],
16	limited	JJ	O	limited	amod	17	SENT_9	[p1l11t1649r327b1728],
17	power	NN	O	power	nsubj	19	SENT_9	[p1l376t1675r649b1750],
18	to	TO	O	to	aux	19	SENT_9	[p1l697t1666r780b1728],
19	predict	VB	O	predict	ccomp	14	SENT_9	[p1l830t1649r1144b1750],
20	relapse	NN	O	relapse	dobj	19	SENT_9	[p1l1188t1649r1499b1750],
21	and	CC	O	and	_	0	SENT_9	[p1l1548t1649r1710b1728],
22	survival	NN	O	survival	conj_and	20	SENT_9	[p1l1761t1649r2127b1728],
23	.	.	O	.	_	0	SENT_9	[p1l1761t1649r2127b1728],

1	A	DT	O	a	det	3	SENT_10	[p1l8t1785r74b1855],
2	major	JJ	O	major	amod	3	SENT_10	[p1l106t1778r349b1878],
3	effort	NN	O	effort	nsubj	23	SENT_10	[p1l381t1777r616b1856],
4	to	TO	O	to	aux	5	SENT_10	[p1l645t1794r724b1856],
5	improve	VB	O	improve	infmod	3	SENT_10	[p1l759t1778r1097b1878],
6	the	DT	O	the	det	7	SENT_10	[p1l1131t1777r1261b1856],
7	control	NN	O	control	dobj	5	SENT_10	[p1l1295t1777r1591b1856],
8	of	IN	O	of	_	0	SENT_10	[p1l1625t1777r1724b1856],
9	lung	NN	O	lung	nn	10	SENT_10	[p1l1738t1777r1926b1878],
10	cancer	NN	O	cancer	prep_of	7	SENT_10	[p1l1957t1803r2133b1856, p1l12t1932r136b1984],
11	entails	VBZ	O	entail	_	0	SENT_10	[p1l170t1905r443b1984],
12	the	DT	O	the	det	13	SENT_10	[p1l483t1905r612b1984],
13	use	NN	O	use	dobj	11	SENT_10	[p1l649t1932r786b1984],
14	of	IN	O	of	_	0	SENT_10	[p1l824t1905r922b1984],
15	molecular	JJ	O	molecular	amod	16	SENT_10	[p1l941t1905r1360b1984],
16	proﬁling	NN	O	proﬁling	prep_of	13	SENT_10	[p1l1393t1905r1769b2006],
17	to	TO	O	to	aux	18	SENT_10	[p1l1804t1922r1883b1984],
18	char	VB	O	char	xcomp	11	SENT_10	[p1l1922t1905r2132b1984],
19	—	NN	O	—	nn	21	SENT_10	[p1l1922t1905r2132b1984],
20	acterize	NN	O	acterize	nn	21	SENT_10	[p1l11t2034r329b2112],
21	tumors	NNS	O	tumor	dobj	18	SENT_10	[p1l357t2050r654b2112],
22	and	CC	O	and	_	0	SENT_10	[p1l683t2033r836b2112],
23	provide	VBP	O	provide	conj_and	11	SENT_10	[p1l862t2033r1167b2134],
24	accurate	JJ	O	accurate	amod	25	SENT_10	[p1l1194t2050r1535b2112],
25	predictions	NNS	O	prediction	dobj	23	SENT_10	[p1l1561t2033r2023b2134],
26	of	IN	O	of	_	0	SENT_10	[p1l2054t2033r2152b2112],
27	the	DT	O	the	det	28	SENT_10	[p1l12t2162r140b2241],
28	outcome	NN	O	outcome	prep_of	25	SENT_10	[p1l177t2179r546b2241],
29	after	IN	O	after	_	0	SENT_10	[p1l583t2162r786b2241],
30	standard	JJ	O	standard	amod	33	SENT_10	[p1l822t2162r1200b2241],
31	or	CC	O	or	_	0	SENT_10	[p1l1239t2188r1328b2241],
32	novel	JJ	O	novel	amod	33	SENT_10	[p1l1363t2162r1587b2241],
33	treatments	NNS	O	treatment	prep_after	23	SENT_10	[p1l1625t2179r2113b2241],
34	.	.	O	.	_	0	SENT_10	[p1l1625t2179r2113b2241],

1	Such	JJ	O	such	amod	3	SENT_11	[p1l142t2290r344b2369],
2	molecular	JJ	O	molecular	amod	3	SENT_11	[p1l379t2290r813b2369],
3	studies	NNS	O	study	nsubj	20	SENT_11	[p1l847t2290r1146b2369],
4	of	IN	O	of	_	0	SENT_11	[p1l1185t2290r1284b2369],
5	lung	NN	O	lung	nn	6	SENT_11	[p1l1301t2290r1495b2391],
6	tumors	NNS	O	tumor	prep_of	3	SENT_11	[p1l1528t2307r1835b2369],
7	began	VBD	O	begin	_	0	SENT_11	[p1l1874t2290r2134b2391],
8	with	IN	O	with	_	0	SENT_11	[p1l7t2418r202b2498],
9	single	JJ	O	single	amod	13	SENT_11	[p1l244t2418r502b2519],
10	or	CC	O	or	_	0	SENT_11	[p1l545t2444r634b2497],
11	relatively	RB	O	relatively	advmod	12	SENT_11	[p1l672t2418r1067b2519],
12	small	JJ	O	small	amod	13	SENT_11	[p1l1106t2418r1343b2497],
13	groups	NNS	O	group	prep_with	7	SENT_11	[p1l1384t2444r1685b2519],
14	of	IN	O	of	_	0	SENT_11	[p1l1729t2418r1830b2497],
15	potential	JJ	O	potential	amod	17	SENT_11	[p1l1850t2435r2132b2519, p1l12t2546r154b2625],
16	prognostic	JJ	O	prognostic	amod	17	SENT_11	[p1l190t2547r665b2647],
17	markers	NNS	O	marker	prep_of	13	SENT_11	[p1l702t2546r1059b2626],
18	and	CC	O	and	_	0	SENT_11	[p1l1098t2546r1258b2625],
19	have	VBP	O	have	aux	20	SENT_11	[p1l1296t2546r1489b2625],
20	progressed	VBN	O	progress	conj_and	7	SENT_11	[p1l1526t2546r2010b2647],
21	to	TO	O	to	_	0	SENT_11	[p1l2049t2563r2131b2625],
22	microarray	NN	O	microarray	nn	23	SENT_11	[p1l11t2675r502b2775],
23	analyses	NNS	O	analysis	prep_to	20	SENT_11	[p1l546t2674r919b2775],
24	of	IN	O	of	_	0	SENT_11	[p1l971t2674r1073b2753],
25	thousands	NNS	O	thousand	prep_of	23	SENT_11	[p1l1103t2674r1564b2753],
26	of	IN	O	of	_	0	SENT_11	[p1l1617t2674r1718b2753],
27	genes	NNS	O	gene	prep_of	25	SENT_11	[p1l1748t2700r1997b2775],
28	in	IN	O	in	_	0	SENT_11	[p1l2048t2675r2133b2752],
29	large	JJ	O	large	amod	30	SENT_11	[p1l10t2802r224b2903],
30	numbers	NNS	O	number	prep_in	27	SENT_11	[p1l261t2802r636b2881],
31	of	IN	O	of	_	0	SENT_11	[p1l676t2802r775b2881],
32	tissue	NN	O	tissue	nn	33	SENT_11	[p1l794t2803r1038b2881],
33	samples	NNS	O	sample	prep_of	30	SENT_11	[p1l1076t2802r1441b2903],
34	.	.	O	.	_	0	SENT_11	[p1l1076t2802r1441b2903],

1	In	IN	O	in	dep	8	SENT_12	[p1l1482t2810r1571b2880],
2	this	DT	O	this	det	3	SENT_12	[p1l1609t2802r1767b2881],
3	issue	NN	O	issue	pobj	1	SENT_12	[p1l1805t2803r2014b2881],
4	of	IN	O	of	_	0	SENT_12	[p1l2052t2802r2152b2881],
5	the	DT	O	the	det	6	SENT_12	[p1l12t2930r143b3009],
6	journal	NN	O	journal	prep_of	3	SENT_12	[p1l163t2930r471b3031],
7	,	,	O	,	_	0	SENT_12	[p1l163t2930r471b3031],
8	Chen	NNP	PERSON	Chen	_	0	SENT_12	[p1l512t2930r730b3009],
9	et	FW	O	et	nn	11	SENT_12	[p1l767t2947r843b3009],
10	al.	FW	O	al.	nn	11	SENT_12	[p1l873t2930r969b3009],
11	report	NN	O	report	dep	8	SENT_12	[p1l1010t2947r1275b3031],
12	on	IN	O	on	_	0	SENT_12	[p1l1306t2956r1411b3009],
13	a	DT	O	a	det	14	SENT_12	[p1l1446t2957r1490b3009],
14	study	NN	O	study	prep_on	11	SENT_12	[p1l1526t2930r1754b3031],
15	of	IN	O	of	_	0	SENT_12	[p1l1786t2930r1885b3009],
16	geneexpression	NN	O	geneexpression	nn	17	SENT_12	[p1l1902t2956r2133b3031, p1l12t3059r470b3159],
17	profiling	NN	O	profiling	prep_of	14	SENT_12	[p1l511t3058r914b3159],
18	in	IN	O	in	_	0	SENT_12	[p1l952t3059r1037b3136],
19	the	DT	O	the	det	23	SENT_12	[p1l1080t3058r1216b3137],
20	most	RBS	O	most	advmod	21	SENT_12	[p1l1258t3075r1479b3137],
21	common	JJ	O	common	amod	23	SENT_12	[p1l1517t3084r1905b3137],
22	lung	NN	O	lung	nn	23	SENT_12	[p1l1943t3058r2137b3159],
23	cancer	NN	O	cancer	prep_in	17	SENT_12	[p1l12t3212r310b3282],
24	,	,	O	,	_	0	SENT_12	[p1l12t3212r310b3282],
25	non	JJ	O	non	amod	26	SENT_12	[p1l368t3186r1013b3265],
26	—	JJ	O	—	amod	30	SENT_12	[p1l368t3186r1013b3265],
27	small	JJ	O	small	amod	30	SENT_12	[p1l368t3186r1013b3265],
28	—	NN	O	—	nn	30	SENT_12	[p1l368t3186r1013b3265],
29	cell	NN	O	cell	nn	30	SENT_12	[p1l368t3186r1013b3265],
30	lung	NN	O	lung	appos	8	SENT_12	[p1l1064t3186r1258b3287],
31	cancer	NN	O	cancer	dep	30	SENT_12	[p1l1308t3191r1647b3265],
32	}	CD	NUMBER	}	num	31	SENT_12	[p1l1308t3191r1647b3265],
33	They	PRP	O	they	nsubj	35	SENT_12	[p1l1695t3186r1907b3287],
34	first	RB	ORDINAL	first	advmod	35	SENT_12	[p1l1954t3186r2139b3265],
35	studied	VBD	O	study	rcmod	31	SENT_12	[p1l13t3314r327b3393],
36	a	DT	O	a	det	38	SENT_12	[p1l370t3341r415b3393],
37	DNA	NN	O	dna	nn	38	SENT_12	[p1l456t3321r664b3393],
38	microarray	NN	O	microarray	dobj	35	SENT_12	[p1l705t3315r1178b3415],
39	of	IN	O	of	_	0	SENT_12	[p1l1219t3314r1319b3393],
40	672	CD	NUMBER	672	prep_of	38	SENT_12	[p1l1345t3320r1493b3393],
41	invasion	NN	O	invasion	nn	44	SENT_12	[p1l1538t3315r2132b3393],
42	—	CD	NUMBER	—	num	44	SENT_12	[p1l1538t3315r2132b3393],
43	asso	NN	O	asso	nn	44	SENT_12	[p1l1538t3315r2132b3393],
44	—	NN	O	—	dep	31	SENT_12	[p1l1538t3315r2132b3393],
45	ciated	VBN	O	ciate	partmod	44	SENT_12	[p1l12t3442r256b3521],
46	genes	NNS	O	gene	dobj	45	SENT_12	[p1l312t3468r570b3543],
47	,	,	O	,	_	0	SENT_12	[p1l312t3468r570b3543],
48	which	WDT	O	which	dobj	52	SENT_12	[p1l627t3442r883b3521],
49	they	PRP	O	they	nsubj	52	SENT_12	[p1l939t3442r1118b3543],
50	had	VBD	O	have	aux	52	SENT_12	[p1l1169t3442r1322b3521],
51	previously	RB	DATE	previously	advmod	52	SENT_12	[p1l1377t3442r1802b3543],
52	identified	VBN	O	identify	rcmod	46	SENT_12	[p1l1856t3442r2132b3521, p1l11t3570r201b3666],
53	,	,	O	,	_	0	SENT_12	[p1l1856t3442r2132b3521, p1l11t3570r201b3666],
54	in	IN	O	in	_	0	SENT_12	[p1l239t3571r323b3648],
55	frozen	JJ	O	frozen	amod	56	SENT_12	[p1l356t3570r634b3649],
56	specimens	NNS	O	specimen	prep_in	52	SENT_12	[p1l669t3571r1117b3671],
57	obtained	VBN	O	obtain	partmod	56	SENT_12	[p1l1154t3570r1533b3649],
58	from	IN	O	from	_	0	SENT_12	[p1l1566t3570r1777b3649],
59	a	DT	O	a	det	60	SENT_12	[p1l1810t3597r1854b3649],
60	series	NN	O	series	prep_from	57	SENT_12	[p1l1888t3571r2131b3649],
61	of	IN	O	of	_	0	SENT_12	[p1l12t3698r113b3777],
62	125	CD	NUMBER	125	num	63	SENT_12	[p1l154t3704r304b3777],
63	patients	NNS	O	patient	prep_of	60	SENT_12	[p1l363t3699r712b3799],
64	in	IN	O	in	_	0	SENT_12	[p1l770t3699r855b3776],
65	Taiwan	NNP	LOCATION	Taiwan	prep_in	63	SENT_12	[p1l907t3699r1227b3777],
66	with	IN	O	with	_	0	SENT_12	[p1l1280t3698r1478b3777],
67	surgically	RB	O	surgically	advmod	69	SENT_12	[p1l1536t3698r1965b3799],
68	re	JJ	O	re	amod	69	SENT_12	[p1l2017t3724r2132b3777],
69	—	NN	O	—	prep_with	57	SENT_12	[p1l2017t3724r2132b3777],

1	sected	JJ	O	sected	amod	3	SENT_13	[p2l13t20r273b99],
2	non	JJ	O	non	amod	3	SENT_13	[p2l306t20r930b99],
3	—	NN	O	—	_	0	SENT_13	[p2l306t20r930b99],
4	small	JJ	O	small	amod	8	SENT_13	[p2l306t20r930b99],
5	—	NN	O	—	nn	8	SENT_13	[p2l306t20r930b99],
6	cell	NN	O	cell	nn	8	SENT_13	[p2l306t20r930b99],
7	lung	NN	O	lung	nn	8	SENT_13	[p2l961t20r1150b121],
8	cancer	NN	O	cancer	dep	3	SENT_13	[p2l1180t46r1469b99],
9	.	.	O	.	_	0	SENT_13	[p2l1180t46r1469b99],

1	The	DT	O	the	det	2	SENT_14	[p2l1504t20r1662b99],
2	specimens	NNS	O	specimen	nsubjpass	14	SENT_14	[p2l1696t21r2130b121],
3	represented	VBD	O	represent	_	0	SENT_14	[p2l11t148r505b249],
4	a	DT	O	a	det	5	SENT_14	[p2l541t175r585b227],
5	mixture	NN	O	mixture	dobj	3	SENT_14	[p2l620t149r958b227],
6	of	IN	O	of	_	0	SENT_14	[p2l995t148r1093b227],
7	tumor	NN	O	tumor	nn	8	SENT_14	[p2l1112t165r1378b227],
8	types	NNS	O	type	prep_of	5	SENT_14	[p2l1411t165r1632b249],
9	and	CC	O	and	_	0	SENT_14	[p2l1670t148r1827b227],
10	stages	NNS	O	stage	prep_of	5	SENT_14	[p2l1864t165r2132b249],
11	and	CC	O	and	_	0	SENT_14	[p2l11t276r171b355],
12	were	VBD	O	be	auxpass	14	SENT_14	[p2l214t302r419b355],
13	randomly	RB	O	randomly	advmod	14	SENT_14	[p2l467t276r889b377],
14	divided	VBN	O	divide	conj_and	3	SENT_14	[p2l933t276r1251b355],
15	into	IN	O	into	_	0	SENT_14	[p2l1298t277r1470b355],
16	a	DT	O	a	det	18	SENT_14	[p2l1519t303r1564b355],
17	training	NN	O	training	nn	18	SENT_14	[p2l1610t277r1970b377],
18	set	NN	O	set	prep_into	14	SENT_14	[p2l2016t293r2138b355],
19	and	CC	O	and	_	0	SENT_14	[p2l11t404r171b483],
20	a	DT	O	a	det	22	SENT_14	[p2l205t431r250b483],
21	test	NN	O	test	nn	22	SENT_14	[p2l284t421r442b483],
22	set	NN	O	set	conj_and	18	SENT_14	[p2l474t421r617b483],
23	.	.	O	.	_	0	SENT_14	[p2l474t421r617b483],

1	None	NN	O	none	nsubj	6	SENT_15	[p2l656t412r887b483],
2	of	IN	O	of	_	0	SENT_15	[p2l923t404r1024b483],
3	the	DT	O	the	det	4	SENT_15	[p2l1041t404r1176b483],
4	patients	NNS	O	patient	prep_of	1	SENT_15	[p2l1210t405r1559b505],
5	had	VBD	O	have	aux	6	SENT_15	[p2l1596t404r1755b483],
6	received	VBN	O	receive	_	0	SENT_15	[p2l1790t404r2134b483],
7	adjuvant	JJ	O	adjuvant	amod	8	SENT_15	[p2l11t532r363b633],
8	chemotherapy	NN	O	chemotherapy	dobj	6	SENT_15	[p2l391t532r995b633],
9	.	.	O	.	_	0	SENT_15	[p2l391t532r995b633],

1	Of	IN	O	of	_	0	SENT_16	[p2l1033t532r1152b611],
2	the	DT	O	the	det	5	SENT_16	[p2l1166t532r1296b611],
3	original	JJ	O	original	amod	5	SENT_16	[p2l1329t532r1657b633],
4	672	CD	NUMBER	672	num	5	SENT_16	[p2l1689t538r1835b611],
5	genes	NNS	O	gene	prep_of	10	SENT_16	[p2l1867t558r2128b633],
6	,	,	O	,	_	0	SENT_16	[p2l1867t558r2128b633],
7	Chen	NNP	PERSON	Chen	nsubj	10	SENT_16	[p2l11t660r234b739],
8	et	FW	O	et	nn	9	SENT_16	[p2l291t677r369b739],
9	al.	FW	O	al.	dep	7	SENT_16	[p2l419t660r518b739],
10	identified	VBN	O	identify	_	0	SENT_16	[p2l578t660r1006b739],
11	16	CD	NUMBER	16	dobj	10	SENT_16	[p2l1065t666r1159b739],
12	that	WDT	O	that	nsubj	20	SENT_16	[p2l1217t660r1391b739],
13	correlated	VBD	O	correlate	rcmod	11	SENT_16	[p2l1443t660r1884b739],
14	with	IN	O	with	_	0	SENT_16	[p2l1935t660r2133b739],
15	increased	VBN	O	increase	amod	16	SENT_16	[p2l11t789r407b868],
16	(	NN	O	(	prep_with	13	SENT_16	[p2l444t795r540b881],
17	4	CD	NUMBER	4	num	18	SENT_16	[p2l444t795r540b881],
18	)	CD	NUMBER	)	dep	16	SENT_16	[p2l444t795r540b881],
19	or	CC	O	or	_	0	SENT_16	[p2l579t815r666b868],
20	decreased	VBD	O	decrease	conj_or	13	SENT_16	[p2l696t789r1106b868],
21	(	CD	NUMBER	(	number	22	SENT_16	[p2l1143t795r1293b881],
22	12	CD	NUMBER	12	num	24	SENT_16	[p2l1143t795r1293b881],
23	)	NN	O	)	nn	24	SENT_16	[p2l1143t795r1293b881],
24	survival	NN	O	survival	dobj	20	SENT_16	[p2l1332t789r1674b868],
25	.	.	O	.	_	0	SENT_16	[p2l1332t789r1674b868],

1	This	DT	O	this	det	2	SENT_17	[p2l1708t789r1892b868],
2	work	NN	O	work	nsubj	3	SENT_17	[p2l1922t789r2138b869],
3	permitted	VBD	O	permit	_	0	SENT_17	[p2l10t917r433b1018],
4	them	PRP	O	they	nsubj	6	SENT_17	[p2l470t917r688b996],
5	to	TO	O	to	aux	6	SENT_17	[p2l725t934r807b996],
6	develop	VB	O	develop	xcomp	3	SENT_17	[p2l845t917r1164b1018],
7	a	DT	O	a	det	8	SENT_17	[p2l1202t944r1247b996],
8	score	NN	NUMBER	score	dobj	6	SENT_17	[p2l1283t943r1503b996],
9	that	WDT	O	that	nsubj	10	SENT_17	[p2l1544t917r1716b996],
10	discriminated	VBD	O	discriminate	rcmod	8	SENT_17	[p2l1749t917r2132b996, p2l11t1045r246b1124],
11	between	IN	O	between	_	0	SENT_17	[p2l284t1045r639b1124],
12	patients	NNS	O	patient	prep_between	10	SENT_17	[p2l676t1046r1013b1146],
13	at	IN	O	at	_	0	SENT_17	[p2l1053t1062r1132b1124],
14	high	JJ	O	high	amod	15	SENT_17	[p2l1165t1045r1359b1146],
15	risk	NN	O	risk	prep_at	10	SENT_17	[p2l1397t1045r1560b1125],
16	for	IN	O	for	_	0	SENT_17	[p2l1593t1045r1719b1124],
17	death	NN	O	death	prep_for	15	SENT_17	[p2l1760t1045r2003b1124],
18	or	CC	O	or	_	0	SENT_17	[p2l2046t1071r2137b1124],
19	recurrence	NN	O	recurrence	prep_for	15	SENT_17	[p2l11t1199r456b1252],
20	and	CC	O	and	_	0	SENT_17	[p2l492t1173r647b1252],
21	those	DT	O	those	prep_at	10	SENT_17	[p2l683t1173r909b1252],
22	at	IN	O	at	_	0	SENT_17	[p2l944t1190r1022b1252],
23	low	JJ	O	low	amod	24	SENT_17	[p2l1052t1173r1204b1253],
24	risk	NN	O	risk	prep_at	21	SENT_17	[p2l1236t1173r1413b1253],
25	.	.	O	.	_	0	SENT_17	[p2l1236t1173r1413b1253],

1	Chen	NNP	PERSON	Chen	nsubj	5	SENT_18	[p2l1454t1173r1669b1252],
2	et	FW	O	et	nn	3	SENT_18	[p2l1706t1190r1781b1252],
3	al.	FW	O	al.	dep	1	SENT_18	[p2l1811t1173r1906b1252],
4	then	RB	O	then	advmod	5	SENT_18	[p2l1948t1173r2134b1252],
5	used	VBD	O	use	_	0	SENT_18	[p2l11t1301r212b1380],
6	a	DT	O	a	det	18	SENT_18	[p2l258t1328r303b1380],
7	real	JJ	O	real	amod	18	SENT_18	[p2l349t1301r749b1380],
8	—	NN	O	—	nn	18	SENT_18	[p2l349t1301r749b1380],
9	time	NN	O	time	nn	18	SENT_18	[p2l349t1301r749b1380],
10	reverse	JJ	O	reverse	amod	18	SENT_18	[p2l797t1301r2132b1402],
11	—	NN	O	—	nn	18	SENT_18	[p2l797t1301r2132b1402],
12	transcriptase	NN	O	transcriptase	nn	18	SENT_18	[p2l797t1301r2132b1402],
13	—	CD	NUMBER	—	num	18	SENT_18	[p2l797t1301r2132b1402],
14	polymer	NN	O	polymer	nn	18	SENT_18	[p2l797t1301r2132b1402],
15	—	CD	NUMBER	—	num	18	SENT_18	[p2l797t1301r2132b1402],
16	ase	NN	O	ase	nn	18	SENT_18	[p2l11t1456r141b1508],
17	chain	NN	O	chain	nn	18	SENT_18	[p2l176t1429r406b1508],
18	reaction	NN	O	reaction	nsubj	20	SENT_18	[p2l440t1430r777b1508],
19	(	CD	NUMBER	(	num	20	SENT_18	[p2l817t1435r1194b1521],
20	RT	NN	O	rt	xcomp	5	SENT_18	[p2l817t1435r1194b1521],
21	.	.	O	.	_	0	SENT_18	[p2l817t1435r1194b1521],

1	—	NN	O	—	_	0	SENT_19	[p2l817t1435r1194b1521],
2	.	.	O	.	_	0	SENT_19	[p2l817t1435r1194b1521],

1	PCR	NN	O	pcr	nn	3	SENT_20	[p2l817t1435r1194b1521],
2	)	NN	O	)	nn	3	SENT_20	[p2l817t1435r1194b1521],
3	assay	NN	O	assay	nsubj	5	SENT_20	[p2l1233t1456r1457b1530],
4	to	TO	O	to	aux	5	SENT_20	[p2l1490t1446r1572b1508],
5	confirm	VB	O	confirm	_	0	SENT_20	[p2l1611t1429r1963b1508],
6	the	DT	O	the	det	8	SENT_20	[p2l2000t1429r2133b1508],
7	microarray	NN	O	microarray	nn	8	SENT_20	[p2l11t1558r484b1658],
8	findings	NNS	O	finding	dobj	5	SENT_20	[p2l515t1557r880b1658],
9	in	IN	O	in	_	0	SENT_20	[p2l917t1558r1000b1635],
10	a	DT	O	a	det	11	SENT_20	[p2l1036t1584r1080b1636],
11	subgroup	NN	O	subgroup	prep_in	5	SENT_20	[p2l1115t1557r1525b1658],
12	of	IN	O	of	_	0	SENT_20	[p2l1566t1557r1667b1636],
13	101	CD	NUMBER	101	num	14	SENT_20	[p2l1691t1563r1839b1636],
14	specimens	NNS	O	specimen	prep_of	11	SENT_20	[p2l1880t1558r2132b1658, p2l11t1711r270b1764],
15	.	.	O	.	_	0	SENT_20	[p2l1880t1558r2132b1658, p2l11t1711r270b1764],

1	The	DT	O	the	det	2	SENT_21	[p2l314t1685r478b1764],
2	RT	NN	O	rt	_	0	SENT_21	[p2l518t1691r864b1769],
3	.	.	O	.	_	0	SENT_21	[p2l518t1691r864b1769],

1	—	NN	O	—	_	0	SENT_22	[p2l518t1691r864b1769],
2	.	.	O	.	_	0	SENT_22	[p2l518t1691r864b1769],

1	PCR	NN	O	pcr	nn	2	SENT_23	[p2l518t1691r864b1769],
2	method	NN	O	method	nsubj	3	SENT_23	[p2l895t1685r1235b1764],
3	showed	VBD	O	show	_	0	SENT_23	[p2l1278t1685r1601b1765],
4	that	IN	O	that	complm	8	SENT_23	[p2l1640t1685r1813b1764],
5	survival	NN	O	survival	nsubjpass	8	SENT_23	[p2l1847t1686r2132b1764, p2l11t1813r86b1892],
6	was	VBD	O	be	auxpass	8	SENT_23	[p2l129t1840r294b1893],
7	significantly	RB	O	significantly	advmod	8	SENT_23	[p2l346t1813r904b1914],
8	associated	VBN	O	associate	ccomp	3	SENT_23	[p2l947t1813r1402b1892],
9	(	NN	O	(	nsubj	17	SENT_23	[p2l1455t1814r1568b1904],
10	in	IN	O	in	_	0	SENT_23	[p2l1455t1814r1568b1904],
11	a	DT	O	a	det	13	SENT_23	[p2l1616t1840r1661b1892],
12	recursivepartitioning	VBG	O	recursivepartition	amod	13	SENT_23	[p2l1707t1814r2132b1892, p2l10t1942r519b2042],
13	decision	NN	O	decision	prep_in	9	SENT_23	[p2l559t1941r1089b2020],
14	—	CD	NUMBER	—	num	17	SENT_23	[p2l559t1941r1089b2020],
15	tree	NN	O	tree	nn	17	SENT_23	[p2l559t1941r1089b2020],
16	analysis	NN	O	analysis	nn	17	SENT_23	[p2l1131t1941r1491b2042],
17	)	NN	O	)	xcomp	8	SENT_23	[p2l1131t1941r1491b2042],
18	with	IN	O	with	_	0	SENT_23	[p2l1538t1941r1733b2021],
19	5	CD	NUMBER	5	prep_with	17	SENT_23	[p2l1781t1949r1823b2020],
20	of	IN	O	of	_	0	SENT_23	[p2l1873t1941r1973b2020],
21	the	DT	O	the	det	23	SENT_23	[p2l2001t1941r2133b2020],
22	16	CD	NUMBER	16	num	23	SENT_23	[p2l15t2075r108b2147],
23	genes	NNS	O	gene	prep_of	19	SENT_23	[p2l146t2094r412b2169],
24	.	.	O	.	_	0	SENT_23	[p2l146t2094r412b2169],

1	The	DT	O	the	det	4	SENT_24	[p2l137t2197r297b2276],
2	median	JJ	O	median	amod	4	SENT_24	[p2l331t2197r655b2276],
3	overall	JJ	O	overall	amod	4	SENT_24	[p2l688t2197r973b2276],
4	survival	NN	O	survival	nsubj	22	SENT_24	[p2l1008t2197r1340b2276],
5	was	VBD	O	be	cop	22	SENT_24	[p2l1368t2224r1530b2276],
6	twice	RB	O	twice	advmod	8	SENT_24	[p2l1566t2198r1793b2277],
7	as	RB	O	as	advmod	8	SENT_24	[p2l1826t2224r1911b2276],
8	long	JJ	O	long	advmod	22	SENT_24	[p2l1945t2197r2137b2298],
9	in	IN	O	in	_	0	SENT_24	[p2l11t2326r96b2403],
10	the	DT	O	the	det	14	SENT_24	[p2l135t2325r271b2404],
11	low	JJ	O	low	amod	14	SENT_24	[p2l309t2325r671b2405],
12	—	NN	O	—	nn	14	SENT_24	[p2l309t2325r671b2405],
13	risk	NN	O	risk	nn	14	SENT_24	[p2l309t2325r671b2405],
14	group	NN	O	group	prep_in	8	SENT_24	[p2l706t2351r964b2426],
15	as	IN	O	as	prep	8	SENT_24	[p2l1004t2352r1091b2404],
16	in	IN	O	in	pcomp	15	SENT_24	[p2l1132t2326r1217b2403],
17	the	DT	O	the	det	20	SENT_24	[p2l1256t2325r1392b2404],
18	high	JJ	O	high	amod	20	SENT_24	[p2l1431t2325r1839b2426],
19	—	NN	O	—	nn	20	SENT_24	[p2l1431t2325r1839b2426],
20	risl	NN	O	risl	pobj	16	SENT_24	[p2l1431t2325r1839b2426],
21	<	JJR	O	<	amod	22	SENT_24	[p2l1431t2325r1839b2426],
22	group	NN	O	group	_	0	SENT_24	[p2l1872t2351r2131b2426],
23	(	CD	NUMBER	(	number	24	SENT_24	[p2l16t2458r145b2543],
24	40	CD	DURATION	40	num	25	SENT_24	[p2l16t2458r145b2543],
25	months	NNS	NUMBER	month	tmod	22	SENT_24	[p2l185t2452r517b2530],
26	VS.	NNP	O	VS.	dep	22	SENT_24	[p2l554t2479r665b2531],
27	20	CD	DURATION	20	num	28	SENT_24	[p2l710t2458r811b2530],
28	months	NNS	NUMBER	month	tmod	22	SENT_24	[p2l850t2452r1236b2547],
29	)	RB	O	)	advmod	22	SENT_24	[p2l850t2452r1236b2547],
30	,	,	O	,	_	0	SENT_24	[p2l850t2452r1236b2547],
31	and	CC	O	and	_	0	SENT_24	[p2l1280t2452r1440b2530],
32	there	EX	O	there	expl	33	SENT_24	[p2l1479t2452r1700b2530],
33	was	VBD	O	be	conj_and	22	SENT_24	[p2l1735t2479r1899b2531],
34	even	RB	O	even	advmod	35	SENT_24	[p2l1942t2478r2133b2531],
35	greater	JJR	O	greater	amod	36	SENT_24	[p2l11t2597r323b2681],
36	improvement	NN	O	improvement	nsubj	33	SENT_24	[p2l362t2581r935b2681],
37	in	IN	O	in	_	0	SENT_24	[p2l970t2581r1053b2658],
38	the	DT	O	the	det	40	SENT_24	[p2l1094t2580r1227b2659],
39	median	JJ	O	median	amod	40	SENT_24	[p2l1267t2580r1591b2659],
40	relapse	NN	O	relapse	prep_in	36	SENT_24	[p2l1631t2580r2133b2681],
41	—	CD	NUMBER	—	num	43	SENT_24	[p2l1631t2580r2133b2681],
42	free	JJ	O	free	amod	43	SENT_24	[p2l1631t2580r2133b2681],
43	survival	NN	O	survival	dep	52	SENT_24	[p2l13t2708r345b2788],
44	in	IN	O	in	_	0	SENT_24	[p2l381t2709r465b2786],
45	the	DT	O	the	det	48	SENT_24	[p2l502t2708r635b2787],
46	low	JJ	O	low	amod	48	SENT_24	[p2l672t2708r1022b2788],
47	—	NN	O	—	nn	48	SENT_24	[p2l672t2708r1022b2788],
48	risk	NN	O	risk	prep_in	43	SENT_24	[p2l672t2708r1022b2788],
49	group	NN	O	group	dep	52	SENT_24	[p2l1055t2734r1308b2809],
50	(	CD	NUMBER	(	num	49	SENT_24	[p2l1352t2714r1479b2800],
51	29	CD	DURATION	29	num	52	SENT_24	[p2l1352t2714r1479b2800],
52	months	NNS	NUMBER	month	dep	36	SENT_24	[p2l1518t2708r1845b2787],
53	vs.	CC	O	vs.	prep	52	SENT_24	[p2l1880t2735r1989b2787],
54	13	CD	DURATION	13	num	55	SENT_24	[p2l2036t2714r2130b2787],
55	months	NNS	NUMBER	month	dep	53	SENT_24	[p2l11t2836r397b2928],
56	)	RB	O	)	advmod	33	SENT_24	[p2l11t2836r397b2928],
57	.	.	O	.	_	0	SENT_24	[p2l11t2836r397b2928],

1	The	DT	O	the	det	3	SENT_25	[p2l447t2836r610b2915],
2	clinical	JJ	O	clinical	amod	3	SENT_25	[p2l658t2836r979b2915],
3	significance	NN	O	significance	nsubjpass	8	SENT_25	[p2l1027t2836r1564b2937],
4	of	IN	O	of	_	0	SENT_25	[p2l1613t2836r1714b2915],
5	these	DT	O	these	det	6	SENT_25	[p2l1743t2836r1970b2915],
6	results	NNS	O	result	prep_of	3	SENT_25	[p2l2018t2862r2132b2915, p2l13t2964r210b3043],
7	was	VBD	O	be	auxpass	8	SENT_25	[p2l242t2991r404b3043],
8	strengthened	VBN	O	strengthen	_	0	SENT_25	[p2l443t2964r1011b3065],
9	by	IN	O	by	_	0	SENT_25	[p2l1046t2964r1142b3065],
10	the	DT	O	the	det	11	SENT_25	[p2l1173t2964r1306b3043],
11	results	NNS	O	result	agent	8	SENT_25	[p2l1341t2964r1624b3043],
12	of	IN	O	of	_	0	SENT_25	[p2l1662t2964r1761b3043],
13	an	DT	O	a	det	15	SENT_25	[p2l1777t2990r1880b3043],
14	independent	JJ	O	independent	amod	15	SENT_25	[p2l1914t2964r2132b3043, p2l10t3092r360b3193],
15	validation	NN	O	validation	prep_of	11	SENT_25	[p2l394t3092r824b3171],
16	involving	VBG	O	involve	_	0	SENT_25	[p2l866t3092r1263b3193],
17	60	CD	NUMBER	60	num	18	SENT_25	[p2l1304t3098r1404b3171],
18	patients	NNS	O	patient	prep_involving	15	SENT_25	[p2l1448t3093r1789b3193],
19	treated	VBN	O	treat	partmod	18	SENT_25	[p2l1835t3092r2134b3171],
20	at	IN	O	at	_	0	SENT_25	[p2l11t3237r88b3299],
21	the	DT	O	the	det	23	SENT_25	[p2l119t3220r250b3299],
22	same	JJ	O	same	amod	23	SENT_25	[p2l287t3246r504b3299],
23	hospital	NN	O	hospital	prep_at	19	SENT_25	[p2l540t3220r901b3321],
24	.	.	O	.	_	0	SENT_25	[p2l540t3220r901b3321],

1	The	DT	O	the	det	2	SENT_26	[p2l938t3220r1097b3299],
2	stage	NN	O	stage	nsubj	12	SENT_26	[p2l1135t3237r1350b3321],
3	of	IN	O	of	_	0	SENT_26	[p2l1387t3220r1485b3299],
4	non	JJ	O	non	amod	10	SENT_26	[p2l1502t3220r2134b3299],
5	—	JJ	O	—	amod	10	SENT_26	[p2l1502t3220r2134b3299],
6	small	JJ	O	small	amod	10	SENT_26	[p2l1502t3220r2134b3299],
7	—	NN	O	—	nn	10	SENT_26	[p2l1502t3220r2134b3299],
8	cell	NN	O	cell	nn	10	SENT_26	[p2l1502t3220r2134b3299],
9	lung	NN	O	lung	nn	10	SENT_26	[p2l10t3348r206b3449],
10	cancer	NN	O	cancer	prep_of	2	SENT_26	[p2l244t3374r533b3427],
11	also	RB	O	also	advmod	12	SENT_26	[p2l571t3348r747b3427],
12	predicted	VBD	O	predict	_	0	SENT_26	[p2l788t3348r1204b3449],
13	survival	NN	O	survival	dobj	12	SENT_26	[p2l1246t3348r1590b3427],
14	in	IN	O	in	_	0	SENT_26	[p2l1629t3349r1714b3426],
15	all	DT	O	all	predet	17	SENT_26	[p2l1754t3348r1863b3427],
16	these	DT	O	these	det	17	SENT_26	[p2l1903t3348r2133b3427],
17	analyses	NNS	O	analysis	prep_in	12	SENT_26	[p2l11t3476r403b3577],
18	,	,	O	,	_	0	SENT_26	[p2l11t3476r403b3577],
19	but	CC	O	but	_	0	SENT_26	[p2l448t3476r590b3555],
20	the	DT	O	the	det	24	SENT_26	[p2l625t3476r759b3555],
21	five	CD	NUMBER	five	num	24	SENT_26	[p2l798t3476r1198b3577],
22	—	NN	O	—	nn	24	SENT_26	[p2l798t3476r1198b3577],
23	gene	NN	O	gene	nn	24	SENT_26	[p2l798t3476r1198b3577],
24	signature	NN	O	signature	nsubj	26	SENT_26	[p2l1238t3477r1649b3577],
25	was	VBD	O	be	cop	26	SENT_26	[p2l1684t3503r1848b3555],
26	effective	JJ	O	effective	conj_but	12	SENT_26	[p2l1890t3476r2132b3555, p2l12t3605r162b3683],
27	in	IN	O	in	_	0	SENT_26	[p2l203t3605r287b3682],
28	predicting	VBG	O	predict	prepc_in	26	SENT_26	[p2l326t3604r773b3705],
29	outcome	NN	O	outcome	dobj	28	SENT_26	[p2l810t3621r1178b3683],
30	within	IN	O	within	_	0	SENT_26	[p2l1214t3604r1499b3683],
31	subgroups	NNS	O	subgroup	prep_within	28	SENT_26	[p2l1539t3604r1985b3705],
32	—	IN	O	—	prep	28	SENT_26	[p2l2023t3649r2137b3657],

1	for	IN	O	for	dep	4	SENT_27	[p3l11t20r131b99],
2	example	NN	O	example	pobj	1	SENT_27	[p3l159t20r526b121],
3	,	,	O	,	_	0	SENT_27	[p3l159t20r526b121],
4	patients	NNS	O	patient	_	0	SENT_27	[p3l560t21r890b121],
5	with	IN	O	with	_	0	SENT_27	[p3l918t20r1108b99],
6	stage	NN	O	stage	nn	8	SENT_27	[p3l1139t37r1353b121],
7	I	CD	NUMBER	i	num	8	SENT_27	[p3l1382t28r1412b98],
8	cancer	NN	O	cancer	prep_with	4	SENT_27	[p3l1442t46r1714b99],
9	(	CD	NUMBER	(	num	10	SENT_27	[p3l1746t26r2128b112],
10	P	NN	O	p	dep	8	SENT_27	[p3l1746t26r2128b112],
11	=	JJ	O	=	amod	13	SENT_27	[p3l1746t26r2128b112],
12	0.02	CD	NUMBER	0.02	tmod	11	SENT_27	[p3l1746t26r2128b112],
13	)	NN	O	)	dep	10	SENT_27	[p3l1746t26r2128b112],
14	.	.	O	.	_	0	SENT_27	[p3l1746t26r2128b112],

1	The	DT	O	the	det	2	SENT_28	[p3l8t148r167b227],
2	signature	NN	O	signature	nsubj	4	SENT_28	[p3l202t149r592b249],
3	was	VBD	O	be	cop	4	SENT_28	[p3l621t175r780b228],
4	further	JJ	O	further	_	0	SENT_28	[p3l816t148r1115b227],
5	veriﬁed	VBN	O	veriﬁed	partmod	4	SENT_28	[p3l1141t148r1458b227],
6	in	IN	O	in	_	0	SENT_28	[p3l1490t149r1572b226],
7	a	DT	O	a	det	8	SENT_28	[p3l1605t175r1649b227],
8	set	NN	O	set	prep_in	5	SENT_28	[p3l1682t165r1799b227],
9	of	IN	O	of	_	0	SENT_28	[p3l1828t148r1926b227],
10	published	VBN	O	publish	amod	12	SENT_28	[p3l1939t148r2132b249, p3l10t276r259b355],
11	microarray	NN	O	microarray	nn	12	SENT_28	[p3l291t277r750b377],
12	data	NNS	O	datum	prep_of	8	SENT_28	[p3l778t276r956b355],
13	from	IN	O	from	_	0	SENT_28	[p3l987t276r1191b355],
14	86	CD	NUMBER	86	num	15	SENT_28	[p3l1224t282r1322b355],
15	patients	NNS	O	patient	prep_from	12	SENT_28	[p3l1353t277r1684b377],
16	in	IN	O	in	_	0	SENT_28	[p3l1717t277r1799b354],
17	a	DT	O	a	det	19	SENT_28	[p3l1830t303r1874b355],
18	Western	JJ	MISC	western	amod	19	SENT_28	[p3l1901t284r2131b355, p3l12t430r150b483],
19	population	NN	O	population	prep_in	15	SENT_28	[p3l192t404r686b505],
20	.	.	O	.	_	0	SENT_28	[p3l192t404r686b505],

1	In	IN	O	in	_	0	SENT_29	[p3l733t412r822b482],
2	summary	NN	O	summary	prep_in	10	SENT_29	[p3l867t430r1292b505],
3	,	,	O	,	_	0	SENT_29	[p3l867t430r1292b505],
4	this	DT	O	this	det	8	SENT_29	[p3l1341t404r1501b483],
5	five	CD	NUMBER	five	num	8	SENT_29	[p3l1546t404r1936b505],
6	—	NN	O	—	nn	8	SENT_29	[p3l1546t404r1936b505],
7	gene	NN	O	gene	nn	8	SENT_29	[p3l1546t404r1936b505],
8	signature	NN	O	signature	nsubjpass	10	SENT_29	[p3l1981t405r2132b505, p3l11t549r288b611],
9	was	VBD	O	be	auxpass	10	SENT_29	[p3l316t559r478b612],
10	found	VBN	O	find	_	0	SENT_29	[p3l513t532r766b611],
11	to	TO	O	to	aux	15	SENT_29	[p3l798t549r879b611],
12	be	VB	O	be	cop	15	SENT_29	[p3l914t532r1009b611],
13	an	DT	O	a	det	15	SENT_29	[p3l1042t558r1145b611],
14	independent	JJ	O	independent	amod	15	SENT_29	[p3l1176t532r1715b633],
15	predictor	NN	O	predictor	xcomp	10	SENT_29	[p3l1740t532r2137b633],
16	of	IN	O	of	_	0	SENT_29	[p3l12t660r110b739],
17	recurrence	NN	O	recurrence	nn	20	SENT_29	[p3l129t686r570b739],
18	and	CC	O	and	_	0	SENT_29	[p3l607t660r762b739],
19	overall	JJ	O	overall	nn	20	SENT_29	[p3l799t660r1075b739],
20	survival	NN	O	survival	prep_of	15	SENT_29	[p3l1114t660r1434b739],
21	in	IN	O	in	_	0	SENT_29	[p3l1470t661r1552b738],
22	three	CD	NUMBER	three	num	23	SENT_29	[p3l1590t660r1803b739],
23	groups	NNS	O	group	prep_in	20	SENT_29	[p3l1841t686r2131b761],
24	of	IN	O	of	_	0	SENT_29	[p3l12t788r112b867],
25	patients	NNS	O	patient	prep_of	23	SENT_29	[p3l128t789r469b889],
26	with	IN	O	with	_	0	SENT_29	[p3l502t788r698b867],
27	non	JJ	O	non	amod	33	SENT_29	[p3l733t788r1378b867],
28	—	JJ	O	—	amod	33	SENT_29	[p3l733t788r1378b867],
29	small	JJ	O	small	amod	33	SENT_29	[p3l733t788r1378b867],
30	—	NN	O	—	nn	33	SENT_29	[p3l733t788r1378b867],
31	cell	NN	O	cell	nn	33	SENT_29	[p3l733t788r1378b867],
32	lung	NN	O	lung	nn	33	SENT_29	[p3l1413t788r1607b889],
33	cancer	NN	O	cancer	prep_with	25	SENT_29	[p3l1640t814r1921b867],
34	who	WP	O	who	nsubjpass	36	SENT_29	[p3l1949t788r2132b867],
35	were	VBD	O	be	auxpass	36	SENT_29	[p3l7t942r208b996],
36	treated	VBN	O	treat	rcmod	15	SENT_29	[p3l253t916r551b995],
37	only	RB	O	only	advmod	36	SENT_29	[p3l595t916r780b1017],
38	with	IN	O	with	_	0	SENT_29	[p3l814t916r1009b995],
39	surgical	JJ	O	surgical	amod	40	SENT_29	[p3l1055t916r1396b1017],
40	resection	NN	O	resection	prep_with	36	SENT_29	[p3l1440t917r1831b995],
41	of	IN	O	of	_	0	SENT_29	[p3l1875t916r1975b995],
42	the	DT	O	the	det	43	SENT_29	[p3l2001t916r2133b995],
43	tumor	NN	O	tumor	prep_of	40	SENT_29	[p3l12t1035r297b1097],
44	.	.	O	.	_	0	SENT_29	[p3l12t1035r297b1097],

1	This	DT	O	this	det	2	SENT_30	[p3l137t1146r322b1225],
2	study	NN	O	study	nsubj	3	SENT_30	[p3l381t1146r614b1247],
3	produced	VBD	O	produce	_	0	SENT_30	[p3l668t1146r1077b1247],
4	robust	JJ	O	robust	amod	7	SENT_30	[p3l1137t1146r1440b1242],
5	,	,	O	,	_	0	SENT_30	[p3l1137t1146r1440b1242],
6	promising	JJ	O	promising	amod	7	SENT_30	[p3l1503t1147r1961b1247],
7	results	NNS	O	result	dobj	3	SENT_30	[p3l2018t1172r2132b1225, p3l13t1274r239b1370],
8	,	,	O	,	_	0	SENT_30	[p3l2018t1172r2132b1225, p3l13t1274r239b1370],
9	but	CC	O	but	_	0	SENT_30	[p3l284t1274r426b1353],
10	it	PRP	O	it	nsubj	12	SENT_30	[p3l460t1275r519b1353],
11	also	RB	O	also	advmod	12	SENT_30	[p3l553t1274r727b1353],
12	raises	VBZ	O	raise	conj_but	3	SENT_30	[p3l767t1275r1017b1353],
13	several	JJ	O	several	amod	14	SENT_30	[p3l1059t1274r1358b1353],
14	questions	NNS	O	question	dobj	12	SENT_30	[p3l1396t1275r1841b1375],
15	.	.	O	.	_	0	SENT_30	[p3l1396t1275r1841b1375],

1	Given	VBN	O	give	dep	24	SENT_31	[p3l1885t1275r2133b1353],
2	that	IN	O	that	complm	5	SENT_31	[p3l12t1402r187b1481],
3	tumors	NNS	O	tumor	nsubj	5	SENT_31	[p3l223t1419r536b1481],
4	are	VBP	O	be	cop	5	SENT_31	[p3l578t1429r710b1481],
5	heterogeneous	JJ	O	heterogeneous	pcomp	1	SENT_31	[p3l751t1402r1390b1503],
6	and	CC	O	and	_	0	SENT_31	[p3l1432t1402r1592b1481],
7	that	IN	O	that	complm	18	SENT_31	[p3l1633t1402r1809b1481],
8	the	DT	O	the	det	10	SENT_31	[p3l1845t1402r1980b1481],
9	biopsy	NN	O	biopsy	nn	10	SENT_31	[p3l2022t1402r2132b1481, p3l12t1556r212b1631],
10	specimens	NNS	O	specimen	nsubjpass	18	SENT_31	[p3l262t1531r719b1631],
11	used	VBN	O	use	partmod	10	SENT_31	[p3l775t1530r975b1609],
12	by	IN	O	by	_	0	SENT_31	[p3l1030t1530r1128b1631],
13	Chen	NNP	PERSON	Chen	agent	11	SENT_31	[p3l1177t1530r1399b1609],
14	et	FW	O	et	nn	15	SENT_31	[p3l1454t1547r1533b1609],
15	al.	FW	O	al.	dobj	11	SENT_31	[p3l1580t1530r1680b1609],
16	were	VBD	O	be	auxpass	18	SENT_31	[p3l1734t1556r1939b1609],
17	not	RB	O	not	neg	18	SENT_31	[p3l1993t1547r2138b1609],
18	microdissected	VBN	O	microdissect	pcomp	1	SENT_31	[p3l11t1658r702b1754],
19	,	,	O	,	_	0	SENT_31	[p3l11t1658r702b1754],
20	the	DT	O	the	det	21	SENT_31	[p3l753t1658r888b1737],
21	analysis	NN	O	analysis	nsubj	26	SENT_31	[p3l932t1658r1279b1759],
22	could	MD	O	could	aux	24	SENT_31	[p3l1327t1658r1565b1737],
23	have	VB	O	have	aux	24	SENT_31	[p3l1610t1658r1803b1737],
24	underestimated	VBN	O	underestimate	_	0	SENT_31	[p3l1847t1658r2132b1737, p3l12t1786r442b1865],
25	or	CC	O	or	_	0	SENT_31	[p3l496t1812r585b1865],
26	overestimated	VBN	O	overestimate	conj_or	24	SENT_31	[p3l635t1786r1251b1865],
27	the	DT	O	the	det	28	SENT_31	[p3l1303t1786r1439b1865],
28	importance	NN	O	importance	dobj	26	SENT_31	[p3l1491t1787r1997b1887],
29	of	IN	O	of	_	0	SENT_31	[p3l2051t1786r2152b1865],
30	invasion	NN	O	invasion	nn	33	SENT_31	[p3l11t1914r673b1993],
31	—	NN	O	—	nn	33	SENT_31	[p3l11t1914r673b1993],
32	related	JJ	O	related	amod	33	SENT_31	[p3l11t1914r673b1993],
33	genes	NNS	O	gene	prep_of	28	SENT_31	[p3l714t1940r972b2015],
34	,	,	O	,	_	0	SENT_31	[p3l714t1940r972b2015],
35	which	WDT	O	which	nsubj	37	SENT_31	[p3l1015t1914r1271b1993],
36	can	MD	O	can	aux	37	SENT_31	[p3l1314t1940r1460b1993],
37	vary	VB	O	vary	rcmod	28	SENT_31	[p3l1497t1940r1674b2015],
38	in	IN	O	in	_	0	SENT_31	[p3l1711t1915r1792b1992],
39	eXpres	NNS	O	expre	prep_in	37	SENT_31	[p3l1835t1940r2132b2015],
40	—	CD	NUMBER	—	num	41	SENT_31	[p3l1835t1940r2132b2015],
41	sion	NN	O	sion	dobj	24	SENT_31	[p3l13t2043r190b2121],
42	throughout	IN	O	throughout	_	0	SENT_31	[p3l232t2042r736b2143],
43	a	DT	O	a	det	44	SENT_31	[p3l768t2069r812b2121],
44	tumor	NN	O	tumor	prep_throughout	24	SENT_31	[p3l849t2059r1136b2121],
45	.	.	O	.	_	0	SENT_31	[p3l849t2059r1136b2121],

1	Furthermore	RB	O	furthermore	advmod	12	SENT_32	[p3l1178t2042r1751b2138],
2	,	,	O	,	_	0	SENT_32	[p3l1178t2042r1751b2138],
3	molecular	JJ	O	molecular	amod	10	SENT_32	[p3l1794t2042r2132b2121, p3l10t2170r124b2249],
4	epidemiologic	JJ	O	epidemiologic	amod	10	SENT_32	[p3l172t2170r788b2271],
5	,	,	O	,	_	0	SENT_32	[p3l172t2170r788b2271],
6	stromal	JJ	O	stromal	conj_and	4	SENT_32	[p3l845t2170r1191b2266],
7	,	,	O	,	_	0	SENT_32	[p3l845t2170r1191b2266],
8	and	CC	O	and	_	0	SENT_32	[p3l1246t2170r1402b2249],
9	vascular	JJ	O	vascular	conj_and	4	SENT_32	[p3l1448t2170r1797b2249],
10	factors	NNS	O	factor	nsubj	12	SENT_32	[p3l1845t2170r2131b2249],
11	are	VBP	O	be	cop	12	SENT_32	[p3l11t2324r143b2377],
12	critical	JJ	O	critical	_	0	SENT_32	[p3l180t2298r487b2377],
13	to	TO	O	to	_	0	SENT_32	[p3l522t2315r605b2377],
14	the	DT	O	the	det	16	SENT_32	[p3l643t2298r778b2377],
15	metastatic	JJ	O	metastatic	amod	16	SENT_32	[p3l814t2299r1275b2377],
16	process	NN	O	process	prep_to	12	SENT_32	[p3l1309t2324r1667b2399],
17	,	,	O	,	_	0	SENT_32	[p3l1309t2324r1667b2399],
18	and	CC	O	and	_	0	SENT_32	[p3l1708t2298r1869b2377],
19	these	DT	O	these	det	20	SENT_32	[p3l1905t2298r2133b2377],
20	elements	NNS	O	element	nsubjpass	24	SENT_32	[p3l12t2426r392b2505],
21	were	VBD	O	be	auxpass	24	SENT_32	[p3l439t2452r640b2505],
22	not	RB	O	not	neg	24	SENT_32	[p3l690t2443r833b2505],
23	specifically	RB	O	specifically	advmod	24	SENT_32	[p3l879t2426r1366b2527],
24	analyzed	VBN	O	analyze	conj_and	12	SENT_32	[p3l1410t2426r1790b2527],
25	in	IN	O	in	_	0	SENT_32	[p3l1838t2427r1922b2504],
26	this	DT	O	this	det	27	SENT_32	[p3l1971t2426r2131b2505],
27	study	NN	O	study	prep_in	24	SENT_32	[p3l13t2554r297b2655],
28	?	.	O	?	_	0	SENT_32	[p3l13t2554r297b2655],

1	The	DT	O	the	det	3	SENT_33	[p3l336t2554r497b2633],
2	statistical	JJ	O	statistical	amod	3	SENT_33	[p3l541t2554r957b2633],
3	design	NN	O	design	nsubj	6	SENT_33	[p3l1000t2554r1281b2655],
4	can	MD	O	can	aux	6	SENT_33	[p3l1324t2580r1473b2633],
5	also	RB	O	also	advmod	6	SENT_33	[p3l1515t2554r1685b2633],
6	influence	VB	O	influence	_	0	SENT_33	[p3l1729t2554r2133b2633],

1	76	CD	NUMBER	76	num	4	SENT_34	[p3l149t2730r186b2753],
2	N	NN	O	n	nn	4	SENT_34	[p3l917t2741r931b2756],
3	ENGLJ	NN	O	englj	nn	4	SENT_34	[p3l946t2741r1024b2763],
4	MED	NN	O	med	_	0	SENT_34	[p3l1038t2741r1090b2756],
5	356	CD	NUMBER	356	dep	4	SENT_34	[p3l1101t2735r1158b2763],
6	;	:	O	;	_	0	SENT_34	[p3l1101t2735r1158b2763],
7	1	CD	NUMBER	1	num	8	SENT_34	[p3l1101t2735r1158b2763],
8	WWW	NNP	O	WWW	dep	4	SENT_34	[p3l1194t2741r1301b2757],
9	,	,	O	,	_	0	SENT_34	[p3l1194t2741r1301b2757],
10	NE	NN	O	ne	nn	12	SENT_34	[p3l1194t2741r1301b2757],
11	M.ORG	NN	O	m.org	nn	12	SENT_34	[p3l1316t2741r1395b2757],
12	JANUARY4	NN	O	january4	appos	8	SENT_34	[p3l1426t2741r1569b2763],
13	,	,	O	,	_	0	SENT_34	[p3l1426t2741r1569b2763],
14	2007	CD	DATE	2007	appos	8	SENT_34	[p3l1580t2741r1643b2762],

1	The	DT	O	the	det	5	SENT_35	[p3l936t2774r987b2798],
2	New	NNP	O	New	nn	5	SENT_35	[p3l996t2775r1058b2798],
3	England	NNP	O	England	nn	5	SENT_35	[p3l1067t2774r1178b2805],
4	Journal	NNP	O	Journal	nn	5	SENT_35	[p3l1187t2774r1284b2798],
5	o	NN	O	o	_	0	SENT_35	[p3l1294t2782r1309b2798],
6	edicine	NN	O	edicine	dep	5	SENT_35	[p3l1360t2774r1455b2798],

1	Downloaded	VBN	O	download	_	0	SENT_36	[p3l378t2815r548b2838],
2	from	IN	O	from	_	0	SENT_36	[p3l557t2815r621b2838],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_36	[p3l630t2815r748b2845],
4	at	IN	O	at	_	0	SENT_36	[p3l759t2819r782b2838],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_36	[p3l790t2815r973b2838],
6	on	IN	O	on	_	0	SENT_36	[p3l982t2822r1015b2838],
7	Janu	NNP	DATE	Janu	prep_on	1	SENT_36	[p3l1023t2815r1084b2838],
8	5	CD	DATE	5	num	7	SENT_36	[p3l1136t2815r1159b2842],
9	,	,	DATE	,	_	0	SENT_36	[p3l1136t2815r1159b2842],
10	2014	CD	DATE	2014	num	7	SENT_36	[p3l1170t2815r1242b2838],
11	.	.	O	.	_	0	SENT_36	[p3l1170t2815r1242b2838],

1	For	IN	O	for	_	0	SENT_37	[p3l1252t2815r1299b2838],
2	personal	JJ	O	personal	amod	3	SENT_37	[p3l1307t2815r1419b2845],
3	use	NN	O	use	pobj	1	SENT_37	[p3l1428t2822r1472b2838],
4	only	RB	O	only	advmod	3	SENT_37	[p3l1482t2815r1546b2845],
5	.	.	O	.	_	0	SENT_37	[p3l1482t2815r1546b2845],

1	No	DT	O	no	det	3	SENT_38	[p3l1557t2815r1597b2838],
2	other	JJ	O	other	amod	3	SENT_38	[p3l1607t2815r1675b2838],
3	uses	NNS	O	use	_	0	SENT_38	[p3l1683t2822r1739b2838],
4	without	IN	O	without	_	0	SENT_38	[p3l1749t2815r1850b2838],
5	permission	NN	O	permission	prep_without	3	SENT_38	[p3l1859t2815r2011b2845],
6	.	.	O	.	_	0	SENT_38	[p3l1859t2815r2011b2845],

1	Copyright	NN	O	copyright	nsubj	6	SENT_39	[p3l728t2856r863b2887],
2	©	CD	NUMBER	©	num	1	SENT_39	[p3l872t2856r896b2880],
3	2007	CD	DATE	2007	num	5	SENT_39	[p3l906t2856r970b2880],
4	Massa	NNP	PERSON	Massa	nn	5	SENT_39	[p3l980t2857r1065b2880],
5	u	NN	O	u	dep	1	SENT_39	[p3l1097t2864r1113b2880],
6	etts	VBZ	O	ett	_	0	SENT_39	[p3l1127t2860r1171b2880],
7	Medical	NNP	ORGANIZATION	Medical	nn	8	SENT_39	[p3l1181t2856r1289b2880],
8	Society	NNP	ORGANIZATION	Society	dobj	6	SENT_39	[p3l1300t2856r1405b2887],
9	.	.	O	.	_	0	SENT_39	[p3l1300t2856r1405b2887],

1	All	DT	O	all	det	2	SENT_40	[p3l1416t2856r1457b2880],
2	rights	NNS	O	rights	nsubj	3	SENT_40	[p3l1466t2856r1541b2887],
3	reserved	VBN	O	reserve	_	0	SENT_40	[p3l1551t2856r1670b2880],
4	.	.	O	.	_	0	SENT_40	[p3l1551t2856r1670b2880],

1	EDITORIAL	NN	O	editorial	_	0	SENT_41	[p3l991t2962r1169b2981],

1	the	DT	O	the	det	2	SENT_42	[p3l12t3175r145b3254],
2	selection	NN	O	selection	nsubj	17	SENT_42	[p3l198t3175r576b3254],
3	of	IN	O	of	_	0	SENT_42	[p3l628t3175r728b3254],
4	a	DT	O	a	det	5	SENT_42	[p3l760t3202r804b3254],
5	signature	NN	O	signature	prep_of	2	SENT_42	[p3l855t3176r1282b3276],
6	,	,	O	,	_	0	SENT_42	[p3l855t3176r1282b3276],
7	and	CC	O	and	_	0	SENT_42	[p3l1338t3175r1496b3254],
8	the	DT	O	the	det	9	SENT_42	[p3l1547t3175r1679b3254],
9	choice	NN	O	choice	conj_and	5	SENT_42	[p3l1731t3175r2000b3254],
10	of	IN	O	of	_	0	SENT_42	[p3l2052t3175r2152b3254],
11	the	DT	O	the	det	12	SENT_42	[p3l12t3303r141b3382],
12	cutoff	NN	O	cutoff	prep_of	9	SENT_42	[p3l194t3303r458b3382],
13	of	IN	O	of	_	0	SENT_42	[p3l492t3303r590b3382],
14	expression	NN	O	expression	nn	15	SENT_42	[p3l625t3304r1066b3404],
15	levels	NNS	O	level	prep_of	12	SENT_42	[p3l1117t3303r1340b3382],
16	surely	RB	O	surely	advmod	17	SENT_42	[p3l1396t3303r1641b3404],
17	influenced	VBD	O	influence	_	0	SENT_42	[p3l1688t3303r2134b3382],
18	how	WRB	O	how	advmod	24	SENT_42	[p3l12t3431r193b3510],
19	the	DT	O	the	det	22	SENT_42	[p3l225t3431r354b3510],
20	original	JJ	O	original	amod	22	SENT_42	[p3l391t3431r720b3532],
21	672	CD	NUMBER	672	num	22	SENT_42	[p3l756t3437r901b3510],
22	genes	NNS	O	gene	nsubjpass	24	SENT_42	[p3l938t3457r1172b3532],
23	were	VBD	O	be	auxpass	24	SENT_42	[p3l1206t3458r1403b3510],
24	selected	VBN	O	select	ccomp	17	SENT_42	[p3l1441t3431r1791b3510],
25	.	.	O	.	_	0	SENT_42	[p3l1441t3431r1791b3510],

1	The	DT	O	the	det	2	SENT_43	[p3l1828t3431r1986b3510],
2	relationship	NN	O	relationship	nsubj	11	SENT_43	[p3l2023t3458r2132b3510, p3l11t3559r454b3660],
3	of	IN	O	of	_	0	SENT_43	[p3l496t3559r597b3638],
4	the	DT	O	the	det	6	SENT_43	[p3l618t3559r754b3638],
5	signature	NN	O	signature	nn	6	SENT_43	[p3l796t3560r1211b3660],
6	genes	NNS	O	gene	prep_of	2	SENT_43	[p3l1251t3585r1498b3660],
7	to	TO	O	to	_	0	SENT_43	[p3l1540t3576r1623b3638],
8	metastasis	NN	O	metastasis	prep_to	6	SENT_43	[p3l1664t3560r2132b3638],
9	may	MD	O	may	aux	11	SENT_43	[p3l12t3713r194b3788],
10	be	VB	O	be	cop	11	SENT_43	[p3l226t3687r322b3766],
11	contributory	JJ	O	contributory	_	0	SENT_43	[p3l358t3687r897b3788],
12	or	CC	O	or	_	0	SENT_43	[p3l928t3713r1016b3766],
13	possibly	RB	O	possibly	advmod	15	SENT_43	[p3l1046t3687r1400b3788],
14	only	RB	O	only	advmod	15	SENT_43	[p3l1431t3687r1614b3788],
15	associative	JJ	O	associative	conj_or	11	SENT_43	[p3l1644t3688r2129b3783],
16	,	,	O	,	_	0	SENT_43	[p3l1644t3688r2129b3783],

1	and	CC	O	and	cc	10	SENT_44	[p4l11t20r169b99],
2	for	IN	O	for	_	0	SENT_44	[p4l205t20r328b99],
3	this	DT	O	this	det	4	SENT_44	[p4l363t20r523b99],
4	reason	NN	O	reason	prep_for	10	SENT_44	[p4l562t46r869b116],
5	,	,	O	,	_	0	SENT_44	[p4l562t46r869b116],
6	proteomics	NNS	O	proteomic	nsubj	10	SENT_44	[p4l911t21r1393b121],
7	will	MD	O	will	aux	10	SENT_44	[p4l1427t20r1592b99],
8	probably	RB	O	probably	advmod	10	SENT_44	[p4l1627t20r2004b121],
9	be	VB	O	be	cop	10	SENT_44	[p4l2037t20r2134b99],
10	useful	JJ	O	useful	_	0	SENT_44	[p4l12t148r284b227],
11	in	IN	O	in	_	0	SENT_44	[p4l323t149r407b226],
12	evaluating	VBG	O	evaluate	prepc_in	10	SENT_44	[p4l448t148r909b249],
13	this	DT	O	this	det	14	SENT_44	[p4l945t148r1109b227],
14	question	NN	O	question	dobj	12	SENT_44	[p4l1151t149r1532b249],
15	of	IN	O	of	_	0	SENT_44	[p4l1572t148r1674b227],
16	cause	NN	O	cause	prep_of	14	SENT_44	[p4l1695t175r1934b227],
17	and	CC	O	and	_	0	SENT_44	[p4l1974t148r2134b227],
18	effect	NN	O	effect	conj_and	16	SENT_44	[p4l12t277r275b356],
19	.	.	O	.	_	0	SENT_44	[p4l12t277r275b356],

1	The	DT	O	the	det	2	SENT_45	[p4l137t405r295b484],
2	work	NN	O	work	nsubj	7	SENT_45	[p4l323t405r539b485],
3	of	IN	O	of	_	0	SENT_45	[p4l568t405r666b484],
4	Chen	NNP	PERSON	Chen	prep_of	2	SENT_45	[p4l679t405r894b484],
5	et	FW	O	et	nn	6	SENT_45	[p4l927t422r1003b484],
6	al.	FW	O	al.	dep	4	SENT_45	[p4l1029t405r1123b484],
7	reflects	VBZ	O	reflect	_	0	SENT_45	[p4l1161t405r1468b484],
8	the	DT	O	the	det	9	SENT_45	[p4l1503t405r1632b484],
9	maturation	NN	O	maturation	dobj	7	SENT_45	[p4l1664t406r2134b484],
10	of	IN	O	of	_	0	SENT_45	[p4l12t533r110b612],
11	the	DT	O	the	det	13	SENT_45	[p4l128t533r257b612],
12	first	JJ	ORDINAL	first	amod	13	SENT_45	[p4l292t533r470b612],
13	phase	NN	O	phase	prep_of	9	SENT_45	[p4l499t533r741b634],
14	of	IN	O	of	_	0	SENT_45	[p4l777t533r875b612],
15	lung	NN	O	lung	nn	18	SENT_45	[p4l891t533r1386b634],
16	—	NN	O	—	nn	18	SENT_45	[p4l891t533r1386b634],
17	cancer	NN	O	cancer	nn	18	SENT_45	[p4l891t533r1386b634],
18	genomics	NNS	O	genomic	prep_of	13	SENT_45	[p4l1418t534r1841b634],
19	,	,	O	,	_	0	SENT_45	[p4l1418t534r1841b634],
20	which	WDT	O	which	nsubjpass	23	SENT_45	[p4l1878t533r2134b612],
21	has	VBZ	O	have	aux	23	SENT_45	[p4l12t662r153b741],
22	been	VBN	O	be	auxpass	23	SENT_45	[p4l223t662r419b741],
23	based	VBN	O	base	rcmod	13	SENT_45	[p4l488t662r726b741],
24	on	IN	O	on	_	0	SENT_45	[p4l794t688r898b741],
25	stored	VBN	O	store	amod	26	SENT_45	[p4l968t662r1223b741],
26	tissue	NN	O	tissue	prep_on	23	SENT_45	[p4l1291t663r1529b741],
27	and	CC	O	and	_	0	SENT_45	[p4l1596t662r1751b741],
28	clinical	JJ	O	clinical	amod	29	SENT_45	[p4l1821t662r2134b741],
29	charts	NNS	O	chart	prep_on	23	SENT_45	[p4l12t790r301b869],
30	.	.	O	.	_	0	SENT_45	[p4l12t790r301b869],

1	The	DT	O	the	det	2	SENT_46	[p4l341t790r502b869],
2	field	NN	O	field	nsubjpass	5	SENT_46	[p4l540t790r733b869],
3	is	VBZ	O	be	auxpass	5	SENT_46	[p4l770t791r836b869],
4	now	RB	DATE	now	advmod	5	SENT_46	[p4l875t816r1060b869],
5	poised	VBN	O	poise	dep	56	SENT_46	[p4l1092t790r1374b891],
6	to	TO	O	to	aux	7	SENT_46	[p4l1411t807r1493b869],
7	begin	VB	O	begin	xcomp	5	SENT_46	[p4l1533t790r1774b891],
8	its	PRP$	O	its	poss	11	SENT_46	[p4l1811t791r1910b869],
9	next	JJ	O	next	amod	11	SENT_46	[p4l1951t807r2139b869],
10	phase	NN	O	phase	nn	11	SENT_46	[p4l11t918r263b1019],
11	—	NN	O	—	nsubj	50	SENT_46	[p4l302t963r410b971],
12	conducting	VBG	O	conduct	partmod	11	SENT_46	[p4l449t918r945b1019],
13	prospective	JJ	O	prospective	amod	14	SENT_46	[p4l982t919r1483b1019],
14	trials	NNS	O	trial	dobj	12	SENT_46	[p4l1525t918r1750b997],
15	of	IN	O	of	_	0	SENT_46	[p4l1796t918r1897b997],
16	adjuvant	JJ	O	adjuvant	amod	17	SENT_46	[p4l1920t918r2133b1019, p4l7t1063r192b1125],
17	chemotherapy	NN	O	chemotherapy	prep_of	14	SENT_46	[p4l243t1046r855b1147],
18	in	IN	O	in	_	0	SENT_46	[p4l905t1047r989b1124],
19	patients	NNS	O	patient	prep_in	17	SENT_46	[p4l1043t1047r1383b1147],
20	with	IN	O	with	_	0	SENT_46	[p4l1437t1046r1632b1125],
21	early	JJ	O	early	amod	23	SENT_46	[p4l1688t1046r1893b1147],
22	lung	NN	O	lung	nn	23	SENT_46	[p4l1943t1046r2137b1147],
23	cancer	NN	O	cancer	prep_with	19	SENT_46	[p4l12t1200r288b1253],
24	who	WP	O	who	nsubjpass	26	SENT_46	[p4l318t1174r497b1253],
25	are	VBP	O	be	auxpass	26	SENT_46	[p4l536t1200r661b1253],
26	selected	VBN	O	select	rcmod	14	SENT_46	[p4l701t1174r1029b1253],
27	because	IN	O	because	mark	29	SENT_46	[p4l1067t1174r1393b1253],
28	they	PRP	O	they	nsubj	29	SENT_46	[p4l1431t1174r1609b1275],
29	have	VBP	O	have	advcl	26	SENT_46	[p4l1642t1174r1826b1253],
30	a	DT	O	a	det	32	SENT_46	[p4l1863t1201r1907b1253],
31	high	JJ	O	high	amod	32	SENT_46	[p4l1943t1174r2134b1275],
32	risk	NN	O	risk	dobj	29	SENT_46	[p4l12t1302r174b1381],
33	of	IN	O	of	_	0	SENT_46	[p4l205t1302r303b1381],
34	relapse	NN	O	relapse	prep_of	32	SENT_46	[p4l319t1302r611b1403],
35	or	CC	O	or	_	0	SENT_46	[p4l647t1328r733b1381],
36	metastasis	NN	O	metastasis	prep_of	32	SENT_46	[p4l764t1303r1203b1381],
37	according	VBG	O	accord	prep	29	SENT_46	[p4l1239t1302r1654b1403],
38	to	TO	O	to	pcomp	37	SENT_46	[p4l1685t1319r1765b1381],
39	the	DT	O	the	det	41	SENT_46	[p4l1801t1302r1931b1381],
40	molecular	JJ	O	molecular	amod	41	SENT_46	[p4l1966t1328r2133b1381, p4l11t1430r295b1509],
41	signature	NN	O	signature	pobj	38	SENT_46	[p4l333t1431r723b1531],
42	identiﬁed	VBN	O	identiﬁed	partmod	41	SENT_46	[p4l762t1430r1165b1509],
43	by	IN	O	by	_	0	SENT_46	[p4l1205t1430r1301b1531],
44	Chen	NNP	PERSON	Chen	agent	42	SENT_46	[p4l1335t1430r1550b1509],
45	et	FW	O	et	nn	46	SENT_46	[p4l1591t1447r1666b1509],
46	al.	FW	O	al.	tmod	12	SENT_46	[p4l1699t1430r1794b1509],
47	or	CC	O	or	_	0	SENT_46	[p4l1840t1456r1926b1509],
48	others	NNS	O	other	nn	49	SENT_46	[p4l1964t1430r2132b1509, p4l12t1565r250b1638],
49	.3	NN	NUMBER	.3	tmod	12	SENT_46	[p4l1964t1430r2132b1509, p4l12t1565r250b1638],
50	>	JJR	O	>	xcomp	7	SENT_46	[p4l1964t1430r2132b1509, p4l12t1565r250b1638],
51	4	CD	NUMBER	4	num	53	SENT_46	[p4l1964t1430r2132b1509, p4l12t1565r250b1638],
52	Such	JJ	O	such	amod	53	SENT_46	[p4l289t1559r486b1638],
53	trials	NNS	O	trial	nsubjpass	56	SENT_46	[p4l524t1559r736b1638],
54	should	MD	O	should	aux	56	SENT_46	[p4l778t1559r1057b1638],
55	be	VB	O	be	auxpass	56	SENT_46	[p4l1095t1559r1190b1638],
56	conducted	VBN	O	conduct	_	0	SENT_46	[p4l1230t1559r1658b1638],
57	to	TO	O	to	aux	58	SENT_46	[p4l1696t1576r1776b1638],
58	validate	VB	O	validate	ccomp	56	SENT_46	[p4l1811t1559r2134b1638],
59	the	DT	O	the	det	61	SENT_46	[p4l12t1687r141b1766],
60	molecular	JJ	O	molecular	amod	61	SENT_46	[p4l191t1687r625b1766],
61	signatures	NNS	O	signature	dobj	58	SENT_46	[p4l673t1688r1118b1788],
62	further	RB	O	further	advmod	58	SENT_46	[p4l1170t1687r1479b1766],
63	and	CC	O	and	_	0	SENT_46	[p4l1525t1687r1682b1766],
64	to	TO	O	to	aux	65	SENT_46	[p4l1733t1704r1813b1766],
65	assess	VB	O	assess	ccomp	56	SENT_46	[p4l1864t1714r2132b1766],
66	whether	IN	O	whether	complm	77	SENT_46	[p4l7t1815r355b1894],
67	patients	NNS	O	patient	nsubj	77	SENT_46	[p4l399t1816r728b1916],
68	selected	VBN	O	select	partmod	67	SENT_46	[p4l779t1815r1108b1894],
69	according	VBG	O	accord	_	0	SENT_46	[p4l1155t1815r1569b1916],
70	to	TO	O	to	prepc_according_to	68	SENT_46	[p4l1614t1832r1693b1894],
71	their	PRP$	O	they	poss	72	SENT_46	[p4l1743t1815r1941b1894],
72	signature	NN	O	signature	pobj	68	SENT_46	[p4l1987t1816r2132b1916, p4l12t1961r294b2023],
73	for	IN	O	for	_	0	SENT_46	[p4l346t1944r472b2023],
74	treatment	NN	O	treatment	prep_for	72	SENT_46	[p4l522t1961r954b2023],
75	will	MD	O	will	aux	77	SENT_46	[p4l997t1944r1164b2023],
76	indeed	RB	O	indeed	advmod	77	SENT_46	[p4l1216t1944r1509b2023],
77	benefit	VB	O	benefit	ccomp	65	SENT_46	[p4l1561t1944r1873b2023],
78	from	IN	O	from	_	0	SENT_46	[p4l1920t1944r2134b2023],
79	standard	JJ	O	standard	amod	81	SENT_46	[p4l13t2072r399b2151],
80	adjuvant	JJ	O	adjuvant	amod	81	SENT_46	[p4l451t2072r821b2173],
81	therapy	NN	O	therapy	prep_from	77	SENT_46	[p4l869t2072r1212b2173],
82	.	.	O	.	_	0	SENT_46	[p4l869t2072r1212b2173],

1	This	DT	O	this	det	3	SENT_47	[p4l1266t2072r1457b2151],
2	next	JJ	O	next	amod	3	SENT_47	[p4l1512t2089r1699b2151],
3	phase	NN	O	phase	nsubj	9	SENT_47	[p4l1746t2072r1998b2173],
4	of	IN	O	of	_	0	SENT_47	[p4l2051t2072r2152b2151],
5	cancer	NN	O	cancer	nn	6	SENT_47	[p4l12t2226r288b2279],
6	genomics	NNS	O	genomic	prep_of	3	SENT_47	[p4l315t2201r715b2301],
7	has	VBZ	O	have	aux	9	SENT_47	[p4l747t2200r888b2279],
8	already	RB	O	already	advmod	9	SENT_47	[p4l920t2200r1221b2301],
9	begun	VBN	O	begin	_	0	SENT_47	[p4l1248t2200r1510b2301],
10	in	IN	O	in	_	0	SENT_47	[p4l1539t2201r1621b2278],
11	lymphoma5	NN	O	lymphoma5	nn	14	SENT_47	[p4l1650t2200r2132b2301],
12	and	CC	O	and	_	0	SENT_47	[p4l11t2328r169b2407],
13	breast	NN	O	breast	conj_and	11	SENT_47	[p4l225t2328r483b2407],
14	cancer	NN	O	cancer	prep_in	9	SENT_47	[p4l532t2332r865b2424],
15	,6	CD	NUMBER	,6	dobj	9	SENT_47	[p4l532t2332r865b2424],
16	with	IN	O	with	_	0	SENT_47	[p4l915t2328r1107b2407],
17	retrospective	JJ	O	retrospective	amod	19	SENT_47	[p4l1161t2329r1701b2429],
18	data	NNS	O	datum	nn	19	SENT_47	[p4l1755t2328r1934b2407],
19	(	NN	O	(	prep_with	15	SENT_47	[p4l1991t2328r2137b2420],
20	for	IN	O	for	_	0	SENT_47	[p4l1991t2328r2137b2420],
21	breast	NN	O	breast	nn	22	SENT_47	[p4l12t2456r270b2535],
22	cancer	NN	O	cancer	prep_for	19	SENT_47	[p4l304t2463r601b2547],
23	)	CD	NUMBER	)	num	22	SENT_47	[p4l304t2463r601b2547],
24	indicating	VBG	O	indicate	partmod	15	SENT_47	[p4l644t2456r1075b2557],
25	that	IN	O	that	complm	29	SENT_47	[p4l1111t2456r1281b2535],
26	adjuvant	JJ	O	adjuvant	amod	27	SENT_47	[p4l1316t2456r1679b2557],
27	treatment	NN	O	treatment	nsubj	29	SENT_47	[p4l1715t2473r2138b2535],
28	is	VBZ	O	be	cop	29	SENT_47	[p4l11t2585r77b2663],
29	beneﬁcial	JJ	O	beneﬁcial	ccomp	24	SENT_47	[p4l111t2584r519b2663],
30	in	IN	O	in	_	0	SENT_47	[p4l550t2585r631b2662],
31	patients	NNS	O	patient	prep_in	29	SENT_47	[p4l661t2585r992b2685],
32	identified	VBN	O	identify	partmod	31	SENT_47	[p4l1025t2584r1428b2663],
33	as	IN	O	as	_	0	SENT_47	[p4l1459t2611r1542b2663],
34	being	VBG	O	be	prepc_as	32	SENT_47	[p4l1577t2584r1811b2685],
35	at	IN	O	at	_	0	SENT_47	[p4l1840t2601r1916b2663],
36	high	JJ	O	high	amod	37	SENT_47	[p4l1943t2584r2133b2685],
37	risk	NN	O	risk	prep_at	34	SENT_47	[p4l12t2712r172b2792],
38	according	VBG	O	accord	_	0	SENT_47	[p4l205t2712r632b2813],
39	to	TO	O	to	prepc_according_to	9	SENT_47	[p4l667t2729r749b2791],
40	genomics	NNS	O	genomic	pobj	9	SENT_47	[p4l788t2713r1262b2813],
41	?	.	O	?	_	0	SENT_47	[p4l788t2713r1262b2813],

1	Next	RB	O	next	advmod	6	SENT_48	[p4l138t2848r363b2936],
2	,	,	O	,	_	0	SENT_48	[p4l138t2848r363b2936],
3	cancer	NN	O	cancer	nn	4	SENT_48	[p4l409t2866r695b2919],
4	genomics	NNS	O	genomic	nsubj	6	SENT_48	[p4l733t2841r1151b2941],
5	will	MD	O	will	aux	6	SENT_48	[p4l1191t2840r1359b2919],
6	expand	VB	O	expand	_	0	SENT_48	[p4l1401t2840r1716b2941],
7	into	IN	O	into	_	0	SENT_48	[p4l1757t2841r1929b2919],
8	two	CD	NUMBER	two	num	9	SENT_48	[p4l1973t2857r2133b2919],
9	areas	NNS	O	area	prep_into	6	SENT_48	[p4l11t2994r254b3047],
10	:	:	O	:	_	0	SENT_48	[p4l11t2994r254b3047],
11	molecular	JJ	O	molecular	amod	12	SENT_48	[p4l288t2968r709b3047],
12	profiles	NNS	O	profile	dep	9	SENT_48	[p4l734t2968r1053b3069],
13	associated	VBN	O	associate	partmod	12	SENT_48	[p4l1085t2968r1515b3047],
14	with	IN	O	with	_	0	SENT_48	[p4l1541t2968r1731b3047],
15	response	NN	O	response	prep_with	13	SENT_48	[p4l1761t2994r2134b3069],
16	or	CC	O	or	_	0	SENT_48	[p4l12t3122r100b3175],
17	resistance	NN	O	resistance	prep_with	13	SENT_48	[p4l132t3097r550b3175],
18	to	TO	O	to	_	0	SENT_48	[p4l586t3113r666b3175],
19	particular	JJ	O	particular	amod	20	SENT_48	[p4l702t3096r1121b3197],
20	standard	NN	O	standard	prep_to	13	SENT_48	[p4l1155t3096r1525b3175],
21	or	CC	O	or	_	0	SENT_48	[p4l1561t3122r1649b3175],
22	novel	JJ	O	novel	amod	23	SENT_48	[p4l1680t3096r1901b3175],
23	therapies	NNS	O	therapy	conj_or	20	SENT_48	[p4l1935t3096r2133b3175, p4l11t3225r222b3325],
24	and	CC	O	and	_	0	SENT_48	[p4l262t3224r420b3303],
25	clinical	JJ	O	clinical	amod	26	SENT_48	[p4l459t3224r769b3303],
26	trials	NNS	O	trial	conj_and	20	SENT_48	[p4l808t3224r1025b3303],
27	based	VBN	O	base	partmod	26	SENT_48	[p4l1067t3224r1309b3303],
28	on	IN	O	on	_	0	SENT_48	[p4l1348t3250r1453b3303],
29	molecular	JJ	O	molecular	amod	30	SENT_48	[p4l1493t3224r1921b3303],
30	profiles	NNS	O	profile	prep_on	27	SENT_48	[p4l1956t3250r2132b3325, p4l12t3352r190b3431],
31	that	WDT	O	that	nsubj	32	SENT_48	[p4l227t3352r397b3431],
32	indicate	VBP	O	indicate	rcmod	30	SENT_48	[p4l424t3352r758b3431],
33	a	DT	O	a	det	34	SENT_48	[p4l791t3379r835b3430],
34	benefit	NN	O	benefit	dobj	32	SENT_48	[p4l868t3352r1167b3431],
35	from	IN	O	from	_	0	SENT_48	[p4l1195t3352r1403b3431],
36	new	JJ	O	new	amod	39	SENT_48	[p4l1436t3378r1612b3431],
37	or	CC	O	or	_	0	SENT_48	[p4l1642t3378r1730b3431],
38	standard	JJ	O	standard	conj_or	36	SENT_48	[p4l1762t3352r2134b3431],
39	agents	NNS	O	agent	prep_from	32	SENT_48	[p4l11t3497r318b3581],
40	.	.	O	.	_	0	SENT_48	[p4l11t3497r318b3581],

1	Recent	JJ	O	recent	amod	2	SENT_49	[p4l368t3487r667b3564],
2	examples	NNS	O	example	nsubj	8	SENT_49	[p4l708t3480r1114b3581],
3	of	IN	O	of	_	0	SENT_49	[p4l1162t3480r1263b3559],
4	molecular	JJ	O	molecular	amod	5	SENT_49	[p4l1290t3480r1732b3559],
5	markers	NNS	O	marker	prep_of	2	SENT_49	[p4l1774t3480r2132b3559],
6	of	IN	O	of	_	0	SENT_49	[p4l12t3608r113b3687],
7	resistance	NN	O	resistance	prep_of	5	SENT_49	[p4l127t3609r541b3687],
8	include	VBP	O	include	_	0	SENT_49	[p4l573t3608r873b3687],
9	expression	NN	O	expression	dobj	8	SENT_49	[p4l906t3609r1349b3709],
10	of	IN	O	of	_	0	SENT_49	[p4l1382t3608r1480b3687],
11	the	DT	O	the	det	13	SENT_49	[p4l1494t3608r1623b3687],
12	excision	NN	O	excision	nn	13	SENT_49	[p4l1657t3609r1990b3687],
13	repair	NN	O	repair	prep_of	9	SENT_49	[p4l2022t3634r2131b3687, p5l11t21r179b121],

1	cross	JJ	O	cross	amod	7	SENT_50	[p5l211t20r1194b121],
2	—	NN	O	—	nn	7	SENT_50	[p5l211t20r1194b121],
3	complementation	NN	O	complementation	nn	7	SENT_50	[p5l211t20r1194b121],
4	group	NN	O	group	nn	7	SENT_50	[p5l1228t46r1474b121],
5	1	CD	NUMBER	1	num	7	SENT_50	[p5l1512t26r1556b98],
6	gene	NN	O	gene	nn	7	SENT_50	[p5l1591t46r1785b121],
7	(	NN	O	(	nsubj	40	SENT_50	[p5l1823t27r2129b112],
8	ERCC1	NN	O	ercc1	nn	11	SENT_50	[p5l1823t27r2129b112],
9	)	CD	NUMBER	)	num	11	SENT_50	[p5l1823t27r2129b112],
10	(	NN	O	(	nn	11	SENT_50	[p5l16t149r482b240],
11	resistance	NN	O	resistance	nsubj	22	SENT_50	[p5l16t149r482b240],
12	to	TO	O	to	_	0	SENT_50	[p5l528t165r611b227],
13	cisplatin	NN	O	cisplatin	nn	14	SENT_50	[p5l658t148r1320b249],
14	—	NN	O	—	prep_to	11	SENT_50	[p5l658t148r1320b249],
15	based	VBN	O	base	partmod	14	SENT_50	[p5l658t148r1320b249],
16	adjuvant	JJ	O	adjuvant	amod	18	SENT_50	[p5l1365t148r1736b249],
17	therapy	NN	O	therapy	nn	18	SENT_50	[p5l1777t148r2129b249],
18	)	NN	O	)	dobj	15	SENT_50	[p5l1777t148r2129b249],
19	and	CC	O	and	_	0	SENT_50	[p5l11t276r171b355],
20	ms	NN	O	m	nn	21	SENT_50	[p5l212t302r323b355],
21	mutations	NNS	O	mutation	conj_and	18	SENT_50	[p5l356t277r799b355],
22	(	VBP	O	(	rcmod	7	SENT_50	[p5l845t277r1310b368],
23	resistance	NN	O	resistance	dobj	22	SENT_50	[p5l845t277r1310b368],
24	to	TO	O	to	_	0	SENT_50	[p5l1349t293r1431b355],
25	cisplatin	NN	O	cisplatin	nn	26	SENT_50	[p5l1472t276r2134b377],
26	—	NN	O	—	prep_to	22	SENT_50	[p5l1472t276r2134b377],
27	based	VBN	O	base	partmod	26	SENT_50	[p5l1472t276r2134b377],
28	therapy	NN	O	therapy	dobj	27	SENT_50	[p5l12t404r341b505],
29	and	CC	O	and	_	0	SENT_50	[p5l387t404r548b483],
30	epidermal	JJ	O	epidermal	amod	33	SENT_50	[p5l600t404r1043b505],
31	growth	NN	O	growth	nn	33	SENT_50	[p5l1094t404r1415b505],
32	factor	NN	O	factor	nn	33	SENT_50	[p5l1467t404r1724b483],
33	receptor	NN	O	receptor	conj_and	28	SENT_50	[p5l1773t421r2137b505],
34	[	CD	NUMBER	[	num	35	SENT_50	[p5l21t538r331b623],
35	EGFR	NN	O	egfr	dep	33	SENT_50	[p5l21t538r331b623],
36	]	CD	NUMBER	]	num	39	SENT_50	[p5l21t538r331b623],
37	tyrosine	NN	O	tyrosine	nn	39	SENT_50	[p5l383t533r737b633],
38	kinase	NN	O	kinase	nn	39	SENT_50	[p5l778t532r1064b612],
39	inhibitors	NNS	O	inhibitor	dep	33	SENT_50	[p5l1105t532r1730b623],
40	)	VBP	O	)	_	0	SENT_50	[p5l1105t532r1730b623],
41	.8	CD	NUMBER	.8	dobj	40	SENT_50	[p5l1105t532r1730b623],
42	'	''	O	'	_	0	SENT_50	[p5l1105t532r1730b623],
43	1	CD	NUMBER	1	number	44	SENT_50	[p5l1105t532r1730b623],
44	°	CD	NUMBER	°	num	46	SENT_50	[p5l1105t532r1730b623],
45	Such	JJ	O	such	amod	46	SENT_50	[p5l1774t532r1978b611],
46	research	NN	O	research	nsubj	47	SENT_50	[p5l2019t559r2133b611, p5l13t660r292b739],
47	suggests	VBZ	O	suggest	rcmod	41	SENT_50	[p5l342t677r717b761],
48	that	IN	O	that	complm	52	SENT_50	[p5l768t660r944b739],
49	molecular	JJ	O	molecular	amod	50	SENT_50	[p5l987t660r1430b739],
50	signatures	NNS	O	signature	nsubj	52	SENT_50	[p5l1477t661r1932b761],
51	can	MD	O	can	aux	52	SENT_50	[p5l1983t686r2134b739],
52	guide	VB	O	guide	ccomp	47	SENT_50	[p5l11t788r246b889],
53	the	DT	O	the	det	54	SENT_50	[p5l289t788r420b867],
54	choice	NN	O	choice	dobj	52	SENT_50	[p5l464t788r741b867],
55	of	IN	O	of	_	0	SENT_50	[p5l790t788r892b867],
56	treatment	NN	O	treatment	prep_of	54	SENT_50	[p5l921t805r1358b867],
57	for	IN	O	for	_	0	SENT_50	[p5l1401t788r1528b867],
58	primary	JJ	O	primary	amod	61	SENT_50	[p5l1571t789r1930b889],
59	and	CC	O	and	_	0	SENT_50	[p5l1974t788r2134b867],
60	adjuvant	JJ	O	adjuvant	amod	61	SENT_50	[p5l11t916r385b1017],
61	therapy	NN	O	therapy	prep_for	52	SENT_50	[p5l422t916r745b1017],
62	.	.	O	.	_	0	SENT_50	[p5l422t916r745b1017],

1	A	DT	O	a	det	2	SENT_51	[p5l137t1052r203b1122],
2	number	NN	O	number	nsubj	17	SENT_51	[p5l265t1044r595b1123],
3	of	IN	O	of	_	0	SENT_51	[p5l658t1044r756b1123],
4	important	JJ	O	important	amod	6	SENT_51	[p5l802t1045r1231b1145],
5	signaling	NN	O	signaling	nn	6	SENT_51	[p5l1293t1044r1684b1145],
6	pathways	NNS	O	pathway	prep_of	2	SENT_51	[p5l1744t1044r2132b1145],
7	that	WDT	O	that	nsubjpass	9	SENT_51	[p5l12t1172r186b1251],
8	are	VBP	O	be	auxpass	9	SENT_51	[p5l223t1198r355b1251],
9	involved	VBN	O	involve	rcmod	6	SENT_51	[p5l398t1172r761b1251],
10	in	IN	O	in	_	0	SENT_51	[p5l804t1173r888b1250],
11	carcinogenesis	NN	O	carcinogenesis	prep_in	9	SENT_51	[p5l933t1173r1587b1273],
12	in	IN	O	in	_	0	SENT_51	[p5l1632t1173r1716b1250],
13	the	DT	O	the	det	14	SENT_51	[p5l1760t1172r1896b1251],
14	lung	NN	O	lung	prep_in	11	SENT_51	[p5l1938t1172r2137b1273],
15	have	VBP	O	have	aux	17	SENT_51	[p5l12t1300r199b1379],
16	now	RB	DATE	now	advmod	17	SENT_51	[p5l247t1326r428b1379],
17	informed	VBN	O	inform	_	0	SENT_51	[p5l471t1300r862b1379],
18	platforms	NNS	O	platform	dobj	17	SENT_51	[p5l908t1300r1316b1401],
19	for	IN	O	for	_	0	SENT_51	[p5l1366t1300r1487b1379],
20	assessing	VBG	O	assess	prepc_for	17	SENT_51	[p5l1531t1301r1926b1401],
21	biomarkers	NNS	O	biomarker	dobj	20	SENT_51	[p5l1972t1300r2133b1379, p5l12t1428r359b1507],
22	associated	VBN	O	associate	partmod	21	SENT_51	[p5l400t1428r844b1507],
23	with	IN	O	with	_	0	SENT_51	[p5l878t1428r1073b1507],
24	sensitivity	NN	O	sensitivity	prep_with	22	SENT_51	[p5l1113t1429r1546b1529],
25	or	CC	O	or	_	0	SENT_51	[p5l1582t1454r1670b1507],
26	resistance	NN	O	resistance	prep_with	22	SENT_51	[p5l1706t1429r2133b1507],
27	to	TO	O	to	_	0	SENT_51	[p5l12t1573r94b1635],
28	various	JJ	O	various	amod	29	SENT_51	[p5l133t1557r443b1635],
29	agents	NNS	O	agent	prep_to	22	SENT_51	[p5l487t1573r762b1657],
30	that	WDT	O	that	nsubj	31	SENT_51	[p5l807t1556r980b1635],
31	target	VBP	O	target	rcmod	29	SENT_51	[p5l1017t1573r1273b1657],
32	these	DT	O	these	det	33	SENT_51	[p5l1311t1556r1534b1635],
33	pathways	NNS	O	pathway	dobj	31	SENT_51	[p5l1575t1556r1999b1657],
34	.	.	O	.	_	0	SENT_51	[p5l1575t1556r1999b1657],

1	In	IN	O	in	_	0	SENT_52	[p5l2045t1564r2134b1634],
2	lung	NN	O	lung	nn	3	SENT_52	[p5l11t1684r201b1785],
3	cancer	NN	O	cancer	prep_in	9	SENT_52	[p5l239t1710r528b1780],
4	,	,	O	,	_	0	SENT_52	[p5l239t1710r528b1780],
5	the	DT	O	the	det	8	SENT_52	[p5l574t1684r704b1763],
6	best	JJS	O	best	amod	8	SENT_52	[p5l746t1684r918b1763],
7	current	JJ	DATE	current	amod	8	SENT_52	[p5l954t1701r1258b1763],
8	examples	NNS	O	example	nsubj	9	SENT_52	[p5l1295t1684r1681b1785],
9	consist	VBP	O	consist	_	0	SENT_52	[p5l1725t1685r2018b1763],
10	of	IN	O	of	_	0	SENT_52	[p5l2054t1684r2152b1763],
11	the	DT	O	the	det	13	SENT_52	[p5l12t1812r141b1891],
12	EGFR	NN	ORGANIZATION	egfr	nn	13	SENT_52	[p5l181t1818r432b1896],
13	mutations	NNS	O	mutation	prep_of	9	SENT_52	[p5l461t1813r883b1891],
14	and	CC	O	and	_	0	SENT_52	[p5l924t1812r1079b1891],
15	amplification	NN	O	amplification	prep_of	9	SENT_52	[p5l1118t1812r1684b1913],
16	that	WDT	O	that	nsubj	17	SENT_52	[p5l1724t1812r1892b1891],
17	identify	VBP	O	identify	rcmod	15	SENT_52	[p5l1926t1812r2133b1891, p5l12t1940r154b2041],
18	patients	NNS	O	patient	dobj	17	SENT_52	[p5l184t1941r514b2041],
19	with	IN	O	with	_	0	SENT_52	[p5l547t1940r737b2019],
20	non	JJ	O	non	amod	26	SENT_52	[p5l772t1940r1396b2019],
21	—	JJ	O	—	amod	26	SENT_52	[p5l772t1940r1396b2019],
22	small	JJ	O	small	amod	26	SENT_52	[p5l772t1940r1396b2019],
23	—	NN	O	—	nn	26	SENT_52	[p5l772t1940r1396b2019],
24	cell	NN	O	cell	nn	26	SENT_52	[p5l772t1940r1396b2019],
25	lung	NN	O	lung	nn	26	SENT_52	[p5l1429t1940r1618b2041],
26	cancer	NN	O	cancer	prep_with	17	SENT_52	[p5l1651t1966r1924b2019],
27	who	WP	O	who	nsubj	28	SENT_52	[p5l1952t1940r2132b2019],
28	respond	VBP	O	respond	rcmod	26	SENT_52	[p5l12t2068r361b2169],
29	preferentially	RB	O	preferentially	advmod	28	SENT_52	[p5l403t2068r996b2169],
30	to	TO	O	to	_	0	SENT_52	[p5l1035t2085r1118b2147],
31	EGFR	NN	ORGANIZATION	egfr	nn	34	SENT_52	[p5l1160t2074r1420b2152],
32	tyrosine	NN	O	tyrosine	nn	34	SENT_52	[p5l1453t2069r1807b2169],
33	kinase	NN	O	kinase	nn	34	SENT_52	[p5l1849t2068r2134b2147],
34	inhibitors	NNS	O	inhibitor	prep_to	28	SENT_52	[p5l11t2196r610b2275],
35	.11	CD	NUMBER	.11	number	36	SENT_52	[p5l11t2196r610b2275],
36	’12	CD	NUMBER	’12	dep	15	SENT_52	[p5l11t2196r610b2275],
37	These	DT	O	these	det	39	SENT_52	[p5l639t2196r882b2275],
38	signaling	NN	O	signaling	nn	39	SENT_52	[p5l916t2196r1305b2297],
39	platforms	NNS	O	platform	nsubj	40	SENT_52	[p5l1331t2196r1737b2297],
40	link	VBP	O	link	rcmod	36	SENT_52	[p5l1769t2196r1937b2275],
41	prePhase	NN	O	prephase	dobj	40	SENT_52	[p5l1963t2222r2133b2297, p6l567t99r776b165],

1	1	CD	NUMBER	1	_	0	SENT_53	[p6l804t105r860b165],
2	:	:	O	:	_	0	SENT_53	[p6l804t105r860b165],
3	Genomic	JJ	O	genomic	amod	4	SENT_53	[p6l887t100r1210b165],
4	signatures	NNS	O	signature	dep	1	SENT_53	[p6l1235t100r1606b185],

1	Stored	VBN	O	store	_	0	SENT_54	[p6l454t203r679b269],
2	specimens	NNS	O	specimen	dobj	1	SENT_54	[p6l712t210r1089b288],
3	plus	CC	O	plus	prep	2	SENT_54	[p6l1123t203r1265b288],
4	clinical	JJ	O	clinical	amod	5	SENT_54	[p6l1294t203r1535b269],
5	data	NNS	O	datum	dep	3	SENT_54	[p6l1566t203r1715b269],

1	Phase	NN	O	phase	_	0	SENT_55	[p6l748t345r957b411],
2	2	CD	NUMBER	2	num	1	SENT_55	[p6l979t351r1041b411],
3	:	:	O	:	_	0	SENT_55	[p6l979t351r1041b411],
4	Validation	NN	O	validation	nn	6	SENT_55	[p6l1065t345r1423b412],
5	Prospective	JJ	O	prospective	amod	6	SENT_55	[p6l784t456r1190b534],
6	trials	NNS	O	trial	dep	1	SENT_55	[p6l1215t449r1388b515],

1	Phase	NN	O	phase	_	0	SENT_56	[p6l332t591r540b657],
2	3	CD	NUMBER	3	num	1	SENT_56	[p6l565t596r625b657],
3	:	:	O	:	_	0	SENT_56	[p6l565t596r625b657],
4	Expansio	NNP	O	Expansio	dep	1	SENT_56	[p6l657t592r975b676],
5	of	IN	O	of	_	0	SENT_56	[p6l1047t590r1129b657],
6	enomic	JJ	O	enomic	amod	7	SENT_56	[p6l1149t592r1446b667],
7	signatures	NNS	O	signature	prep_of	4	SENT_56	[p6l1470t592r1840b676],

1	Preclinical	JJ	O	preclinical	_	0	SENT_57	[p6l554t695r906b761],
2	a	DT	O	a	det	4	SENT_57	[p6l938t718r972b761],
3	d	NN	O	d	nn	4	SENT_57	[p6l1026t695r1063b761],
4	cli	NN	O	cli	dep	1	SENT_57	[p6l1095t695r1166b761],
5	ical	JJ	O	ical	amod	6	SENT_57	[p6l1226t695r1335b761],
6	studies	NNS	O	study	dep	1	SENT_57	[p6l1368t695r1619b761],

1	Algorithm	NN	O	algorithm	_	0	SENT_58	[p6l905t943r1258b1028],

1	Clinical	JJ	O	clinical	amod	2	SENT_59	[p6l686t1051r940b1117],
2	characteristics	NNS	O	characteristic	_	0	SENT_59	[p6l972t1051r1481b1117],

1	Molecular	JJ	O	molecular	amod	2	SENT_60	[p6l756t1160r1108b1226],
2	imaging	NN	O	imaging	_	0	SENT_60	[p6l1135t1165r1421b1246],

1	Proteomics	NNP	O	Proteomics	nn	2	SENT_61	[p6l888t1274r1285b1334],
2	Genomics	NNPS	O	Genomics	_	0	SENT_61	[p6l904t1382r1264b1442],

1	Prediction	NN	O	prediction	_	0	SENT_62	[p6l649t3391r1000b3457],
2	of	IN	O	of	_	0	SENT_62	[p6l1029t3390r1110b3457],
3	metastasis	NN	O	metastasis	prep_of	1	SENT_62	[p6l1124t3392r1502b3457],

1	‘	NN	O	‘	nn	2	SENT_63	[p7l367t184r573b292],
2	Lungs	NNS	O	lung	_	0	SENT_63	[p7l367t184r573b292],
3	Prediction	NN	O	prediction	dep	2	SENT_63	[p7l338t327r689b393],
4	of	IN	O	of	_	0	SENT_63	[p7l718t326r799b393],
5	drug	NN	O	drug	nn	6	SENT_63	[p7l809t327r974b412],
6	sensitivity	NN	O	sensitivity	prep_of	3	SENT_63	[p7l999t329r1357b413],
7	or	CC	O	or	_	0	SENT_63	[p7l1381t349r1454b393],
8	resistance	NN	O	resistance	prep_of	3	SENT_63	[p7l1479t329r1837b393],

1	Phase	NN	O	phase	_	0	SENT_64	[p7l555t636r763b701],
2	4	CD	NUMBER	4	num	1	SENT_64	[p7l787t642r847b701],
3	:	:	O	:	_	0	SENT_64	[p7l787t642r847b701],
4	Personalized	VBN	O	personalize	dep	1	SENT_64	[p7l880t636r1324b701],
5	therapy	NN	O	therapy	dobj	4	SENT_64	[p7l1351t636r1620b721],

1	Figure	NNP	O	Figure	_	0	SENT_65	[p7l83t850r303b933],
2	1	CD	NUMBER	1	dep	1	SENT_65	[p7l334t855r391b913],
3	.	.	O	.	_	0	SENT_65	[p7l334t855r391b913],

1	Development	NN	O	development	_	0	SENT_66	[p7l425t848r909b933],
2	of	IN	O	of	_	0	SENT_66	[p7l934t847r1016b913],
3	Personalized	JJ	O	personalized	amod	4	SENT_66	[p7l1034t848r1485b913],
4	Drugs	NNS	O	drug	prep_of	1	SENT_66	[p7l1521t854r1736b933],
5	for	IN	O	for	_	0	SENT_66	[p7l1763t847r1865b913],
6	Lung	NN	O	lung	nn	7	SENT_66	[p7l1896t854r2070b933],
7	Cancer	NN	O	cancer	prep_for	1	SENT_66	[p7l77t962r343b1035],
8	,	,	O	,	_	0	SENT_66	[p7l77t962r343b1035],
9	from	IN	O	from	_	0	SENT_66	[p7l370t956r539b1022],
10	Identification	NN	O	identification	prep_from	1	SENT_66	[p7l575t956r1051b1022],
11	of	IN	O	of	_	0	SENT_66	[p7l1082t956r1164b1022],
12	Genomic	JJ	O	genomic	amod	13	SENT_66	[p7l1177t959r1503b1022],
13	Signatures	NNS	O	signature	prep_of	10	SENT_66	[p7l1530t959r1912b1042],
14	to	TO	O	to	_	0	SENT_66	[p7l75t1076r146b1131],
15	Prospective	JJ	O	prospective	amod	16	SENT_66	[p7l179t1067r594b1150],
16	Trials	NNS	O	trial	prep_to	13	SENT_66	[p7l619t1065r812b1131],
17	of	IN	O	of	_	0	SENT_66	[p7l840t1064r922b1131],
18	Personalized	JJ	O	personalized	amod	19	SENT_66	[p7l939t1065r1391b1131],
19	Therapy	NN	O	therapy	prep_of	16	SENT_66	[p7l1421t1065r1730b1151],
20	.	.	O	.	_	0	SENT_66	[p7l1421t1065r1730b1151],

1	clinical	JJ	O	clinical	amod	4	SENT_67	[p7l10t1372r311b1452],
2	and	CC	O	and	_	0	SENT_67	[p7l353t1372r506b1452],
3	clinical	JJ	O	clinical	amod	4	SENT_67	[p7l551t1372r848b1452],
4	assessments	NNS	O	assessment	nsubj	22	SENT_67	[p7l891t1389r1399b1452],
5	of	IN	O	of	_	0	SENT_67	[p7l1446t1372r1544b1452],
6	genomics	NNS	O	genomic	prep_of	4	SENT_67	[p7l1568t1373r1964b1474],
7	(	CD	NUMBER	(	num	6	SENT_67	[p7l2015t1373r2150b1465, p7l10t1502r325b1604],
8	including	VBG	O	include	_	0	SENT_67	[p7l2015t1373r2150b1465, p7l10t1502r325b1604],
9	global	JJ	O	global	amod	11	SENT_67	[p7l364t1502r625b1604],
10	gene	NN	O	gene	nn	11	SENT_67	[p7l666t1528r863b1604],
11	expression	NN	O	expression	prep_including	6	SENT_67	[p7l906t1503r1352b1604],
12	and	CC	O	and	_	0	SENT_67	[p7l1394t1502r1550b1582],
13	epigenomics	NNS	O	epigenomic	conj_and	11	SENT_67	[p7l1593t1503r2146b1604],
14	)	CD	NUMBER	)	num	13	SENT_67	[p7l1593t1503r2146b1604],
15	and	CC	O	and	_	0	SENT_67	[p7l9t1632r169b1712],
16	proteomic	JJ	O	proteomic	amod	17	SENT_67	[p7l218t1633r671b1734],
17	assessments	NNS	O	assessment	conj_and	11	SENT_67	[p7l720t1649r1265b1712],
18	of	IN	O	of	_	0	SENT_67	[p7l1319t1632r1420b1712],
19	pathway	NN	O	pathway	nn	20	SENT_67	[p7l1451t1632r1821b1734],
20	activation	NN	O	activation	prep_of	17	SENT_67	[p7l1866t1633r2150b1712, p7l10t1763r275b1842],
21	.13	CD	NUMBER	.13	num	20	SENT_67	[p7l1866t1633r2150b1712, p7l10t1763r275b1842],
22	Given	VBN	O	give	partmod	60	SENT_67	[p7l315t1763r554b1842],
23	the	DT	O	the	det	25	SENT_67	[p7l593t1762r724b1842],
24	recent	JJ	O	recent	amod	25	SENT_67	[p7l762t1779r1020b1842],
25	approval	NN	O	approval	dobj	22	SENT_67	[p7l1053t1762r1412b1864],
26	by	IN	O	by	_	0	SENT_67	[p7l1450t1762r1546b1864],
27	the	DT	O	the	det	31	SENT_67	[p7l1580t1762r1710b1842],
28	Food	NNP	ORGANIZATION	Food	nn	31	SENT_67	[p7l1747t1762r1959b1842],
29	and	CC	ORGANIZATION	and	_	0	SENT_67	[p7l1995t1762r2152b1842],
30	Drug	NNP	ORGANIZATION	Drug	nn	31	SENT_67	[p7l8t1899r230b1994],
31	Administration	NNP	ORGANIZATION	Administration	agent	22	SENT_67	[p7l257t1892r931b1972],
32	of	IN	O	of	_	0	SENT_67	[p7l967t1892r1067b1972],
33	the	DT	O	the	det	38	SENT_67	[p7l1085t1892r1218b1972],
34	EGFR	NN	ORGANIZATION	egfr	nn	38	SENT_67	[p7l1253t1898r1511b1977],
35	inhibitor	NN	O	inhibitor	nn	38	SENT_67	[p7l1535t1892r1921b1972],
36	erlo	NN	O	erlo	nn	38	SENT_67	[p7l1955t1892r2150b1972],
37	—	NN	O	—	nn	38	SENT_67	[p7l1955t1892r2150b1972],
38	tinib	NN	O	tinib	prep_of	31	SENT_67	[p7l10t2022r213b2102],
39	(	CD	NUMBER	(	num	40	SENT_67	[p7l265t2022r743b2115],
40	November	NNP	DATE	November	dep	31	SENT_67	[p7l265t2022r743b2115],
41	2004	CD	DATE	2004	num	40	SENT_67	[p7l786t2028r1024b2115],
42	)	CD	NUMBER	)	dep	40	SENT_67	[p7l786t2028r1024b2115],
43	and	CC	O	and	_	0	SENT_67	[p7l1074t2022r1234b2102],
44	of	IN	O	of	dep	48	SENT_67	[p7l1279t2022r1380b2102],
45	the	DT	O	the	det	47	SENT_67	[p7l1407t2022r1541b2102],
46	angiogenesis	NN	O	angiogenesis	nn	47	SENT_67	[p7l1586t2023r2149b2124],
47	inhibitor	NN	O	inhibitor	pobj	44	SENT_67	[p7l8t2152r395b2232],
48	bevacizumab	NN	O	bevacizumab	conj_and	40	SENT_67	[p7l444t2152r1011b2232],
49	(	CD	NUMBER	(	num	48	SENT_67	[p7l1068t2152r1443b2244],
50	October	NNP	DATE	October	tmod	22	SENT_67	[p7l1068t2152r1443b2244],
51	2006	CD	DATE	2006	num	50	SENT_67	[p7l1491t2158r1731b2244],
52	)	NN	O	)	npadvmod	22	SENT_67	[p7l1491t2158r1731b2244],
53	for	IN	O	for	_	0	SENT_67	[p7l1787t2152r1912b2232],
54	lung	NN	O	lung	nn	55	SENT_67	[p7l1959t2152r2154b2254],
55	cancer	NN	O	cancer	prep_for	22	SENT_67	[p7l10t2307r303b2377],
56	,	,	O	,	_	0	SENT_67	[p7l10t2307r303b2377],
57	it	PRP	O	it	nsubj	60	SENT_67	[p7l347t2282r405b2360],
58	is	VBZ	O	be	cop	60	SENT_67	[p7l437t2282r502b2360],
59	now	RB	DATE	now	advmod	60	SENT_67	[p7l542t2307r725b2361],
60	crucial	JJ	O	crucial	_	0	SENT_67	[p7l760t2281r1042b2360],
61	to	TO	O	to	aux	62	SENT_67	[p7l1081t2298r1161b2360],
62	create	VB	O	create	xcomp	60	SENT_67	[p7l1202t2298r1448b2360],
63	molecular	JJ	O	molecular	amod	64	SENT_67	[p7l1487t2281r1911b2360],
64	tools	NNS	O	tool	dobj	62	SENT_67	[p7l1947t2281r2149b2360],
65	that	WDT	O	that	nsubj	67	SENT_67	[p7l10t2411r179b2491],
66	can	MD	O	can	aux	67	SENT_67	[p7l211t2437r358b2491],
67	predict	VB	O	predict	rcmod	64	SENT_67	[p7l392t2411r690b2513],
68	the	DT	O	the	det	69	SENT_67	[p7l721t2411r851b2491],
69	response	NN	O	response	dobj	67	SENT_67	[p7l888t2437r1261b2513],
70	of	IN	O	of	_	0	SENT_67	[p7l1297t2411r1397b2491],
71	cancers	NNS	O	cancer	prep_of	69	SENT_67	[p7l1415t2437r1730b2491],
72	to	TO	O	to	_	0	SENT_67	[p7l1772t2428r1854b2491],
73	single	JJ	O	single	amod	74	SENT_67	[p7l1896t2411r2151b2513],
74	agents	NNS	O	agent	prep_to	67	SENT_67	[p7l8t2558r287b2643],
75	or	CC	O	or	_	0	SENT_67	[p7l329t2567r418b2621],
76	combination	NN	O	combination	nn	77	SENT_67	[p7l455t2541r1007b2621],
77	chemotherapies	NNS	O	chemotherapy	conj_or	74	SENT_67	[p7l1047t2541r1757b2643],
78	,	,	O	,	_	0	SENT_67	[p7l1047t2541r1757b2643],
79	in	IN	O	in	mark	82	SENT_67	[p7l1801t2542r1885b2620],
80	order	NN	O	order	dep	82	SENT_67	[p7l1925t2541r2154b2621],
81	to	TO	O	to	aux	82	SENT_67	[p7l10t2688r92b2751],
82	guide	VB	O	guide	purpcl	67	SENT_67	[p7l136t2671r384b2773],
83	the	DT	O	the	det	84	SENT_67	[p7l428t2671r565b2751],
84	development	NN	O	development	dobj	82	SENT_67	[p7l610t2671r1180b2773],
85	of	IN	O	of	_	0	SENT_67	[p7l1220t2671r1322b2751],
86	new	JJ	O	new	amod	87	SENT_67	[p7l1348t2697r1530b2751],
87	drugs	NNS	O	drug	prep_of	84	SENT_67	[p7l1571t2671r1823b2773],
88	or	CC	O	or	_	0	SENT_67	[p7l1870t2697r1961b2751],
89	improve	VB	O	improve	conj_or	82	SENT_67	[p7l2001t2672r2150b2750, p7l8t2827r249b2903],
90	routine	JJ	O	routine	amod	92	SENT_67	[p7l295t2802r604b2881],
91	clinical	JJ	O	clinical	amod	92	SENT_67	[p7l644t2801r949b2881],
92	care	NN	O	care	dobj	89	SENT_67	[p7l989t2828r1182b2881],
93	.	.	O	.	_	0	SENT_67	[p7l989t2828r1182b2881],

1	These	DT	O	these	det	3	SENT_68	[p7l1223t2801r1471b2881],
2	prognostic	JJ	O	prognostic	amod	3	SENT_68	[p7l1508t2802r1963b2903],
3	sigN	NN	O	sign	_	0	SENT_68	[p7l2003t2802r2150b2903, p7l524t2987r538b3002],

1	ENGLJ	NNP	O	ENGLJ	_	0	SENT_69	[p7l553t2987r631b3009],
2	MED	NNP	O	MED	rcmod	1	SENT_69	[p7l645t2987r697b3002],
3	356	CD	NUMBER	356	dep	2	SENT_69	[p7l708t2981r765b3009],
4	;	:	O	;	_	0	SENT_69	[p7l708t2981r765b3009],
5	!	.	O	!	_	0	SENT_69	[p7l708t2981r765b3009],

1	WWW	NNP	O	WWW	_	0	SENT_70	[p7l801t2987r908b3003],
2	,	,	O	,	_	0	SENT_70	[p7l801t2987r908b3003],
3	NE	NN	O	ne	appos	1	SENT_70	[p7l801t2987r908b3003],
4	M.ORG	NNP	O	M.ORG	nn	5	SENT_70	[p7l923t2987r1002b3003],
5	JANUARY	NNP	DATE	JANUARY	dep	1	SENT_70	[p7l1033t2987r1146b3009],
6	4	CD	DATE	4	num	5	SENT_70	[p7l1155t2987r1176b3009],
7	,	,	DATE	,	_	0	SENT_70	[p7l1155t2987r1176b3009],
8	2007	CD	DATE	2007	num	5	SENT_70	[p7l1188t2987r1250b3008],
9	77	CD	DATE	77	dep	5	SENT_70	[p7l1979t2978r2016b2999],

1	The	DT	O	the	det	4	SENT_71	[p7l702t3020r752b3044],
2	New	NNP	O	New	nn	4	SENT_71	[p7l762t3021r824b3044],
3	Englan	NNP	O	Englan	nn	4	SENT_71	[p7l833t3020r927b3051],
4	oumal	NN	O	oumal	_	0	SENT_71	[p7l966t3020r1050b3044],
5	of	IN	O	of	_	0	SENT_71	[p7l1060t3020r1088b3044],
6	Medicine	NN	MISC	medicine	prep_of	4	SENT_71	[p7l1095t3020r1220b3044],

1	Downloaded	VBN	O	download	_	0	SENT_72	[p7l144t3061r314b3084],
2	from	IN	O	from	_	0	SENT_72	[p7l322t3061r387b3084],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_72	[p7l396t3061r514b3091],
4	at	IN	O	at	_	0	SENT_72	[p7l524t3065r547b3084],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_72	[p7l556t3061r738b3084],
6	on	IN	O	on	_	0	SENT_72	[p7l748t3068r780b3084],
7	January	NNP	DATE	January	prep_on	1	SENT_72	[p7l789t3061r891b3091],
8	5	CD	DATE	5	num	7	SENT_72	[p7l902t3061r924b3088],
9	,	,	DATE	,	_	0	SENT_72	[p7l902t3061r924b3088],
10	2014	CD	DATE	2014	num	7	SENT_72	[p7l935t3061r1007b3084],
11	.	.	O	.	_	0	SENT_72	[p7l935t3061r1007b3084],

1	For	IN	O	for	_	0	SENT_73	[p7l1018t3061r1064b3084],
2	personal	JJ	O	personal	amod	3	SENT_73	[p7l1072t3061r1184b3091],
3	use	NN	O	use	pobj	1	SENT_73	[p7l1194t3068r1237b3084],
4	only	RB	O	only	advmod	3	SENT_73	[p7l1247t3061r1312b3091],
5	.	.	O	.	_	0	SENT_73	[p7l1247t3061r1312b3091],

1	No	DT	O	no	det	3	SENT_74	[p7l1322t3061r1362b3084],
2	other	JJ	O	other	amod	3	SENT_74	[p7l1372t3061r1440b3084],
3	uses	NNS	O	use	_	0	SENT_74	[p7l1448t3068r1504b3084],
4	without	IN	O	without	_	0	SENT_74	[p7l1515t3061r1616b3084],
5	permission	NN	O	permission	prep_without	3	SENT_74	[p7l1624t3061r1777b3091],
6	.	.	O	.	_	0	SENT_74	[p7l1624t3061r1777b3091],

1	Copyright	NN	O	copyright	_	0	SENT_75	[p7l494t3102r628b3133],
2	©	CD	NUMBER	©	num	6	SENT_75	[p7l638t3102r661b3126],
3	2007	CD	DATE	2007	num	6	SENT_75	[p7l671t3102r736b3126],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_75	[p7l746t3102r937b3126],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_75	[p7l947t3102r1055b3126],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_75	[p7l1065t3102r1170b3133],
7	.	.	O	.	_	0	SENT_75	[p7l1065t3102r1170b3133],

1	All	DT	O	all	det	2	SENT_76	[p7l1181t3102r1222b3126],
2	rights	NNS	O	rights	nsubj	3	SENT_76	[p7l1232t3102r1306b3133],
3	reserved	VBN	O	reserve	_	0	SENT_76	[p7l1316t3102r1435b3126],
4	.	.	O	.	_	0	SENT_76	[p7l1316t3102r1435b3126],

1	EDITORIAL	NN	O	editorial	_	0	SENT_77	[p7l991t3208r1168b3227],

1	natures	NNS	O	nature	nsubj	8	SENT_78	[p7l11t3438r321b3500],
2	can	MD	O	can	aux	3	SENT_78	[p7l357t3447r503b3500],
3	consist	VB	O	consist	_	0	SENT_78	[p7l537t3422r830b3500],
4	of	IN	O	of	_	0	SENT_78	[p7l859t3421r958b3500],
5	new	JJ	O	new	amod	6	SENT_78	[p7l972t3447r1146b3501],
6	genes	NNS	O	gene	prep_of	3	SENT_78	[p7l1175t3447r1409b3522],
7	or	CC	O	or	_	0	SENT_78	[p7l1446t3447r1533b3500],
8	include	VBP	O	include	conj_or	3	SENT_78	[p7l1562t3421r1864b3500],
9	genes	NNS	O	gene	dobj	8	SENT_78	[p7l1897t3447r2131b3522],
10	already	RB	O	already	advmod	11	SENT_78	[p7l11t3544r312b3645],
11	established	VBN	O	establish	partmod	9	SENT_78	[p7l340t3544r804b3623],
12	during	IN	O	during	_	0	SENT_78	[p7l836t3544r1115b3645],
13	earlier	JJR	O	earlier	amod	15	SENT_78	[p7l1145t3544r1407b3623],
14	genomic	JJ	O	genomic	amod	15	SENT_78	[p7l1435t3545r1793b3645],
15	testing	NN	O	testing	prep_during	11	SENT_78	[p7l1824t3545r2128b3645],
16	.	.	O	.	_	0	SENT_78	[p7l1824t3545r2128b3645],

1	The	DT	O	the	det	2	SENT_79	[p7l8t3667r165b3746],
2	signature	NN	O	signature	nsubj	3	SENT_79	[p7l197t3668r584b3768],
3	reported	VBN	O	report	_	0	SENT_79	[p7l614t3667r967b3768],
4	by	IN	O	by	_	0	SENT_79	[p7l998t3667r1093b3768],
5	Chen	NNP	PERSON	Chen	prep_by	3	SENT_79	[p7l1119t3667r1332b3746],
6	et	FW	O	et	nn	7	SENT_79	[p7l1363t3684r1439b3746],
7	al.	FW	O	al.	dobj	3	SENT_79	[p7l1463t3667r1580b3763],
8	,	,	O	,	_	0	SENT_79	[p7l1463t3667r1580b3763],
9	for	IN	O	for	_	0	SENT_79	[p7l1615t3667r1735b3746],
10	example	NN	O	example	prep_for	7	SENT_79	[p7l1762t3667r2128b3768],
11	,	,	O	,	_	0	SENT_79	[p7l1762t3667r2128b3768],

1	includes	VBZ	O	include	ccomp	6	SENT_80	[p8l11t18r363b97],
2	ERBB3	NNP	O	ERBB3	dobj	1	SENT_80	[p8l406t25r688b114],
3	,	,	O	,	_	0	SENT_80	[p8l406t25r688b114],
4	a	DT	O	a	det	5	SENT_80	[p8l736t45r780b97],
5	gene	NN	O	gene	nsubj	6	SENT_80	[p8l820t44r1018b119],
6	associated	VBN	O	associate	_	0	SENT_80	[p8l1060t18r1505b97],
7	with	IN	O	with	_	0	SENT_80	[p8l1543t18r1738b97],
8	sensitiv	NN	O	sensitiv	nn	10	SENT_80	[p8l1782t19r2131b97],
9	—	CD	NUMBER	—	num	10	SENT_80	[p8l1782t19r2131b97],
10	ity	NN	O	ity	prep_with	6	SENT_80	[p8l11t142r118b242],
11	to	TO	O	to	_	0	SENT_80	[p8l152t158r233b220],
12	EGFR	NN	ORGANIZATION	egfr	nn	15	SENT_80	[p8l271t147r527b225],
13	tyrosine	NN	O	tyrosine	nn	15	SENT_80	[p8l555t142r901b242],
14	kinase	NN	O	kinase	nn	15	SENT_80	[p8l939t141r1217b221],
15	inhibitors	NNS	O	inhibitor	prep_to	6	SENT_80	[p8l1255t141r1780b220],
16	.	.	O	.	_	0	SENT_80	[p8l1255t141r1780b220],

1	“	NN	O	“	_	0	SENT_81	[p8l1255t141r1780b220],

1	This	DT	O	this	det	3	SENT_82	[p8l137t264r325b343],
2	new	JJ	O	new	amod	3	SENT_82	[p8l363t290r540b343],
3	phase	NN	O	phase	nsubj	12	SENT_82	[p8l571t264r820b365],
4	of	IN	O	of	_	0	SENT_82	[p8l856t264r956b343],
5	target	NN	O	target	nn	6	SENT_82	[p8l973t281r1230b365],
6	profiling	NN	O	profiling	prep_of	3	SENT_82	[p8l1258t264r1648b365],
7	and	CC	O	and	_	0	SENT_82	[p8l1680t264r1837b343],
8	agentspeciﬁc	NN	O	agentspeciﬁc	nn	9	SENT_82	[p8l1872t281r2132b365, p8l13t387r343b488],
9	profiling	NN	O	profiling	prep_of	3	SENT_82	[p8l382t387r772b488],
10	will	MD	O	will	aux	12	SENT_82	[p8l806t387r971b466],
11	probably	RB	O	probably	advmod	12	SENT_82	[p8l1010t387r1387b488],
12	require	VB	O	require	_	0	SENT_82	[p8l1424t388r1730b488],
13	an	DT	O	a	det	16	SENT_82	[p8l1772t413r1875b466],
14	algo	FW	O	algo	nn	16	SENT_82	[p8l1916t387r2132b488],
15	—	FW	O	—	nn	16	SENT_82	[p8l1916t387r2132b488],
16	rithm	NN	O	rithm	dobj	12	SENT_82	[p8l11t510r260b589],
17	that	WDT	O	that	nsubj	19	SENT_82	[p8l305t510r482b589],
18	would	MD	O	would	aux	19	SENT_82	[p8l517t510r789b590],
19	include	VB	O	include	rcmod	16	SENT_82	[p8l833t510r1154b589],
20	genomic	JJ	O	genomic	acomp	19	SENT_82	[p8l1198t511r1601b611],
21	,	,	O	,	_	0	SENT_82	[p8l1198t511r1601b611],
22	proteomic	JJ	O	proteomic	appos	16	SENT_82	[p8l1650t511r2128b611],
23	,	,	O	,	_	0	SENT_82	[p8l1650t511r2128b611],
24	clinical	JJ	O	clinical	appos	22	SENT_82	[p8l12t633r339b729],
25	,	,	O	,	_	0	SENT_82	[p8l12t633r339b729],
26	and	CC	O	and	_	0	SENT_82	[p8l375t633r530b712],
27	imaging	NN	O	imaging	nn	28	SENT_82	[p8l560t634r913b734],
28	factors	NNS	O	factor	nsubj	29	SENT_82	[p8l941t633r1221b712],
29	(	VBP	O	(	conj_and	12	SENT_82	[p8l1259t634r1432b734],
30	Fig	NN	O	fig	dobj	29	SENT_82	[p8l1259t634r1432b734],
31	.	.	O	.	_	0	SENT_82	[p8l1259t634r1432b734],

1	1	CD	NUMBER	1	_	0	SENT_83	[p8l1473t639r1565b724],
2	)	NN	O	)	dep	1	SENT_83	[p8l1473t639r1565b724],
3	.	.	O	.	_	0	SENT_83	[p8l1473t639r1565b724],

1	The	DT	O	the	det	2	SENT_84	[p8l1597t633r1756b712],
2	proﬁles	NNS	O	proﬁles	nsubjpass	9	SENT_84	[p8l1785t633r2128b734],
3	,	,	O	,	_	0	SENT_84	[p8l1785t633r2128b734],
4	we	PRP	O	we	nsubj	5	SENT_84	[p8l7t783r124b836],
5	predict	VBP	O	predict	parataxis	9	SENT_84	[p8l167t756r491b857],
6	,	,	O	,	_	0	SENT_84	[p8l167t756r491b857],
7	will	MD	O	will	aux	9	SENT_84	[p8l536t756r700b836],
8	be	VB	O	be	auxpass	9	SENT_84	[p8l744t756r840b835],
9	used	VBN	O	use	_	0	SENT_84	[p8l884t756r1080b835],
10	for	IN	O	for	_	0	SENT_84	[p8l1124t756r1247b835],
11	the	DT	O	the	det	12	SENT_84	[p8l1288t756r1421b835],
12	development	NN	O	development	prep_for	9	SENT_84	[p8l1465t756r2013b857],
13	of	IN	O	of	_	0	SENT_84	[p8l2052t756r2152b835],
14	novel	JJ	O	novel	amod	15	SENT_84	[p8l11t879r229b958],
15	drugs	NNS	O	drug	prep_of	12	SENT_84	[p8l265t879r524b980],
16	.	.	O	.	_	0	SENT_84	[p8l265t879r524b980],

1	Patients	NNS	O	patient	nsubjpass	9	SENT_85	[p8l564t880r892b958],
2	with	IN	O	with	_	0	SENT_85	[p8l925t879r1115b958],
3	early	JJ	O	early	amod	6	SENT_85	[p8l1151t879r1594b980],
4	—	JJ	O	—	amod	6	SENT_85	[p8l1151t879r1594b980],
5	stage	NN	O	stage	nn	6	SENT_85	[p8l1151t879r1594b980],
6	cancers	NNS	O	cancer	prep_with	1	SENT_85	[p8l1631t905r1941b958],
7	will	MD	O	will	aux	9	SENT_85	[p8l1974t879r2134b959],
8	be	VB	O	be	auxpass	9	SENT_85	[p8l12t1002r109b1081],
9	assigned	VBN	O	assign	_	0	SENT_85	[p8l141t1002r501b1103],
10	to	TO	O	to	_	0	SENT_85	[p8l533t1019r612b1081],
11	particular	JJ	O	particular	amod	12	SENT_85	[p8l645t1002r1056b1103],
12	drugs	NNS	O	drug	prep_to	9	SENT_85	[p8l1086t1002r1320b1103],
13	on	IN	O	on	_	0	SENT_85	[p8l1356t1028r1460b1081],
14	the	DT	O	the	det	15	SENT_85	[p8l1493t1002r1621b1081],
15	basis	NN	O	basis	prep_on	9	SENT_85	[p8l1655t1002r1857b1081],
16	of	IN	O	of	_	0	SENT_85	[p8l1893t1002r1991b1081],
17	the	DT	O	the	det	19	SENT_85	[p8l2005t1002r2133b1081],
18	molecular	JJ	O	molecular	amod	19	SENT_85	[p8l11t1125r432b1204],
19	characteristics	NNS	O	characteristic	prep_of	15	SENT_85	[p8l465t1125r1065b1204],
20	of	IN	O	of	_	0	SENT_85	[p8l1103t1125r1202b1204],
21	the	DT	O	the	det	22	SENT_85	[p8l1220t1125r1349b1204],
22	tumors	NNS	O	tumor	prep_of	19	SENT_85	[p8l1386t1142r1709b1204],
23	.	.	O	.	_	0	SENT_85	[p8l1386t1142r1709b1204],

1	Then	RB	O	then	advmod	14	SENT_86	[p8l1747t1125r1960b1204],
2	the	DT	O	the	det	3	SENT_86	[p8l1997t1125r2133b1204],
3	development	NN	O	development	nsubjpass	14	SENT_86	[p8l12t1248r577b1349],
4	of	IN	O	of	_	0	SENT_86	[p8l610t1248r712b1327],
5	drugs	NNS	O	drug	prep_of	3	SENT_86	[p8l732t1248r981b1349],
6	for	IN	O	for	_	0	SENT_86	[p8l1021t1248r1148b1327],
7	the	DT	O	the	det	8	SENT_86	[p8l1183t1248r1319b1327],
8	treatment	NN	O	treatment	prep_for	5	SENT_86	[p8l1357t1265r1794b1327],
9	of	IN	O	of	_	0	SENT_86	[p8l1827t1248r1928b1327],
10	lung	NN	O	lung	nn	11	SENT_86	[p8l1944t1248r2137b1349],
11	cancer	NN	O	cancer	prep_of	8	SENT_86	[p8l12t1397r287b1450],
12	will	MD	O	will	aux	14	SENT_86	[p8l316t1371r477b1450],
13	be	VB	O	be	auxpass	14	SENT_86	[p8l514t1371r608b1450],
14	focused	VBN	O	focus	_	0	SENT_86	[p8l644t1371r971b1450],
15	on	IN	O	on	_	0	SENT_86	[p8l1007t1397r1111b1450],
16	personalized	JJ	O	personalized	amod	17	SENT_86	[p8l1146t1371r1692b1472],
17	therapy	NN	O	therapy	prep_on	14	SENT_86	[p8l1728t1371r2056b1472],
18	.	.	O	.	_	0	SENT_86	[p8l1728t1371r2056b1472],

1	N	NN	O	n	nn	2	SENT_87	[p8l95t1509r151b1563],
2	o	NN	O	o	nn	4	SENT_87	[p8l155t1522r190b1562],
3	potential	JJ	O	potential	amod	4	SENT_87	[p8l217t1504r505b1579],
4	conﬂict	NN	O	conﬂict	nsubjpass	12	SENT_87	[p8l533t1503r779b1562],
5	of	IN	O	of	_	0	SENT_87	[p8l803t1503r879b1562],
6	interest	NN	O	interest	prep_of	4	SENT_87	[p8l892t1504r1138b1562],
7	relevant	JJ	O	relevant	amod	6	SENT_87	[p8l1161t1504r1418b1563],
8	to	TO	O	to	_	0	SENT_87	[p8l1442t1516r1502b1562],
9	this	DT	O	this	det	10	SENT_87	[p8l1530t1503r1647b1562],
10	article	NN	O	article	prep_to	7	SENT_87	[p8l1676t1504r1873b1562],
11	was	VBD	O	be	auxpass	12	SENT_87	[p8l1897t1523r2019b1563],
12	reported	VBN	O	report	_	0	SENT_87	[p8l2048t1523r2133b1562, p8l9t1583r239b1658],
13	.	.	O	.	_	0	SENT_87	[p8l2048t1523r2133b1562, p8l9t1583r239b1658],

1	From	IN	O	from	dep	10	SENT_88	[p8l16t1711r182b1766],
2	the	DT	O	the	det	4	SENT_88	[p8l207t1706r311b1766],
3	Department	NNP	O	Department	nn	4	SENT_88	[p8l340t1711r747b1785],
4	ofThoracic/Head	NN	O	ofthoracic/head	pobj	1	SENT_88	[p8l769t1705r1355b1785],
5	and	CC	O	and	_	0	SENT_88	[p8l1383t1706r1500b1766],
6	Neck	NNP	ORGANIZATION	Neck	nn	8	SENT_88	[p8l1532t1706r1698b1766],
7	Medical	NNP	ORGANIZATION	Medical	nn	8	SENT_88	[p8l1724t1706r1982b1766],
8	Oncology	NNP	ORGANIZATION	Oncology	conj_and	4	SENT_88	[p8l2009t1710r2133b1766, p8l11t1786r243b1865],
9	,	,	O	,	_	0	SENT_88	[p8l2009t1710r2133b1766, p8l11t1786r243b1865],
10	University	NNP	ORGANIZATION	University	_	0	SENT_88	[p8l300t1791r636b1865],
11	of	IN	ORGANIZATION	of	_	0	SENT_88	[p8l684t1785r755b1846],
12	Texas	NNP	ORGANIZATION	Texas	nn	16	SENT_88	[p8l791t1791r974b1846],
13	M.D.	NNP	ORGANIZATION	M.D.	nn	16	SENT_88	[p8l1031t1791r1187b1846],
14	Anderson	NNP	ORGANIZATION	Anderson	nn	16	SENT_88	[p8l1237t1786r1561b1846],
15	Cancer	NNP	ORGANIZATION	Cancer	nn	16	SENT_88	[p8l1615t1790r1849b1846],
16	Center	NNP	ORGANIZATION	Center	prep_of	10	SENT_88	[p8l1896t1790r2130b1857],
17	,	,	O	,	_	0	SENT_88	[p8l1896t1790r2130b1857],
18	Houston	NNP	LOCATION	Houston	dep	10	SENT_88	[p8l16t1867r326b1921],
19	.	.	O	.	_	0	SENT_88	[p8l16t1867r326b1921],

1	1	LS	NUMBER	1	_	0	SENT_89	[p8l13t1973r61b2024],
2	.	.	O	.	_	0	SENT_89	[p8l13t1973r61b2024],

1	Chen	NNP	PERSON	Chen	nn	2	SENT_90	[p8l140t1965r307b2024],
2	H-Y	NNP	O	H-Y	_	0	SENT_90	[p8l331t1970r462b2036],
3	,	,	O	,	_	0	SENT_90	[p8l331t1970r462b2036],
4	Yu	NNP	O	Yu	nn	5	SENT_90	[p8l488t1970r567b2024],
5	S-L	NNP	O	S-L	appos	2	SENT_90	[p8l593t1969r712b2036],
6	,	,	O	,	_	0	SENT_90	[p8l593t1969r712b2036],
7	Chen	NNP	PERSON	Chen	nn	8	SENT_90	[p8l740t1965r908b2024],
8	C-H	NNP	O	C-H	appos	2	SENT_90	[p8l932t1969r1078b2037],
9	,	,	O	,	_	0	SENT_90	[p8l932t1969r1078b2037],
10	et	FW	O	et	nn	11	SENT_90	[p8l1107t1978r1166b2023],
11	al.	FW	O	al.	appos	2	SENT_90	[p8l1186t1965r1260b2024],
12	.	.	O	.	_	0	SENT_90	[p8l1186t1965r1260b2024],

1	A	DT	O	a	det	4	SENT_91	[p8l1285t1970r1334b2023],
2	five	CD	NUMBER	five	num	4	SENT_91	[p8l1356t1965r1656b2041],
3	—	NN	O	—	nn	4	SENT_91	[p8l1356t1965r1656b2041],
4	gene	NN	O	gene	_	0	SENT_91	[p8l1356t1965r1656b2041],
5	signature	NN	O	signature	nn	8	SENT_91	[p8l1681t1966r1990b2041],
6	and	CC	O	and	_	0	SENT_91	[p8l2014t1965r2134b2024],
7	clinical	JJ	O	clinical	conj_and	5	SENT_91	[p8l11t2044r252b2102],
8	outcome	NN	O	outcome	dep	4	SENT_91	[p8l286t2057r567b2103],
9	in	IN	O	in	_	0	SENT_91	[p8l601t2045r665b2102],
10	non-small-cell	JJ	O	non-small-cell	amod	12	SENT_91	[p8l698t2044r1193b2103],
11	lung	NN	O	lung	nn	12	SENT_91	[p8l1226t2044r1374b2120],
12	cancer	NN	O	cancer	prep_in	8	SENT_91	[p8l1406t2063r1635b2103],
13	.	.	O	.	_	0	SENT_91	[p8l1406t2063r1635b2103],

1	N	NN	O	n	nn	3	SENT_92	[p8l1672t2049r1728b2103],
2	Engl	NNP	O	Engl	nn	3	SENT_92	[p8l1760t2044r1908b2120],
3	J	NNP	O	J	nsubj	4	SENT_92	[p8l1934t2049r1962b2112],
4	Med	VBD	O	med	_	0	SENT_92	[p8l1993t2044r2134b2103],
5	2007	CD	DATE	2007	dobj	4	SENT_92	[p8l11t2144r515b2211],
6	;	:	O	;	_	0	SENT_92	[p8l11t2144r515b2211],
7	356:11	CD	NUMBER	356:11	number	8	SENT_92	[p8l11t2144r515b2211],
8	—	CD	NUMBER	—	dep	5	SENT_92	[p8l11t2144r515b2211],
9	20	CD	NUMBER	20	dep	8	SENT_92	[p8l11t2144r515b2211],
10	.	.	O	.	_	0	SENT_92	[p8l11t2144r515b2211],

1	2	LS	NUMBER	2	_	0	SENT_93	[p8l9t2226r61b2278],
2	.	.	O	.	_	0	SENT_93	[p8l9t2226r61b2278],

1	Fidler	NNP	PERSON	Fidler	nn	4	SENT_94	[p8l138t2219r327b2278],
2	U.	NNP	O	U.	nn	4	SENT_94	[p8l359t2224r424b2287],
3	The	NNP	O	The	nn	4	SENT_94	[p8l460t2219r582b2277],
4	pathogenesis	NN	O	pathogenesis	_	0	SENT_94	[p8l616t2219r1048b2295],
5	of	IN	O	of	_	0	SENT_94	[p8l1085t2219r1161b2278],
6	cancer	NN	O	cancer	nn	7	SENT_94	[p8l1182t2238r1398b2277],
7	metastasis	NN	O	metastasis	prep_of	4	SENT_94	[p8l1430t2220r1796b2278],
8	:	:	O	:	_	0	SENT_94	[p8l1430t2220r1796b2278],
9	the	DT	O	the	det	11	SENT_94	[p8l1834t2219r1936b2277],
10	‘	NN	O	‘	nn	11	SENT_94	[p8l1974t2219r2134b2278],
11	seed	NN	O	seed	dep	4	SENT_94	[p8l1974t2219r2134b2278],
12	and	CC	O	and	_	0	SENT_94	[p8l10t2298r130b2357],
13	soil	NN	O	soil	nn	15	SENT_94	[p8l157t2298r288b2357],
14	’	CD	NUMBER	’	num	15	SENT_94	[p8l157t2298r288b2357],
15	hypothesis	NN	O	hypothesis	dep	4	SENT_94	[p8l318t2298r673b2373],
16	revisited	VBN	O	revisit	partmod	15	SENT_94	[p8l700t2298r996b2358],
17	.	.	O	.	_	0	SENT_94	[p8l700t2298r996b2358],

1	Nat	NNP	O	Nat	nn	3	SENT_95	[p8l1025t2303r1143b2357],
2	Rev	NN	O	rev	nn	3	SENT_95	[p8l1164t2303r1284b2360],
3	Cancer	NN	O	cancer	_	0	SENT_95	[p8l1307t2302r1536b2357],
4	2003	CD	DATE	2003	dep	3	SENT_95	[p8l1559t2302r1997b2369],
5	;	:	O	;	_	0	SENT_95	[p8l1559t2302r1997b2369],
6	3:453	CD	NUMBER	3:453	number	7	SENT_95	[p8l1559t2302r1997b2369],
7	—	CD	NUMBER	—	dep	3	SENT_95	[p8l1559t2302r1997b2369],
8	8	CD	NUMBER	8	dep	7	SENT_95	[p8l1559t2302r1997b2369],
9	.	.	O	.	_	0	SENT_95	[p8l1559t2302r1997b2369],

1	3	LS	NUMBER	3	_	0	SENT_96	[p8l11t2383r61b2435],
2	.	.	O	.	_	0	SENT_96	[p8l11t2383r61b2435],

1	Potti	NNP	PERSON	Potti	nn	2	SENT_97	[p8l138t2377r295b2435],
2	A	NNP	O	A	_	0	SENT_97	[p8l321t2381r388b2447],
3	,	,	O	,	_	0	SENT_97	[p8l321t2381r388b2447],
4	Mukherjee	NNP	PERSON	Mukherjee	nn	5	SENT_97	[p8l420t2376r770b2451],
5	S	NNP	O	S	appos	2	SENT_97	[p8l801t2380r853b2447],
6	,	,	O	,	_	0	SENT_97	[p8l801t2380r853b2447],
7	Petersen	NNP	PERSON	Petersen	nn	8	SENT_97	[p8l886t2381r1164b2434],
8	R	NNP	PERSON	R	appos	2	SENT_97	[p8l1193t2381r1259b2447],
9	,	,	O	,	_	0	SENT_97	[p8l1193t2381r1259b2447],
10	et	FW	O	et	nn	11	SENT_97	[p8l1293t2389r1352b2434],
11	al.	FW	O	al.	appos	2	SENT_97	[p8l1378t2376r1452b2435],
12	.	.	O	.	_	0	SENT_97	[p8l1378t2376r1452b2435],

1	A	DT	O	a	det	3	SENT_98	[p8l1484t2381r1533b2434],
2	genomic	JJ	O	genomic	amod	3	SENT_98	[p8l1560t2377r1843b2452],
3	strategy	NN	O	strategy	nsubj	5	SENT_98	[p8l1873t2389r2138b2452],
4	to	TO	O	to	aux	5	SENT_98	[p8l11t2468r73b2514],
5	refine	VB	O	refine	_	0	SENT_98	[p8l109t2455r304b2513],
6	prognosis	NN	O	prognosis	dobj	5	SENT_98	[p8l338t2456r665b2531],
7	in	IN	O	in	_	0	SENT_98	[p8l701t2456r764b2513],
8	early	JJ	O	early	amod	13	SENT_98	[p8l800t2455r1154b2531],
9	—	JJ	O	—	amod	13	SENT_98	[p8l800t2455r1154b2531],
10	stage	NN	O	stage	nn	13	SENT_98	[p8l800t2455r1154b2531],
11	non-small-cell	JJ	O	non-small-cell	amod	13	SENT_98	[p8l1189t2455r1685b2514],
12	lung	NN	O	lung	nn	13	SENT_98	[p8l1719t2455r1867b2531],
13	cancer	NN	O	cancer	prep_in	5	SENT_98	[p8l1901t2474r2130b2514],
14	.	.	O	.	_	0	SENT_98	[p8l1901t2474r2130b2514],

1	N	NN	O	n	nn	3	SENT_99	[p8l9t2556r65b2610],
2	Engl	NNP	O	Engl	nn	3	SENT_99	[p8l88t2551r283b2627],
3	]	NNP	O	]	nsubj	4	SENT_99	[p8l88t2551r283b2627],
4	Med	VBD	O	med	_	0	SENT_99	[p8l305t2551r447b2610],
5	2006	CD	DATE	2006	dobj	4	SENT_99	[p8l472t2555r1034b2622],
6	;	:	O	;	_	0	SENT_99	[p8l472t2555r1034b2622],
7	355:570	CD	NUMBER	355:570	num	8	SENT_99	[p8l472t2555r1034b2622],
8	-80	CD	NUMBER	-80	dep	5	SENT_99	[p8l472t2555r1034b2622],
9	.	.	O	.	_	0	SENT_99	[p8l472t2555r1034b2622],

1	4	LS	NUMBER	4	_	0	SENT_100	[p8l9t2635r61b2686],
2	.	.	O	.	_	0	SENT_100	[p8l9t2635r61b2686],

1	Raponi	NN	MISC	raponus	nn	2	SENT_101	[p8l138t2628r376b2702],
2	M	NN	O	m	_	0	SENT_101	[p8l403t2632r486b2698],
3	,	,	O	,	_	0	SENT_101	[p8l403t2632r486b2698],
4	Zhang	NNP	PERSON	Zhang	nn	5	SENT_101	[p8l518t2627r729b2703],
5	Y	NN	PERSON	y	appos	2	SENT_101	[p8l754t2632r808b2699],
6	,	,	O	,	_	0	SENT_101	[p8l754t2632r808b2699],
7	Yu	NN	PERSON	yu	nn	8	SENT_101	[p8l840t2632r919b2686],
8	J	NN	PERSON	j	appos	2	SENT_101	[p8l941t2632r985b2698],
9	,	,	O	,	_	0	SENT_101	[p8l941t2632r985b2698],
10	et	FW	O	et	nn	11	SENT_101	[p8l1019t2640r1078b2685],
11	al.	FW	O	al.	appos	2	SENT_101	[p8l1103t2627r1178b2686],
12	.	.	O	.	_	0	SENT_101	[p8l1103t2627r1178b2686],

1	Gene	NN	O	gene	nn	3	SENT_102	[p8l1212t2631r1380b2686],
2	expression	NN	O	expression	nn	3	SENT_102	[p8l1410t2628r1760b2702],
3	signatures	NNS	O	signature	_	0	SENT_102	[p8l1791t2628r2133b2703],
4	for	IN	O	for	_	0	SENT_102	[p8l9t2723r104b2783],
5	predicting	VBG	O	predict	prepc_for	3	SENT_102	[p8l122t2724r467b2799],
6	prognosis	NN	O	prognosis	dobj	5	SENT_102	[p8l485t2724r813b2799],
7	of	IN	O	of	_	0	SENT_102	[p8l837t2723r914b2782],
8	squamous	JJ	O	squamous	amod	9	SENT_102	[p8l923t2743r1257b2799],
9	cell	NN	O	cell	prep_of	6	SENT_102	[p8l1281t2724r1394b2782],
10	and	CC	O	and	_	0	SENT_102	[p8l1415t2724r1536b2782],
11	adenocarcinomas	NNS	O	adenocarcinoma	conj_and	6	SENT_102	[p8l1557t2724r2138b2782],
12	of	IN	O	of	_	0	SENT_102	[p8l10t2819r86b2878],
13	the	DT	O	the	det	14	SENT_102	[p8l99t2820r200b2878],
14	lung	NN	O	lung	prep_of	11	SENT_102	[p8l225t2820r389b2895],
15	.	.	O	.	_	0	SENT_102	[p8l225t2820r389b2895],

1	Cancer	NN	O	cancer	_	0	SENT_103	[p8l419t2824r648b2878],
2	Res	NNP	O	Res	dep	1	SENT_103	[p8l671t2825r786b2882],
3	2006	CD	DATE	2006	num	2	SENT_103	[p8l814t2824r1375b2891],
4	;	:	O	;	_	0	SENT_103	[p8l814t2824r1375b2891],
5	66:7466	CD	NUMBER	66:7466	number	6	SENT_103	[p8l814t2824r1375b2891],
6	—	CD	NUMBER	—	dep	1	SENT_103	[p8l814t2824r1375b2891],
7	72	CD	NUMBER	72	dep	6	SENT_103	[p8l814t2824r1375b2891],
8	.	.	O	.	_	0	SENT_103	[p8l814t2824r1375b2891],

1	5	CD	NUMBER	5	_	0	SENT_104	[p8l10t2922r60b2973],
2	.	.	O	.	_	0	SENT_104	[p8l10t2922r60b2973],

1	Lossos	NNP	O	Lossos	nsubj	5	SENT_105	[p8l137t2920r360b2973],
2	IS	VBZ	O	be	cop	5	SENT_105	[p8l388t2919r469b2986],
3	,	,	O	,	_	0	SENT_105	[p8l388t2919r469b2986],
4	Czervvinski	NNP	PERSON	Czervvinski	nn	5	SENT_105	[p8l501t2915r876b2974],
5	DK	NNP	O	DK	_	0	SENT_105	[p8l902t2920r1022b2986],
6	,	,	O	,	_	0	SENT_105	[p8l902t2920r1022b2986],
7	Alizadeh	NNP	PERSON	Alizadeh	nn	8	SENT_105	[p8l1051t2915r1345b2973],
8	AA	NNP	O	AA	appos	5	SENT_105	[p8l1369t2920r1489b2986],
9	,	,	O	,	_	0	SENT_105	[p8l1369t2920r1489b2986],
10	et	FW	O	et	nn	11	SENT_105	[p8l1522t2927r1580b2973],
11	al.	FW	O	al.	appos	8	SENT_105	[p8l1603t2915r1678b2973],
12	.	.	O	.	_	0	SENT_105	[p8l1603t2915r1678b2973],

1	Prediction	NN	O	prediction	_	0	SENT_106	[p8l1709t2915r2050b2973],
2	of	IN	O	of	_	0	SENT_106	[p8l2078t2914r2153b2973],
3	survival	NN	O	survival	prep_of	1	SENT_106	[p8l11t3011r266b3071],
4	in	IN	O	in	_	0	SENT_106	[p8l295t3011r359b3068],
5	diffuse	JJ	O	diffuse	amod	6	SENT_106	[p8l389t3010r621b3070],
6	large	JJ	O	large	prep_in	1	SENT_106	[p8l650t3011r1032b3086],
7	.	.	O	.	_	0	SENT_106	[p8l650t3011r1032b3086],

1	—	NN	O	—	_	0	SENT_107	[p8l650t3011r1032b3086],
2	.	.	O	.	_	0	SENT_107	[p8l650t3011r1032b3086],

1	B	NN	O	b	_	0	SENT_108	[p8l650t3011r1032b3086],
2	.	.	O	.	_	0	SENT_108	[p8l650t3011r1032b3086],

1	—	NN	O	—	_	0	SENT_109	[p8l650t3011r1032b3086],
2	.	.	O	.	_	0	SENT_109	[p8l650t3011r1032b3086],

1	cell	NN	O	cell	nn	2	SENT_110	[p8l650t3011r1032b3086],
2	lymphoma	NN	O	lymphoma	nsubj	7	SENT_110	[p8l1060t3011r1413b3086],
3	based	VBN	O	base	_	0	SENT_110	[p8l1442t3011r1629b3069],
4	on	IN	O	on	prepc_based_on	2	SENT_110	[p8l1660t3030r1740b3069],
5	the	DT	O	the	det	6	SENT_110	[p8l1770t3011r1872b3069],
6	expres	NNS	O	expre	pobj	2	SENT_110	[p8l1902t3030r2138b3086],
7	—	VBP	O	—	_	0	SENT_110	[p8l1902t3030r2138b3086],
8	sion	NN	O	sion	dobj	7	SENT_110	[p8l11t3107r145b3165],
9	of	IN	O	of	_	0	SENT_110	[p8l171t3106r248b3165],
10	six	CD	NUMBER	six	num	11	SENT_110	[p8l261t3107r351b3165],
11	genes	NNS	O	gene	prep_of	8	SENT_110	[p8l375t3126r580b3182],
12	.	.	O	.	_	0	SENT_110	[p8l375t3126r580b3182],

1	N	NN	O	n	nn	3	SENT_111	[p8l608t3112r664b3166],
2	Engl	NNP	O	Engl	nn	3	SENT_111	[p8l688t3107r883b3182],
3	]	NNP	O	]	nsubj	4	SENT_111	[p8l688t3107r883b3182],
4	Med	VBD	O	med	_	0	SENT_111	[p8l906t3107r1047b3165],
5	2004	CD	DATE	2004	dobj	4	SENT_111	[p8l1074t3111r1666b3178],
6	;	:	O	;	_	0	SENT_111	[p8l1074t3111r1666b3178],
7	350:1828	CD	NUMBER	350:1828	number	8	SENT_111	[p8l1074t3111r1666b3178],
8	—	CD	NUMBER	—	dep	5	SENT_111	[p8l1074t3111r1666b3178],
9	37	CD	NUMBER	37	dep	8	SENT_111	[p8l1074t3111r1666b3178],
10	.	.	O	.	_	0	SENT_111	[p8l1074t3111r1666b3178],

1	6	CD	NUMBER	6	_	0	SENT_112	[p8l9t3209r60b3261],
2	.	.	O	.	_	0	SENT_112	[p8l9t3209r60b3261],

1	Fan	NN	O	fan	_	0	SENT_113	[p8l137t3208r256b3261],
2	C	NN	O	c	dep	1	SENT_113	[p8l288t3207r351b3274],
3	,	,	O	,	_	0	SENT_113	[p8l288t3207r351b3274],
4	Oh	UH	O	oh	dep	5	SENT_113	[p8l387t3203r483b3261],
5	DS	NN	O	d	dobj	2	SENT_113	[p8l513t3207r622b3274],
6	,	,	O	,	_	0	SENT_113	[p8l513t3207r622b3274],
7	Wessels	NNP	PERSON	Wessels	nn	8	SENT_113	[p8l655t3203r914b3261],
8	L	NNP	O	L	appos	1	SENT_113	[p8l946t3208r1004b3274],
9	,	,	O	,	_	0	SENT_113	[p8l946t3208r1004b3274],
10	et	FW	O	et	nn	11	SENT_113	[p8l1040t3215r1099b3261],
11	al.	FW	O	al.	appos	8	SENT_113	[p8l1126t3203r1201b3261],
12	.	.	O	.	_	0	SENT_113	[p8l1126t3203r1201b3261],

1	Concordance	NN	O	concordance	nsubj	5	SENT_114	[p8l1237t3203r1669b3261],
2	among	IN	O	among	_	0	SENT_114	[p8l1701t3222r1930b3278],
3	geneexpression	NN	O	geneexpression	nn	4	SENT_114	[p8l1959t3222r2138b3278, p8l10t3299r614b3374],
4	—	NN	O	—	prep_among	1	SENT_114	[p8l1959t3222r2138b3278, p8l10t3299r614b3374],
5	based	VBN	O	base	_	0	SENT_114	[p8l1959t3222r2138b3278, p8l10t3299r614b3374],
6	predictors	NNS	O	predictor	dobj	5	SENT_114	[p8l647t3299r993b3374],
7	for	IN	O	for	_	0	SENT_114	[p8l1028t3298r1125b3357],
8	breast	NN	O	breast	nn	9	SENT_114	[p8l1157t3299r1365b3357],
9	cancer	NN	O	cancer	prep_for	6	SENT_114	[p8l1396t3318r1633b3357],
10	.	.	O	.	_	0	SENT_114	[p8l1396t3318r1633b3357],

1	N	NN	O	n	nn	3	SENT_115	[p8l1669t3304r1726b3358],
2	Engl	NNP	O	Engl	nn	3	SENT_115	[p8l1757t3299r1910b3374],
3	J	NNP	O	J	nsubj	4	SENT_115	[p8l1935t3304r1964b3367],
4	Med	VBD	O	med	_	0	SENT_115	[p8l1994t3299r2139b3357],
5	2006	CD	DATE	2006	dobj	4	SENT_115	[p8l9t3398r531b3465],
6	;	:	O	;	_	0	SENT_115	[p8l9t3398r531b3465],
7	355:560	CD	NUMBER	355:560	number	8	SENT_115	[p8l9t3398r531b3465],
8	—	CD	NUMBER	—	dep	5	SENT_115	[p8l9t3398r531b3465],
9	9	CD	NUMBER	9	dep	8	SENT_115	[p8l9t3398r531b3465],
10	.	.	O	.	_	0	SENT_115	[p8l9t3398r531b3465],

1	7	CD	NUMBER	7	_	0	SENT_116	[p8l11t3498r60b3549],
2	.	.	O	.	_	0	SENT_116	[p8l11t3498r60b3549],

1	Paik	NNP	PERSON	Paik	nn	2	SENT_117	[p8l137t3491r283b3550],
2	S	NNP	PERSON	S	_	0	SENT_117	[p8l304t3495r355b3562],
3	,	,	O	,	_	0	SENT_117	[p8l304t3495r355b3562],
4	Tang	NNP	PERSON	Tang	nn	5	SENT_117	[p8l381t3495r548b3566],
5	G	NNP	PERSON	G	appos	2	SENT_117	[p8l569t3495r639b3562],
6	,	,	O	,	_	0	SENT_117	[p8l569t3495r639b3562],
7	Shak	NNP	PERSON	Shak	nn	8	SENT_117	[p8l668t3491r830b3551],
8	S	NNP	O	S	appos	2	SENT_117	[p8l850t3495r902b3562],
9	,	,	O	,	_	0	SENT_117	[p8l850t3495r902b3562],
10	et	FW	O	et	nn	11	SENT_117	[p8l931t3503r990b3549],
11	al.	FW	O	al.	appos	2	SENT_117	[p8l1009t3491r1083b3549],
12	.	.	O	.	_	0	SENT_117	[p8l1009t3491r1083b3549],

1	Gene	NN	O	gene	nn	2	SENT_118	[p8l1111t3495r1280b3549],
2	expression	NN	O	expression	_	0	SENT_118	[p8l1303t3491r1655b3566],
3	and	CC	O	and	_	0	SENT_118	[p8l1678t3491r1798b3549],
4	benefit	NN	O	benefit	conj_and	2	SENT_118	[p8l1822t3490r2056b3549],
5	of	IN	O	of	_	0	SENT_118	[p8l2077t3490r2153b3549],
6	chemotherapy	NN	O	chemotherapy	prep_of	2	SENT_118	[p8l10t3587r479b3662],
7	in	IN	O	in	_	0	SENT_118	[p8l501t3587r564b3644],
8	women	NNS	O	woman	prep_in	2	SENT_118	[p8l586t3606r827b3646],
9	with	IN	O	with	_	0	SENT_118	[p8l849t3587r998b3646],
10	node	NN	O	node	npadvmod	12	SENT_118	[p8l1023t3587r1503b3662],
11	—	CD	NUMBER	—	num	10	SENT_118	[p8l1023t3587r1503b3662],
12	negative	JJ	O	negative	amod	17	SENT_118	[p8l1023t3587r1503b3662],
13	,	,	O	,	_	0	SENT_118	[p8l1023t3587r1503b3662],
14	estrogen	NN	O	estrogen	npadvmod	15	SENT_118	[p8l1532t3599r1818b3662],
15	receptorpositive	JJ	O	receptorpositive	amod	17	SENT_118	[p8l1842t3599r2138b3662, p8l8t3683r263b3758],
16	breast	NN	O	breast	nn	17	SENT_118	[p8l290t3683r491b3741],
17	cancer	NN	O	cancer	prep_with	8	SENT_118	[p8l514t3702r744b3741],
18	.	.	O	.	_	0	SENT_118	[p8l514t3702r744b3741],

1	J	NNP	O	J	nn	3	SENT_119	[p8l767t3688r795b3751],
2	Clin	NNP	O	Clin	nn	3	SENT_119	[p8l819t3683r955b3741],
3	Oncol	NNP	O	Oncol	_	0	SENT_119	[p8l981t3683r1176b3741],
4	2006	CD	DATE	2006	num	3	SENT_119	[p8l1201t3687r1765b3754],
5	;	:	O	;	_	0	SENT_119	[p8l1201t3687r1765b3754],
6	24:3726	CD	NUMBER	24:3726	number	7	SENT_119	[p8l1201t3687r1765b3754],
7	—	CD	NUMBER	—	dep	3	SENT_119	[p8l1201t3687r1765b3754],
8	34	CD	NUMBER	34	dep	7	SENT_119	[p8l1201t3687r1765b3754],
9	.	.	O	.	_	0	SENT_119	[p8l1201t3687r1765b3754],

1	8	CD	NUMBER	8	_	0	SENT_120	[p9l8t22r60b76],
2	.	.	O	.	_	0	SENT_120	[p9l8t22r60b76],

1	Olaussen	JJ	PERSON	olaussen	amod	2	SENT_121	[p9l139t17r430b76],
2	KA	NN	O	ka	_	0	SENT_121	[p9l453t22r571b88],
3	,	,	O	,	_	0	SENT_121	[p9l453t22r571b88],
4	Dunant	NNP	PERSON	Dunant	nn	5	SENT_121	[p9l598t22r843b76],
5	A	NNP	O	A	appos	2	SENT_121	[p9l860t22r926b88],
6	,	,	O	,	_	0	SENT_121	[p9l860t22r926b88],
7	Fouret	NNP	O	Fouret	nn	8	SENT_121	[p9l953t22r1162b76],
8	P	NN	O	p	appos	2	SENT_121	[p9l1180t22r1230b88],
9	,	,	O	,	_	0	SENT_121	[p9l1180t22r1230b88],
10	et	FW	O	et	nn	11	SENT_121	[p9l1259t29r1316b75],
11	al.	FW	O	al.	appos	2	SENT_121	[p9l1336t17r1408b75],
12	.	.	O	.	_	0	SENT_121	[p9l1336t17r1408b75],

1	DNA	NN	O	dna	nn	2	SENT_122	[p9l1435t22r1592b76],
2	repair	NN	O	repair	nsubj	16	SENT_122	[p9l1613t17r1804b92],
3	by	IN	O	by	_	0	SENT_122	[p9l1826t17r1899b92],
4	ERCC1	NN	O	ercc1	prep_by	2	SENT_122	[p9l1918t21r2139b79],
5	in	IN	O	in	_	0	SENT_122	[p9l8t113r72b170],
6	non	JJ	O	non	amod	12	SENT_122	[p9l98t113r594b171],
7	—	JJ	O	—	amod	12	SENT_122	[p9l98t113r594b171],
8	small	JJ	O	small	amod	12	SENT_122	[p9l98t113r594b171],
9	—	NN	O	—	nn	12	SENT_122	[p9l98t113r594b171],
10	cell	NN	O	cell	nn	12	SENT_122	[p9l98t113r594b171],
11	lung	NN	O	lung	nn	12	SENT_122	[p9l619t113r768b188],
12	cancer	NN	O	cancer	prep_in	4	SENT_122	[p9l792t132r1007b171],
13	and	CC	O	and	_	0	SENT_122	[p9l1030t113r1151b171],
14	cisplatin	NN	O	cisplatin	nn	15	SENT_122	[p9l1177t113r1676b188],
15	—	NN	O	—	prep_in	4	SENT_122	[p9l1177t113r1676b188],
16	based	VBN	O	base	_	0	SENT_122	[p9l1177t113r1676b188],
17	adjuvant	JJ	O	adjuvant	amod	18	SENT_122	[p9l1701t113r1980b188],
18	chemotherapy	NN	O	chemotherapy	dobj	16	SENT_122	[p9l2003t113r2138b171, p9l9t209r376b284],
19	.	.	O	.	_	0	SENT_122	[p9l2003t113r2138b171, p9l9t209r376b284],

1	N	NN	O	n	nn	2	SENT_123	[p9l404t214r460b268],
2	EnglJ	NN	O	englj	nsubj	3	SENT_123	[p9l484t209r679b284],
3	Med	VBD	O	med	_	0	SENT_123	[p9l701t209r843b267],
4	2006	CD	DATE	2006	dobj	3	SENT_123	[p9l869t213r1430b280],
5	;	:	O	;	_	0	SENT_123	[p9l869t213r1430b280],
6	355:983	CD	NUMBER	355:983	num	7	SENT_123	[p9l869t213r1430b280],
7	-91	CD	NUMBER	-91	dep	4	SENT_123	[p9l869t213r1430b280],
8	.	.	O	.	_	0	SENT_123	[p9l869t213r1430b280],

1	9	CD	NUMBER	9	_	0	SENT_124	[p9l9t311r60b363],
2	.	.	O	.	_	0	SENT_124	[p9l9t311r60b363],

1	Pao	NNP	PERSON	Pao	nn	2	SENT_125	[p9l137t310r253b363],
2	W	NNP	PERSON	W	_	0	SENT_125	[p9l283t310r365b376],
3	,	,	O	,	_	0	SENT_125	[p9l283t310r365b376],
4	Wang	NNP	PERSON	Wang	nn	5	SENT_125	[p9l399t310r590b380],
5	TY	NNP	PERSON	TY	appos	2	SENT_125	[p9l618t309r720b376],
6	,	,	O	,	_	0	SENT_125	[p9l618t309r720b376],
7	Riely	NNP	PERSON	Riely	nn	9	SENT_125	[p9l756t305r922b380],
8	G	NNP	O	G	nn	9	SENT_125	[p9l950t309r1042b376],
9	]	NNS	O	]	appos	2	SENT_125	[p9l950t309r1042b376],
10	,	,	O	,	_	0	SENT_125	[p9l950t309r1042b376],
11	et	FW	O	et	nn	12	SENT_125	[p9l1079t317r1139b363],
12	al.	FW	O	al.	appos	2	SENT_125	[p9l1167t305r1241b363],
13	.	.	O	.	_	0	SENT_125	[p9l1167t305r1241b363],

1	KRAS	NNP	ORGANIZATION	KRAS	_	0	SENT_126	[p9l1277t309r1469b367],
2	mutations	NNS	O	mutation	dep	1	SENT_126	[p9l1503t305r1836b364],
3	and	CC	O	and	_	0	SENT_126	[p9l1870t305r1990b363],
4	primary	JJ	O	primary	amod	5	SENT_126	[p9l2022t305r2138b380, p9l9t420r182b476],
5	resistance	NN	O	resistance	dep	1	SENT_126	[p9l209t401r546b459],
6	of	IN	O	of	_	0	SENT_126	[p9l576t400r654b459],
7	lung	NN	O	lung	nn	8	SENT_126	[p9l668t401r820b476],
8	adenocarcinomas	NNS	O	adenocarcinoma	prep_of	1	SENT_126	[p9l846t401r1439b459],
9	to	TO	O	to	_	0	SENT_126	[p9l1471t413r1534b459],
10	gefitinib	NN	O	gefitinib	nn	14	SENT_126	[p9l1564t400r1857b476],
11	or	CC	O	or	_	0	SENT_126	[p9l1889t420r1958b459],
12	erlo	JJ	O	erlo	conj_or	10	SENT_126	[p9l1986t401r2138b459],
13	—	NN	O	—	nn	14	SENT_126	[p9l1986t401r2138b459],
14	tinib	NN	O	tinib	prep_to	8	SENT_126	[p9l9t497r187b555],
15	.	.	O	.	_	0	SENT_126	[p9l9t497r187b555],

1	PLoS	NNP	O	PLoS	nn	2	SENT_127	[p9l218t501r376b555],
2	Med	NNP	O	Med	_	0	SENT_127	[p9l402t497r544b555],
3	2005	CD	DATE	2005	num	5	SENT_127	[p9l571t501r933b568],
4	;	:	O	;	_	0	SENT_127	[p9l571t501r933b568],
5	2	CD	NUMBER	2	dep	2	SENT_127	[p9l571t501r933b568],
6	:	:	O	:	_	0	SENT_127	[p9l571t501r933b568],
7	e17	NN	O	e17	dep	2	SENT_127	[p9l571t501r933b568],
8	.	.	O	.	_	0	SENT_127	[p9l571t501r933b568],

1	10	CD	NUMBER	10	_	0	SENT_128	[p9l12t598r98b651],
2	.	.	O	.	_	0	SENT_128	[p9l12t598r98b651],

1	Winton	NNP	PERSON	Winton	nn	2	SENT_129	[p9l136t593r384b651],
2	T	NN	O	t	_	0	SENT_129	[p9l413t597r472b664],
3	,	,	O	,	_	0	SENT_129	[p9l413t597r472b664],
4	Livingston	NNP	PERSON	Livingston	nn	5	SENT_129	[p9l506t593r857b668],
5	R	NNP	PERSON	R	appos	2	SENT_129	[p9l888t598r953b664],
6	,	,	O	,	_	0	SENT_129	[p9l888t598r953b664],
7	Johnson	NNP	PERSON	Johnson	nn	8	SENT_129	[p9l981t593r1258b661],
8	D	NNP	O	D	appos	2	SENT_129	[p9l1289t598r1356b664],
9	,	,	O	,	_	0	SENT_129	[p9l1289t598r1356b664],
10	et	FW	O	et	nn	11	SENT_129	[p9l1393t605r1452b651],
11	al.	FW	O	al.	appos	2	SENT_129	[p9l1479t593r1554b651],
12	.	.	O	.	_	0	SENT_129	[p9l1479t593r1554b651],

1	Vinorelbine	NN	O	vinorelbine	_	0	SENT_130	[p9l1587t593r1972b651],
2	plus	CC	O	plus	prep	1	SENT_130	[p9l2003t593r2137b668],
3	cisplatin	NN	O	cisplatin	dep	2	SENT_130	[p9l10t689r292b764],
4	vs.	CC	O	vs.	prep	1	SENT_130	[p9l312t708r396b748],
5	observation	NN	O	observation	dep	4	SENT_130	[p9l425t689r810b748],
6	in	IN	O	in	_	0	SENT_130	[p9l833t689r897b746],
7	resected	JJ	O	resected	amod	9	SENT_130	[p9l921t689r1192b747],
8	non	JJ	O	non	amod	9	SENT_130	[p9l1215t689r1712b747],
9	—	NN	O	—	prep_in	1	SENT_130	[p9l1215t689r1712b747],
10	small	JJ	O	small	amod	14	SENT_130	[p9l1215t689r1712b747],
11	—	NN	O	—	nn	14	SENT_130	[p9l1215t689r1712b747],
12	cell	NN	O	cell	nn	14	SENT_130	[p9l1215t689r1712b747],
13	lung	NN	O	lung	nn	14	SENT_130	[p9l1734t689r1883b764],
14	cancer	NN	O	cancer	dep	9	SENT_130	[p9l1905t708r2135b747],
15	.	.	O	.	_	0	SENT_130	[p9l1905t708r2135b747],

1	N	NN	O	n	nn	3	SENT_131	[p9l7t790r64b844],
2	Engl	NNP	O	Engl	nn	3	SENT_131	[p9l87t785r283b860],
3	]	NNP	O	]	nsubj	4	SENT_131	[p9l87t785r283b860],
4	Med	VBD	O	med	_	0	SENT_131	[p9l305t785r447b843],
5	2005	CD	DATE	2005	dobj	4	SENT_131	[p9l473t789r1066b856],
6	;	:	O	;	_	0	SENT_131	[p9l473t789r1066b856],
7	352:2589	CD	NUMBER	352:2589	number	8	SENT_131	[p9l473t789r1066b856],
8	—	CD	NUMBER	—	dep	5	SENT_131	[p9l473t789r1066b856],
9	97	CD	NUMBER	97	dep	8	SENT_131	[p9l473t789r1066b856],
10	.	.	O	.	_	0	SENT_131	[p9l473t789r1066b856],

1	11	CD	NUMBER	11	_	0	SENT_132	[p9l12t888r98b939],
2	.	.	O	.	_	0	SENT_132	[p9l12t888r98b939],

1	Lynch	NNP	PERSON	Lynch	nn	2	SENT_133	[p9l137t881r332b956],
2	TJ	NNP	PERSON	TJ	_	0	SENT_133	[p9l355t885r442b952],
3	,	,	O	,	_	0	SENT_133	[p9l355t885r442b952],
4	Bell	NNP	ORGANIZATION	Bell	nn	5	SENT_133	[p9l470t881r596b939],
5	DW	NNP	ORGANIZATION	DW	appos	2	SENT_133	[p9l619t886r752b952],
6	,	,	O	,	_	0	SENT_133	[p9l619t886r752b952],
7	Sordella	NNP	PERSON	Sordella	nn	8	SENT_133	[p9l783t881r1051b939],
8	R	NNP	PERSON	R	appos	2	SENT_133	[p9l1074t886r1140b952],
9	,	,	O	,	_	0	SENT_133	[p9l1074t886r1140b952],
10	et	FW	O	et	nn	11	SENT_133	[p9l1170t893r1229b939],
11	al.	FW	O	al.	appos	2	SENT_133	[p9l1250t881r1325b939],
12	.	.	O	.	_	0	SENT_133	[p9l1250t881r1325b939],

1	Activating	VBG	O	activate	amod	2	SENT_134	[p9l1352t881r1692b956],
2	mutations	NNS	O	mutation	_	0	SENT_134	[p9l1715t881r2049b940],
3	in	IN	O	in	_	0	SENT_134	[p9l2075t881r2139b938],
4	the	DT	O	the	det	7	SENT_134	[p9l9t977r111b1035],
5	epidermal	JJ	O	epidermal	amod	7	SENT_134	[p9l135t977r468b1052],
6	growth	NN	O	growth	nn	7	SENT_134	[p9l491t977r731b1052],
7	factor	NN	O	factor	prep_in	2	SENT_134	[p9l754t976r948b1035],
8	receptor	NN	O	receptor	nn	10	SENT_134	[p9l969t989r1243b1052],
9	underlying	VBG	O	underlie	amod	10	SENT_134	[p9l1264t977r1623b1052],
10	responsiveness	NN	O	responsiveness	dep	2	SENT_134	[p9l1643t977r2137b1052],
11	of	IN	O	of	_	0	SENT_134	[p9l10t1072r86b1131],
12	non	JJ	O	non	amod	18	SENT_134	[p9l101t1073r598b1131],
13	—	JJ	O	—	amod	18	SENT_134	[p9l101t1073r598b1131],
14	small	JJ	O	small	amod	18	SENT_134	[p9l101t1073r598b1131],
15	—	NN	O	—	nn	18	SENT_134	[p9l101t1073r598b1131],
16	cell	NN	O	cell	nn	18	SENT_134	[p9l101t1073r598b1131],
17	lung	NN	O	lung	nn	18	SENT_134	[p9l626t1073r775b1148],
18	cancer	NN	O	cancer	prep_of	10	SENT_134	[p9l803t1092r1019b1131],
19	to	TO	O	to	_	0	SENT_134	[p9l1047t1085r1109b1131],
20	gefitinib	NN	O	gefitinib	prep_to	10	SENT_134	[p9l1140t1072r1444b1148],
21	.	.	O	.	_	0	SENT_134	[p9l1140t1072r1444b1148],

1	N	NN	O	n	nn	3	SENT_135	[p9l1476t1078r1532b1132],
2	Engl	NNP	O	Engl	nn	3	SENT_135	[p9l1560t1073r1709b1148],
3	J	NNP	O	J	nsubj	4	SENT_135	[p9l1731t1078r1760b1141],
4	Med	VBD	O	med	_	0	SENT_135	[p9l1785t1073r1928b1131],
5	2004	CD	DATE	2004	dobj	4	SENT_135	[p9l1957t1077r2136b1144],
6	;	:	O	;	_	0	SENT_135	[p9l1957t1077r2136b1144],
7	350:2129	CD	NUMBER	350:2129	number	8	SENT_135	[p9l10t1173r426b1227],
8	—	CD	NUMBER	—	dep	5	SENT_135	[p9l10t1173r426b1227],
9	39	CD	NUMBER	39	dep	8	SENT_135	[p9l10t1173r426b1227],
10	.	.	O	.	_	0	SENT_135	[p9l10t1173r426b1227],

1	12	CD	NUMBER	12	_	0	SENT_136	[p9l12t1271r98b1322],
2	.	.	O	.	_	0	SENT_136	[p9l12t1271r98b1322],

1	Tsao	NNP	PERSON	Tsao	nn	2	SENT_137	[p9l136t1268r288b1322],
2	MS	NN	O	m	_	0	SENT_137	[p9l310t1268r431b1335],
3	,	,	O	,	_	0	SENT_137	[p9l310t1268r431b1335],
4	Sakurada	NNP	ORGANIZATION	Sakurada	nn	5	SENT_137	[p9l461t1264r769b1323],
5	A	NNP	ORGANIZATION	A	appos	2	SENT_137	[p9l788t1269r856b1335],
6	,	,	O	,	_	0	SENT_137	[p9l788t1269r856b1335],
7	Cutz	NNP	O	Cutz	nn	8	SENT_137	[p9l884t1268r1034b1323],
8	JC	NNP	O	JC	appos	2	SENT_137	[p9l1049t1268r1144b1335],
9	,	,	O	,	_	0	SENT_137	[p9l1049t1268r1144b1335],
10	et	FW	O	et	nn	11	SENT_137	[p9l1172t1276r1231b1322],
11	al.	FW	O	al.	appos	2	SENT_137	[p9l1251t1264r1325b1322],
12	.	.	O	.	_	0	SENT_137	[p9l1251t1264r1325b1322],

1	Erlotinib	NNP	O	Erlotinib	_	0	SENT_138	[p9l1352t1264r1645b1322],
2	in	IN	O	in	_	0	SENT_138	[p9l1669t1264r1733b1321],
3	lung	NN	O	lung	nn	4	SENT_138	[p9l1755t1264r1904b1339],
4	cancer	NN	O	cancer	prep_in	1	SENT_138	[p9l1925t1283r2141b1322],
5	—	CD	NUMBER	—	number	6	SENT_138	[p9l7t1394r92b1400],
6	molecular	JJ	O	molecular	dep	1	SENT_138	[p9l119t1360r451b1419],
7	and	CC	O	and	_	0	SENT_138	[p9l478t1360r598b1419],
8	clinical	JJ	O	clinical	amod	9	SENT_138	[p9l628t1360r870b1418],
9	predictors	NNS	O	predictor	dep	1	SENT_138	[p9l898t1360r1233b1435],
10	of	IN	O	of	_	0	SENT_138	[p9l1264t1359r1341b1418],
11	outcome	NN	O	outcome	prep_of	6	SENT_138	[p9l1356t1372r1657b1419],
12	.	.	O	.	_	0	SENT_138	[p9l1356t1372r1657b1419],

1	N	NN	O	n	nn	3	SENT_139	[p9l1689t1365r1746b1419],
2	Engl	NNP	O	Engl	nn	3	SENT_139	[p9l1773t1360r1922b1435],
3	J	NNP	O	J	nsubj	4	SENT_139	[p9l1943t1365r1971b1428],
4	Med	VBD	O	med	_	0	SENT_139	[p9l1996t1360r2139b1418],
5	2005	CD	DATE	2005	dobj	4	SENT_139	[p9l9t1460r571b1527],
6	;	:	O	;	_	0	SENT_139	[p9l9t1460r571b1527],
7	353:133	CD	NUMBER	353:133	number	8	SENT_139	[p9l9t1460r571b1527],
8	—	CD	NUMBER	—	dep	5	SENT_139	[p9l9t1460r571b1527],
9	44	CD	NUMBER	44	dep	8	SENT_139	[p9l9t1460r571b1527],
10	.	.	O	.	_	0	SENT_139	[p9l9t1460r571b1527],

1	[	NN	O	[	nn	2	SENT_140	[p9l608t1461r923b1527],
2	Erratum	NN	O	erratum	nsubj	7	SENT_140	[p9l608t1461r923b1527],
3	,	,	O	,	_	0	SENT_140	[p9l608t1461r923b1527],
4	N	NN	O	n	appos	2	SENT_140	[p9l951t1461r1008b1515],
5	Engl	NNP	O	Engl	nn	6	SENT_140	[p9l1031t1456r1227b1531],
6	]	NNP	O	]	dep	4	SENT_140	[p9l1031t1456r1227b1531],
7	Med	VBD	O	med	_	0	SENT_140	[p9l1249t1456r1391b1514],
8	2006	CD	DATE	2006	dobj	7	SENT_140	[p9l1417t1460r1928b1527],
9	;	:	O	;	_	0	SENT_140	[p9l1417t1460r1928b1527],
10	355:1746	CD	NUMBER	355:1746	dep	8	SENT_140	[p9l1417t1460r1928b1527],
11	.	.	O	.	_	0	SENT_140	[p9l1417t1460r1928b1527],
12	]	SYM	O	]	dep	8	SENT_140	[p9l1417t1460r1928b1527],

1	13	CD	NUMBER	13	_	0	SENT_141	[p9l12t1558r98b1610],
2	.	.	O	.	_	0	SENT_141	[p9l12t1558r98b1610],

1	Potti	NNP	PERSON	Potti	nn	2	SENT_142	[p9l137t1552r294b1610],
2	A	NNP	O	A	_	0	SENT_142	[p9l319t1557r385b1623],
3	,	,	O	,	_	0	SENT_142	[p9l319t1557r385b1623],
4	Dressman	NNP	O	Dressman	nn	5	SENT_142	[p9l416t1557r750b1610],
5	HK	NNP	MISC	HK	appos	2	SENT_142	[p9l777t1557r903b1623],
6	,	,	O	,	_	0	SENT_142	[p9l777t1557r903b1623],
7	Bild	NNP	O	Bild	nn	8	SENT_142	[p9l933t1552r1064b1610],
8	A	NNP	O	A	appos	2	SENT_142	[p9l1089t1557r1156b1623],
9	,	,	O	,	_	0	SENT_142	[p9l1089t1557r1156b1623],
10	et	FW	O	et	nn	11	SENT_142	[p9l1188t1564r1247b1610],
11	al.	FW	O	al.	appos	2	SENT_142	[p9l1271t1552r1345b1610],
12	.	.	O	.	_	0	SENT_142	[p9l1271t1552r1345b1610],

1	Genomic	JJ	O	genomic	amod	2	SENT_143	[p9l1377t1552r1676b1610],
2	signatures	NNS	O	signature	nsubj	4	SENT_143	[p9l1704t1552r2047b1627],
3	to	TO	O	to	aux	4	SENT_143	[p9l2077t1564r2139b1610],
4	guide	VB	O	guide	_	0	SENT_143	[p9l9t1648r192b1723],
5	the	DT	O	the	det	6	SENT_143	[p9l235t1648r336b1706],
6	use	NN	O	use	dobj	4	SENT_143	[p9l379t1667r486b1707],
7	of	IN	O	of	_	0	SENT_143	[p9l529t1647r606b1706],
8	chemotherapeutics	NNS	O	chemotherapeutic	prep_of	6	SENT_143	[p9l634t1648r1282b1723],
9	.	.	O	.	_	0	SENT_143	[p9l634t1648r1282b1723],

1	Nat	NNP	O	Nat	nn	2	SENT_144	[p9l1326t1653r1446b1707],
2	Med	NNP	O	Med	_	0	SENT_144	[p9l1482t1648r1624b1706],
3	2006	CD	DATE	2006	num	2	SENT_144	[p9l1666t1652r2138b1719],
4	;	:	O	;	_	0	SENT_144	[p9l1666t1652r2138b1719],
5	12:1294	CD	NUMBER	12:1294	num	6	SENT_144	[p9l1666t1652r2138b1719],
6	—	NN	O	—	dep	2	SENT_144	[p9l1666t1652r2138b1719],
7	300	CD	NUMBER	300	dep	6	SENT_144	[p9l10t1746r145b1800],
8	.	.	O	.	_	0	SENT_144	[p9l10t1746r145b1800],

1	14	CD	NUMBER	14	_	0	SENT_145	[p9l12t1846r98b1897],
2	.	.	O	.	_	0	SENT_145	[p9l12t1846r98b1897],

1	Fujimoto	NNP	PERSON	Fujimoto	nn	2	SENT_146	[p9l137t1839r433b1914],
2	N	NNP	O	N	_	0	SENT_146	[p9l469t1844r541b1910],
3	,	,	O	,	_	0	SENT_146	[p9l469t1844r541b1910],
4	Wislez	NNP	O	Wislez	nn	5	SENT_146	[p9l579t1839r799b1897],
5	M	NNP	O	M	appos	2	SENT_146	[p9l833t1844r916b1910],
6	,	,	O	,	_	0	SENT_146	[p9l833t1844r916b1910],
7	Zhang	NNP	PERSON	Zhang	nn	8	SENT_146	[p9l956t1839r1168b1914],
8	J	NNP	PERSON	J	appos	2	SENT_146	[p9l1194t1844r1238b1910],
9	,	,	O	,	_	0	SENT_146	[p9l1194t1844r1238b1910],
10	et	FW	O	et	nn	11	SENT_146	[p9l1280t1851r1338b1897],
11	al.	FW	O	al.	appos	2	SENT_146	[p9l1371t1839r1446b1897],
12	.	.	O	.	_	0	SENT_146	[p9l1371t1839r1446b1897],

1	High	JJ	O	high	amod	2	SENT_147	[p9l1486t1839r1651b1914],
2	expression	NN	O	expression	_	0	SENT_147	[p9l1688t1839r2039b1914],
3	of	IN	O	of	_	0	SENT_147	[p9l2077t1838r2153b1897],
4	ErbB	NN	O	erbb	nn	6	SENT_147	[p9l8t1935r164b1993],
5	family	NN	O	family	nn	6	SENT_147	[p9l198t1934r410b2010],
6	members	NNS	O	member	prep_of	2	SENT_147	[p9l439t1935r743b1993],
7	and	CC	O	and	_	0	SENT_147	[p9l778t1935r898b1993],
8	their	PRP$	O	they	poss	9	SENT_147	[p9l932t1935r1088b1993],
9	ligands	NNS	O	ligand	prep_of	2	SENT_147	[p9l1118t1935r1359b2010],
10	in	IN	O	in	_	0	SENT_147	[p9l1393t1935r1457b1992],
11	lung	NN	O	lung	nn	12	SENT_147	[p9l1488t1935r1637b2010],
12	adenocarcinomas	NNS	O	adenocarcinoma	prep_in	9	SENT_147	[p9l1668t1935r2138b1993, p9l9t2050r142b2089],
13	that	WDT	O	that	nsubj	15	SENT_147	[p9l173t2031r305b2089],
14	are	VBP	O	be	cop	15	SENT_147	[p9l330t2050r429b2089],
15	sensitive	JJ	O	sensitive	rcmod	9	SENT_147	[p9l460t2031r741b2090],
16	to	TO	O	to	_	0	SENT_147	[p9l771t2043r834b2089],
17	inhibition	NN	O	inhibition	prep_to	15	SENT_147	[p9l863t2031r1195b2089],
18	of	IN	O	of	_	0	SENT_147	[p9l1224t2030r1301b2089],
19	epidermal	JJ	O	epidermal	amod	22	SENT_147	[p9l1317t2031r1650b2106],
20	growth	NN	O	growth	nn	22	SENT_147	[p9l1678t2031r1919b2106],
21	factor	NN	O	factor	nn	22	SENT_147	[p9l1948t2030r2141b2089],
22	receptor	NN	O	receptor	prep_of	17	SENT_147	[p9l9t2139r297b2202],
23	.	.	O	.	_	0	SENT_147	[p9l9t2139r297b2202],

1	Cancer	NNP	O	Cancer	nn	2	SENT_148	[p9l328t2131r557b2185],
2	Res	NNP	O	Res	_	0	SENT_148	[p9l580t2131r695b2189],
3	2005	CD	DATE	2005	num	2	SENT_148	[p9l722t2131r1316b2198],
4	;	:	O	;	_	0	SENT_148	[p9l722t2131r1316b2198],
5	65:11478	CD	NUMBER	65:11478	number	6	SENT_148	[p9l722t2131r1316b2198],
6	—	CD	NUMBER	—	dep	2	SENT_148	[p9l722t2131r1316b2198],
7	85	CD	NUMBER	85	dep	6	SENT_148	[p9l722t2131r1316b2198],
8	.	.	O	.	_	0	SENT_148	[p9l722t2131r1316b2198],

1	Copyright	NN	O	copyright	_	0	SENT_149	[p9l11t2213r264b2278],
2	©	CD	NUMBER	©	num	6	SENT_149	[p9l289t2218r342b2273],
3	2007	CD	DATE	2007	num	6	SENT_149	[p9l369t2217r504b2263],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_149	[p9l523t2213r906b2263],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_149	[p9l929t2213r1139b2263],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_149	[p9l1159t2215r1356b2277],
7	.	.	O	.	_	0	SENT_149	[p9l1159t2215r1356b2277],

1	EARLY	NNP	O	EARLY	nn	5	SENT_150	[p9l874t2393r939b2409],
2	JOB	NNP	O	JOB	nn	5	SENT_150	[p9l948t2393r989b2414],
3	ALERT	NNP	O	ALERT	nn	5	SENT_150	[p9l1001t2393r1067b2409],
4	SERVICE	NNP	O	SERVICE	nn	5	SENT_150	[p9l1078t2393r1167b2409],
5	AVAILABLE	NNP	O	AVAILABLE	_	0	SENT_150	[p9l1179t2393r1295b2409],
6	AT	IN	O	at	dep	5	SENT_150	[p9l1306t2393r1333b2409],
7	THE	DT	O	the	det	9	SENT_150	[p9l1344t2393r1387b2409],
8	NEJM	NNP	O	NEJM	nn	9	SENT_150	[p9l1401t2393r1456b2414],
9	CAREERCENTER	NNP	O	CAREERCENTER	pobj	6	SENT_150	[p9l1469t2393r1639b2409],

1	Register	NNP	O	Register	_	0	SENT_151	[p9l807t2428r912b2457],
2	to	TO	O	to	aux	3	SENT_151	[p9l920t2433r943b2451],
3	receive	VB	O	receive	infmod	1	SENT_151	[p9l952t2428r1037b2451],
4	weekly	JJ	SET	weekly	dobj	3	SENT_151	[p9l1045t2428r1132b2457],
5	e	SYM	O	e	dep	8	SENT_151	[p9l1139t2428r1218b2451],
6	—	CD	NUMBER	—	num	8	SENT_151	[p9l1139t2428r1218b2451],
7	mail	NN	O	mail	nn	8	SENT_151	[p9l1139t2428r1218b2451],
8	messages	NNS	O	message	dep	1	SENT_151	[p9l1226t2435r1346b2457],
9	with	IN	O	with	_	0	SENT_151	[p9l1354t2428r1410b2451],
10	the	DT	O	the	det	13	SENT_151	[p9l1419t2428r1458b2451],
11	latest	JJS	O	latest	amod	13	SENT_151	[p9l1466t2428r1534b2451],
12	job	NN	O	job	nn	13	SENT_151	[p9l1537t2428r1579b2457],
13	openings	NNS	O	opening	prep_with	8	SENT_151	[p9l1588t2428r1704b2457],
14	that	WDT	O	that	nsubj	15	SENT_151	[p9l845t2465r894b2488],
15	match	VBP	O	match	rcmod	8	SENT_151	[p9l901t2465r979b2488],
16	your	PRP$	O	you	poss	17	SENT_151	[p9l987t2473r1043b2494],
17	specialty	NN	O	specialty	dobj	15	SENT_151	[p9l1052t2465r1166b2495],
18	,	,	O	,	_	0	SENT_151	[p9l1052t2465r1166b2495],
19	as	RB	O	as	advmod	20	SENT_151	[p9l1176t2473r1201b2488],
20	well	RB	O	well	dep	1	SENT_151	[p9l1209t2465r1261b2488],
21	as	IN	O	as	mark	29	SENT_151	[p9l1270t2473r1295b2488],
22	preferred	JJ	O	preferred	amod	24	SENT_151	[p9l1304t2465r1420b2495],
23	geographic	JJ	O	geographic	amod	24	SENT_151	[p9l1428t2465r1570b2495],
24	region	NN	O	region	nsubj	29	SENT_151	[p9l1578t2466r1666b2495],
25	,	,	O	,	_	0	SENT_151	[p9l1578t2466r1666b2495],
26	practice	NN	O	practice	nn	27	SENT_151	[p9l814t2503r913b2532],
27	setting	NN	O	setting	appos	24	SENT_151	[p9l922t2503r1014b2532],
28	,	,	O	,	_	0	SENT_151	[p9l922t2503r1014b2532],
29	call	VB	O	call	dep	20	SENT_151	[p9l1024t2503r1067b2526],
30	schedule	NN	O	schedule	dobj	29	SENT_151	[p9l1076t2503r1193b2531],
31	,	,	O	,	_	0	SENT_151	[p9l1076t2503r1193b2531],
32	and	CC	O	and	_	0	SENT_151	[p9l1203t2503r1249b2526],
33	more	RBR	O	more	conj_and	30	SENT_151	[p9l1257t2510r1330b2526],
34	.	.	O	.	_	0	SENT_151	[p9l1257t2510r1330b2526],

1	Visit	NN	O	visit	_	0	SENT_152	[p9l1339t2503r1397b2526],
2	the	DT	O	the	det	4	SENT_152	[p9l1404t2503r1442b2526],
3	NEJM	NNP	MISC	NEJM	nn	4	SENT_152	[p9l1451t2505r1523b2529],
4	Careercenter	NNP	MISC	Careercenter	dep	1	SENT_152	[p9l1532t2504r1699b2526],
5	at	IN	O	at	_	0	SENT_152	[p9l973t2545r996b2563],
6	www.nejmjobs.org	NNP	O	www.nejmjobs.org	prep_at	4	SENT_152	[p9l1003t2540r1253b2570],
7	for	IN	O	for	_	0	SENT_152	[p9l1260t2540r1297b2563],
8	more	JJR	O	more	amod	9	SENT_152	[p9l1305t2548r1370b2563],
9	information	NN	O	information	prep_for	6	SENT_152	[p9l1378t2540r1537b2563],
10	.	.	O	.	_	0	SENT_152	[p9l1378t2540r1537b2563],

1	73	CD	NUMBER	73	num	4	SENT_153	[p9l149t2676r185b2698],
2	N	NN	O	n	nn	4	SENT_153	[p9l917t2686r931b2701],
3	ENGLJ	NN	O	englj	nn	4	SENT_153	[p9l946t2686r1024b2708],
4	MED	NN	O	med	_	0	SENT_153	[p9l1038t2686r1090b2701],
5	356	CD	NUMBER	356	num	7	SENT_153	[p9l1101t2680r1158b2708],
6	;	:	O	;	_	0	SENT_153	[p9l1101t2680r1158b2708],
7	1	CD	NUMBER	1	dep	4	SENT_153	[p9l1101t2680r1158b2708],
8	WWW	NNP	O	WWW	nn	11	SENT_153	[p9l1194t2686r1395b2708],
9	,	,	O	,	_	0	SENT_153	[p9l1194t2686r1395b2708],
10	NEJM.ORG	NNP	O	NEJM.ORG	appos	11	SENT_153	[p9l1194t2686r1395b2708],
11	JANUARY	NNP	DATE	JANUARY	dep	4	SENT_153	[p9l1426t2686r1538b2708],
12	4,2007	CD	DATE	4,2007	num	11	SENT_153	[p9l1547t2686r1643b2708],

1	The	DT	O	the	det	4	SENT_154	[p9l936t2719r987b2743],
2	New	NNP	O	New	nn	4	SENT_154	[p9l996t2720r1058b2743],
3	England	NNP	O	England	nn	4	SENT_154	[p9l1067t2719r1178b2750],
4	Journal	NNP	O	Journal	_	0	SENT_154	[p9l1187t2719r1284b2743],
5	of	IN	O	of	_	0	SENT_154	[p9l1294t2719r1323b2743],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_154	[p9l1330t2719r1455b2743],

1	Downloaded	VBN	O	download	_	0	SENT_155	[p9l378t2760r548b2783],
2	from	IN	O	from	_	0	SENT_155	[p9l557t2760r621b2783],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_155	[p9l630t2760r748b2790],
4	at	IN	O	at	_	0	SENT_155	[p9l759t2764r782b2783],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_155	[p9l790t2760r973b2783],
6	on	IN	O	on	_	0	SENT_155	[p9l982t2767r1015b2783],
7	January	NNP	DATE	January	prep_on	1	SENT_155	[p9l1023t2760r1126b2790],
8	5	CD	DATE	5	num	7	SENT_155	[p9l1136t2760r1159b2787],
9	,	,	DATE	,	_	0	SENT_155	[p9l1136t2760r1159b2787],
10	2014	CD	DATE	2014	num	7	SENT_155	[p9l1169t2760r1242b2783],
11	.	.	O	.	_	0	SENT_155	[p9l1169t2760r1242b2783],

1	For	IN	O	for	_	0	SENT_156	[p9l1252t2760r1299b2783],
2	personal	JJ	O	personal	amod	3	SENT_156	[p9l1307t2760r1419b2790],
3	use	NN	O	use	pobj	1	SENT_156	[p9l1428t2767r1472b2783],
4	only	RB	O	only	advmod	3	SENT_156	[p9l1482t2760r1546b2790],
5	.	.	O	.	_	0	SENT_156	[p9l1482t2760r1546b2790],

1	No	DT	O	no	det	3	SENT_157	[p9l1557t2760r1597b2783],
2	other	JJ	O	other	amod	3	SENT_157	[p9l1607t2760r1675b2783],
3	uses	NNS	O	use	_	0	SENT_157	[p9l1683t2767r1739b2783],
4	without	IN	O	without	_	0	SENT_157	[p9l1749t2760r1850b2783],
5	permission	NN	O	permission	prep_without	3	SENT_157	[p9l1859t2760r2011b2790],
6	.	.	O	.	_	0	SENT_157	[p9l1859t2760r2011b2790],

1	Copyright	NN	O	copyright	_	0	SENT_158	[p9l728t2801r863b2832],
2	©	CD	NUMBER	©	num	6	SENT_158	[p9l872t2801r896b2825],
3	2007	CD	DATE	2007	num	6	SENT_158	[p9l906t2801r970b2825],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_158	[p9l980t2801r1171b2825],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_158	[p9l1181t2801r1289b2825],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_158	[p9l1300t2801r1405b2832],
7	.	.	O	.	_	0	SENT_158	[p9l1300t2801r1405b2832],

1	All	DT	O	all	det	2	SENT_159	[p9l1416t2801r1457b2825],
2	rights	NNS	O	rights	nsubj	3	SENT_159	[p9l1466t2801r1541b2832],
3	reserved	VBN	O	reserve	_	0	SENT_159	[p9l1551t2801r1670b2825],
4	.	.	O	.	_	0	SENT_159	[p9l1551t2801r1670b2825],

